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Abstract 
The rise in market-approved cellular therapies demands for advancements in process 
analytical technology (PAT) capable of fulfilling the requirements of this new industry. Unlike 
conventional biopharmaceuticals, cell-based therapies (CBT) are complex “live” products, 
with a high degree of inherent biological variability. This exacerbates the need for in-process 
monitoring and control of critical product attributes, in order to guarantee safety, efficacious 
and continuous supply of this CBT. There are therefore mutual industrial and regulatory 
motivations for high throughput, non-invasive and non-destructive sensors, amenable to 
integration in an enclosed automated cell culture system. While a plethora of analytical 
methods is available for direct characterization of cellular parameters, only a few satisfy the 
requirements for online quality monitoring of industrial-scale bioprocesses. 
In the last twenty years, quartz crystal resonators (QCR) have demonstrated a high degree 
of versatility and applicability across different biomedical applications, capable of acting as 
both gravimetric and force balances. The strain induced by micron-sized particles attached 
onto the oscillating quartz causes significant deviations in the magnitude of any odd Fourier 
harmonic responses, as a function of the oscillation frequency and amplitude. This 
transduction principle, named Anharmonic Acoustic Detection Technique (ADT), could 
potentially complement traditional quartz resonators in the study of cell-surface interactions.  
The initial part of the experimental work covered in this thesis investigates the interactions 
between model micron-sized particle with surface-immobilized proteins and the QCR. In a 
coupled oscillator system, the relative amount/density of molecular complexes formed 
between the particle and the resonator, modifies the nonlinear acoustic response measured 
by the third Fourier harmonic of the current. A second part extends the investigation towards 
  
    
 
characterization of membrane antigen expression of cord-blood derived CD34+ 
erythroprogenitors, differentiated down the erythroid lineage. The final contribution of this 
work demonstrates the feasibility of implementing QCR sensors as online quality monitoring 
tools for surface marker profiling and characterization of cell mechanical properties, features 
also appropriate for applications in point-of-care clinical diagnostics.   
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Nomenclature and abbreviations 
 
Symbol/ abbreviation Definition 
PAT Process analytical technology 
CBT Cell-based therapy 
ω Angular frequency (rads.s-1) 
𝑓0 Fundamental resonance frequency 
𝑓𝑛 Fundamental resonance frequency (n is overtone number) 
Ω Ohm (electric resistance) 
β Nonlinearity coefficient of a quartz crystal resonator 
QCM Quartz crystal microbalance 
QCR Quartz crystal resonator 
𝐼𝑛𝑓 Current magnitude at nth harmonic number 
Γ Resonance bandwidth 
DUT Device under test 
PCB Printed circuit board 
NSA Non-specific adsorption 
ø Spherical particle diameter 
MP Microparticle 
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Introduction to Thesis 
Scope 
The work in this thesis has been mainly carried out in the context of the EPSRC-funded 
project “Challenge-Led Regenerative Medicine Manufacturing Research”. The work was also 
supported by the EU-funded Norosensor and RAPP-ID projects.  
 
Objectives 
The overall objective of this work is to investigate the fundamental principles of quartz crystal 
resonators, in particular the anharmonic acoustic response, in order to characterize cell-
surface interactions. This can be broken down into the following objectives:    
1. Define user specification requirements for process analytical tools employed in 
characterization of cell-based product quality attributes (Chapter I); 
2. Define the benefits of quality monitoring based on measurement of morphological 
and mechanical cell parameters (Chapter I);   
3. Characterize particle-surface interactions in a model system, by measuring both 
linear and nonlinear QCR response (Chapter III and IV); 
4. Investigate the effect of different extents of multivalent interactions between a model 
particle and the QCR (Chapter IV); 
5. Investigate the effect of different expressions of cell-membrane antigen on the QCR 
acoustic signal (Chapter VI). 
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Contributions 
The work carried out in this thesis has led to the following contributions: 
• Definition of user specification requirements for sensor technology along with the 
underlying industrial motivations for implementation of in-process quality monitoring 
systems in cell-based therapy manufacturing; 
• Characterisation of a coupled oscillator system via anharmonic acoustic transduction; 
• Analytical method capable of quantifying ligand concentration on the microparticles in 
real-time by also discriminating between stronger (specific) and weaker (non-specific) 
interactions without resorting to extensive sample preparation procedures; 
• A molecular dissociation method relying entirely on acoustic force for portable 
automated sensing; 
• Analytical method for relative quantification of cell-membrane antigen expression that 
could be directly employed in online quality monitoring. 
 
Structure 
• Chapter I introduces cell-based therapies (CBT) along with a brief account of the 
current status of the industry. A second part discusses considerations of process 
analytical technology (PAT) implementation in the context of CBT manufacturing, 
aimed at informing future developments in sensor technology; 
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• In Chapter II, fundamental principles of quartz crystal resonators (QCR) as 
gravimetric and force microbalances are reviewed, along aspects relevant to its use 
and development in biosensing applications; 
• Chapter III evaluates the QCR of nonlinear acoustic behaviour of a QCR, by probing 
microparticle-surface contact mechanics at different amplitudes of surface 
displacement. The methodology presented here provides the backbone of the 
experimental work presented in this thesis; 
• Chapter IV extends from the previous chapter by formulating a nonlinearity 
coefficient that takes into account both energy dissipation and attenuation of 
nonlinear response to improve further discrimination between different types of 
particle-surface interactions.  
• Chapter V describes a novel molecular dissociation assay based on acoustic bond-
rupture. Here the QCR is used as both sensitive device and force actuator, with the 
aim to simultaneously generation and measurement of bond rupture; 
• In Chapter VI, the acoustic response of the quartz crystal resonator is interpreted 
based on the expression of membrane markers and cell morphology as measured by 
flow cytometry analysis of cord-derived erythroprogenitor cells. 
• Lastly, a section summarising the work and contributions thereof, along with 
recommendations for future work in the field.  
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1. Chapter I 
Industrial and regulatory requirements for online monitoring systems in 
manufacturing of cel l-based therapies. 
1.1. Introduction 
The increasing number of commercialised cell-based therapies (CBT) demands for 
expandable processes capable of delivering continuous supplies of safe and affordable 
products [1]. This relatively young field often resorts to tools and strategies from the 
traditional pharmaceutical industry, despite the significant differences in product complexity 
and manufacturing requirements [2]. Chief amongst these is the complexity and variability 
associated with both product and raw materials. Unlike say, small molecule compounds and 
recombinant proteins, CBT may exert a therapeutic effect via multiple mechanisms of action 
(MoA) and possess the capability to adapt in response to their environment [3]. This 
represents a challenge to defining standard design spaces within which measurement 
parameters exist. More importantly, unlike traditional pharma, manufacturing costs represent 
a large portion of the overall cost of CBT products, significantly affecting reimbursement 
strategies.  
Technological advances adopted at early stages of product development can improve quality 
risk management, assuring a safe, continuous and affordable product supply. However, 
despite its advantages, the introduction of innovative solutions to assist quality assurance 
within highly regulated industries, namely pharmaceuticals, can sometimes be regarded as 
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counterproductive and encouraging of greater regulatory oversight [4]. Furthermore, a lack of 
incentive may stem from the fact that manufacturing costs of pharmaceuticals account for a 
very small portion of their overall lifetime costs. Without a high level of product and process 
understanding, high rates of batch rejection as well and low cross-site standard 
comparability are expected. In 2004, the Food and Drug Administration (FDA) released a 
draft guidance encouraging the adoption of process analytical technology (PAT) for design, 
analysis and control of manufacturing, through timely measurements of process and product 
attributes, including raw and in-process materials [5]. PAT thus comprises a collection of 
instrumental, modelling and mathematical tools to ensure consistent “first-time” quality 
during manufacturing via continuous enhancement of product and process understanding. 
To this end, a wide range of tools have been explored within the context of drug 
manufacturing [6].  
The implementation of process analytics in pharmaceutical manufacturing is part of a greater 
initiative termed Quality by Design (QbD). This initiative aims to incorporate a systematic 
approach in product development, supported by scientific knowledge and risk management 
of product and processes. This also entails shifting quality control upstream of the 
manufacturing process and evade the possibility of batch re-processing or rejection, 
applicable to all stages of a product lifecycle. Consequently, in-process testing and controls 
should generate enough data to replace the corresponding end-point testing, defined as 
real-time release testing (RTRT).  
The aim of the work described in this chapter is to present an analysis of both technology 
and regulatory requirements relevant to the development of analytical instruments designed 
for continuous monitoring and release testing of cell-based therapeutics. The aim is to 
provide a set of user specification requirements that can help bridge disciplinary gaps 
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between PAT and CBT developers, as well as regulatory entities. This entails aligning 
existing and future opportunities with the associated technical and translational challenges. 
  
1.2. Overview of cell therapy manufacturing 
In the last decade a number of cell-based therapy (CBT) products have successfully gained 
market entry as a sign of regained mutual support from investors and the general public. 
CBT fit under the therapeutic umbrella of regenerative medicine, also inclusive of medical 
devices (e.g. decellularised scaffolds, tissue inlays, cell suspensions), applied to restore the 
normal physiology of cells, tissues and organs [7]. The current clinical development pipeline 
highlights a potential for CBT to target a diverse range of clinical indications ranging from 
tissue regeneration to viral infections, targeting unmet and low prevalence diseases.  
The source of cellular material splits CBT into two categories: autologous (cells from and 
administered back to the same patient) and allogeneic (from healthy donor used to treat 
many patients) [1]. Non-compatibility between donors can elicit immunorejection while in 
other cases the patient’s own cells may not be suitable or accessible for ex vivo processing.  
In most cases, the therapeutic mechanism of action (MoA) of the cellular component of CBT 
can be generally regarded as secretory. Through direct stimulation of native cells (i.e. trophic 
effect, immunoregulation, immunosuppression) or through restoration of normal tissue 
function/architecture through secretion of extracellular matrix (ECM) components.  
Advances in tissue engineering have also potentiated the development of cellularised grafts, 
providing a solid support and protection for maintenance of in vivo cell function or sustained 
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active ingredient release. Examples with market approval include Apligraf® (Organogenesis), 
MACI® (Verticel) and Osteocel® (NuVasive) as well as PEC-Encap™ (Viacyte Inc., Canada) 
which is still in clinical evaluation. 
As of the time this section was written, only seven cellular products had been approved in 
the EU: Provenge1, ChondroCelect and, MACI , Holoclar, Strimvelis, Zalmoxis and Spherox. 
However, three have been discontinued due to low pre-launch sales [8], [9] while Strimvelis 
has recently secured NICE approval for reimbursement in the United Kingdom [10]. 
Commercialisation of CBT is greatly constrained by relatively high cost of goods (CoGs) and 
labour-intensive procedures. This creates little opportunity for cost-effective, automated and 
high-volume manufacturing2, thus inciting manufacturers to target therapeutic niches with 
more favourable reimbursement conditions [11]. The successful commercialisation of CBT is 
hence tightly linked to the development of novel manufacturing solutions capable of 
delivering a safe, robust and cost-effective supply of these products [12], [13].  
  
                                                
1 Discontinued from May 2015 (EU only) due to commercial reasons. 
2Unless otherwise specified, the term “manufacturing” is hereby comprised of all the steps involved in the 
recovery, processing, storage, labelling, or distribution of any human cell or tissue, and the screening or testing of 
the cell or tissue donor (21 CFR 1271.3(e)). 
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1.3. Regulatory landscape 
1.3.1. European Union (EU) 
Advanced therapy medicinal products (ATMP) are subject to a centralised market 
authorisation procedure overseen by the European Medicines Agency (EMA) Committee for 
Advanced Therapies (EMA), as established by Regulation (EC) No 1394/2007. 
Complementary European Directives 2004/23/EC, 2006/86/EC, 2006/17/EC and 
2001/83/EC set the standards for recovery, screening, testing, processing, storage, or 
distribution of cells and tissues as well as other human medicinal products. Additional 
guidelines on quality control aspects of both ATMP and respective manufacturing processes 
are outlined in CHMP/410869/2006 and CPMP/BWP/3326/99 (xenogeneic). Directives 
instruct national competent authorities in each one of the Member States in the same way as 
the Medicines and Healthcare Products Regulatory Agency (MHRA) regulates all medicines 
and medical devices in the United Kingdom. EC has adopted a “hospital exemption scheme” 
to satisfy unmet clinical needs.  
 
1.3.2. United States (US) 
Manufacturing of biologics in the USA is regulated by the Centre for Biologics Evaluation and 
Research of the Food and Drug Administration. The FDA regulates HCT/Ps according to two 
classifications outlined in the Public Health and Safety (PHS) Act. Section 361 – human cells, 
tissues, and cellular and tissue-based products (HCTP/s) are solely regulated under 21 CFR 
Part 1271 and must be exclusively intended for homologous use, having undergone “minimal 
manipulation”, not combined with other non-cell/tissue components and independent of 
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metabolic activity of living cells unless it is for autologous, blood-related or reproductive use. 
“351” HCTP/s fail to meet these criteria and are thus regulated as biologics according to the 
Investigational New Drug/Device Exemption (IND/IDE) framework. Certain processing steps 
(i.e. in vitro cell expansion) convey the risk of altering relevant biological characteristics of 
cells, referred to as “more-than-minimal” manipulation (21 CFR 1271.3). The FDA is thus 
ready to consider appropriate clinical data and experience indicative that a specific 
processing procedure does not alter relevant biological properties, lowering the level of 
regulation to which the product is subjected as result (FDA, 1997). 
The FDA describes cGMP (current good manufacturing practice) guidelines for 
manufacturing and distribution of biological products in 21 CFR parts 600-680. Products 
containing (or derived from) genetically modified cells are classified as genetic therapy 
products and applicable characterisation release tests may differ from other products in this 
category (i.e. retroviral and plasmid vectors) (FDA, 1998). 
In this context, tissue-engineered products (TEP) may follow under the category of vascular 
organs and minimally manipulated bone marrow which falls outside of the FDA 
supervision[14].  
 
1.3.3. Japan 
Japan pioneers due to governmental-driven initiatives to capitalize on Nobel-prize winning 
induced pluripotent stem cell (iPS) cell technology. Distribution of CBT in Japan is regulated 
under the Pharmaceuticals and Medical Devices Act (PMD Act) and approved by the 
Ministry of Health Labour and Welfare (MHLW). The recently Act on Safety of Regenerative 
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Medicine (RM Act) promises to expedite development and commercialisation of regenerative 
medicine products. Highly probable indications of benefit and safety to the patient 
demonstrated during early clinical research is entitled to conditional marketing approval [15]. 
1.3.4. International harmonisation 
In 1990, regulatory and industrial representatives from the European Union, Japan and US 
initiated the International Conference on Harmonisation (ICH) with the goal of standardising 
safety, efficacy and quality of medicines through a scientific risk-based approach to 
pharmaceutical development and manufacturing. Additional best practices that complement 
cGMP specific to CBT can be found in communications released by the Process and 
Product Development (PPD) subcommittee of the ISCT.  All members of the International 
Conference on Harmonisation have adopted some form of accelerated/adaptive pathway 
that enables streamlining market access of CBT based on demonstration of satisfactory 
phase I/II results.   
1.3.5. Combination devices 
Applicable cGMP requirements will depend on the constituent parts (21 CFR Part 4), 
generally under one single market application. Medical devices are characterized into three 
(or 4 in EU) classes based on the risk to the patient safety and benefit. In the US, the 
therapeutic mechanism of action dictates whether a device is regulated by the Centre for 
Devices and Radiological Health (CDRH), like in the case of skin grafts, or it follows the 
biologics/drug approval pathway, like artificial livers [16]. Regulatory burden is lowered were 
“substantial equivalents” (510k) exist or indeed “Humanitarian Device” Exemption is 
applicable to treat rare disorders with a likely beneficial outcome.   
  
    
Page 23 of 289 
 
1.4. Process flow 
CBT processing is still predominantly batch or fed-batch in nature, carried out in physically 
delimited unit operations that confer the agility required to deal with the possible segregation 
of donor cellular material and low volume manufacturing. Moreover, many unit operations 
are still highly manual and labour-intensive, which gives rise to user variability. Figure 1 
illustrates a generalized process flow map with the different operation steps detailing how 
the cell material is processed from source to patient. The time frame will vary according to 
the products shelf-life.  
Figure 1 Systems and equipment for preclinical and clinical manufacturing of cells. Blue bars span over 
operation units relevant to each of the systems presented. 
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1.4.1. Biopsy  
Initially a donor biopsy is obtained from a tissue source dictated by the target cell type and 
clinical indication. Common tissue biopsies include cartilage, peripheral and cord blood, skin, 
bone marrow and adipose tissue. Chemical and serological tests are carried out at this point 
to evaluate the risk of disease transmission and immunorejection. The eventual likelihood of 
the latter scenario is evaluated by the level of compatibility in human leukocyte antigens 
(HLA) between donor and patient. Although HLA matching is undoubtedly one of the 
heaviest weighing factors, a successful therapeutic outcome is also dependent on additional 
donor characteristics such as age, gender and body mass index. These have been shown to 
affect therapeutically relevant cell attributes, such as proliferation rate and 
immunosuppression [17]–[19]. Managing such inconsistencies in input cell material helps 
formulate the downstream operating space. 
Peripheral blood represents the least invasive route to cellular material and it was only up 
until recently thought to be predominantly consisted of differentiated cells of myeloid lineage 
[20]. In the case of solid tissue biopsies like cartilage and fat, cells are isolated from the 
extracellular matrix (ECM) constituents via mechanically-assisted enzymatic digestion. 
1.4.2. Isolation/enrichment  
A centrifugation step separates cell types according to their respective density such as in the 
case of blood fractionation. Different cell populations can be identified and isolated with 
respect to the expression of panel of surface marker proteins. This is generally carried out 
through magnetic-/fluorescence-assisted cell sorting (M/FACS).  
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The theme of cell isolation/enrichment is central to this discussion and it takes place at 
different process stages. The presence of multiple cell types may lead to undesired 
paracrine regulation in culture conditions, leading to phenotypic changes that fall out of the 
quality target product profile (QTPP). There are however examples where co-culture is 
required, which include the use of fibroblast feeder layers to maintain human embryonic 
stem cells (hESCs) and human induced pluripotent stem cells (iPSCs) [21]. On the other 
hand, some cell-based treatments benefit from mixed cell consortia that facilitate numerous 
MoA phases such as homing and immunosuppression.    
High recovery yields are crucial at this stage as certain cell populations are often found at 
very low numbers in vivo (e.g. ≤0.01% mesenchymal stem cells in bone marrow [22]). Unlike 
monoclonal antibodies, cells cannot withstand the pressures exerted in ultracentrifugation 
and chromatographic filtration. Positive selection strategies include size, density, adhesion to 
plastic and surface marker expression.  
1.4.3. Expansion and activation  
CBT infusion doses require high cell doses (~106-109 cells) depending on the patient weight, 
targeted clinical indication and delivery efficiency. To reach this number, cells proliferate in 
controlled conditions either in suspension (e.g. lymphocytes, HSC) or as surface-adherent 
monolayers (e.g. mesenchymal, fibroblasts). In the particular cases of tissue-engineered 
constructs (TEC), cells are seeded onto a solid framework that confers grafting support 
whilst emulating the three-dimensional structure of the native ECM (reviewed by [23]).  
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Growth medium in cell culture is also supplemented with growth factors and serum (equine 
or bovine) that either help maintain or induce phenotypes. There have been major efforts to 
mitigate the use of serum due to its undefined and variable nature as well as for the potential 
contamination threat it poses (i.e. BSE) [24], [25]. Moreover, limited global supply ramps up 
the cost and threatens to cause disruptions in continuous manufacturing. 
High expansion yields help to achieve high cell doses with the minimum number and 
duration of culture steps. The continuous proliferation burden unexperienced under 
physiological conditions alters the cells metabolic activity and induces replicative 
senescence [26], [27]. An examples is seen with manipulated umbilical cord blood (UCB) 
units where expansion ex vivo before transplantation affects engraftment kinetics [28]. 
Some target indications require cell activation and genetic modification steps, the most 
common example being CAR-T cells. Safer GMP-compliant consistency  artificial antigen-
presenting cells (AAPCs) or antibody-coated magnetic beads helps for activation or with viral 
vectors mRNA electroporation [29]. 
1.4.4. Harvest  
One of the greatest challenges encountered in CBT processing is the development of closed 
automated systems capable of clinical scale harvesting and purification (>10L). The variety 
of cell types and respective handling requirements renders the possibility of universal 
integrated solutions nearly unattainable. The goal is the simultaneous removal separation of 
cells from culture impurities/waste (i.e. serum, viral vectors) without significant losses in their 
number and viability. Depending on lot size, volume reduction can be through differential 
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centrifugation benchtop equipment (Cytomate, Baxter Oncology), to continuous closed 
centrifugation or tangential-flow filtration (TFF) systems [30]. Harvesting cells might happen 
repeatedly throughout the process and even before administration. For these reasons it is 
important to manage not only the workload but any source of cumulative cell damage, 
phenotypic drift and contamination possible. 
Mechanically-assisted short enzymatic digestion frees adherent cells into suspension for 
harvest from a solid substrate (e.g. microcarriers, tissue flask). The proteolytic activity of 
trypsin may change the proteomic surface composition of the plasma membrane and 
prolonged treatment durations might damage cells [31]. Different methods for enzyme-free 
dissociation strategies have been reported that equally facilitate large scale harvesting [32], 
[33]. Miotto et al. (2017) presents an alternative method of cell self-detachment based on 
endogenous MMP expression with the potential applications in continuous bioprocessing. 
1.4.5. Formulation and preservation. 
A final cell suspension in saline solution is dispensed in volumes varying from 0.5 mL to 20 
mL. The choice of containers ranges from intravenous bags to more robust glass vials (e.g. 
Daikyo Crystal Zenith®) depending on the downstream application. That is due to the fact 
that CBT formulations can be stored frozen or cold, or even administered fresh such as in 
the case of Strimvelis. Final product stability may require addition of excipients that provide 
the necessary buffered conditions and preservation. Post-thawing removal of cryoprotectant 
agents such dimethyl sulfoxide (DMSO) prior to transplantation is required whilst retaining 
appropriate cell number and viability. Cprep (Closed Cell Systems) is an example of a close 
systems integrating thaw, wash and reformulation in syringe ready for administration.   
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1.5. Quality and characterisation thereof 
1.5.1. Critical quality attributes and target product profile 
This idea of continuous quality verification (CQV), whereby a process is constantly 
monitored, evaluated and adjusted, helps defining a robust design space (DS) within which 
process adjustments (i.e. drug formulation, scale up) can occur without warranting further 
regulatory oversight [35]. Contrary to traditional pharmaceutical manufacturing, the cell 
therapy industry is characterized by small customized batch production using highly variable 
raw materials (i.e. serum, platelet lysate), creating a volatile manufacturing scenario that 
traditional quality management techniques struggle to adjust to. Moreover the lack of 
standards and product consistency is one of the most important challenge faced in CBT 
processing according to industry key opinion leaders [36].  
At early stages of development, assessing the impact of process parameters and material 
attributes on the final product quality profile is crucial to formulating a GMP-compliant 
manufacturing process. Characterization of starting material and active substances 
(including cellular) helps predicting and controlling process deviations in the form of 
feedback control loops.  
Compliance with testing standards and specifications is important to maintain a level of 
confidence, specifying how medicinal products should be tested prior to release, ensuring 
both safety and efficacy according to the regulatory requirements. This also provides 
common quality standards across different regions, harmonising quality standards of quality 
of both medicines and the substances used to manufacture them. Some examples include: 
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• American Society for Testing and Materials (ASTM). Under the jurisdiction of F04.43, 
standards and recommendations can be found on a variety of cell characterization 
topics including automated colony forming unit assays (ASTM F2944-12) and 
automated cell size and number estimation through Coulter principle (ASTM F2149-
16); 
• U.S. Pharmacopeial convention (see <1046>), as well as European and Japan 
Pharmacopeia conventions; 
• International Organization for Standardization (ISO), namely ISO/TC 194 (Biological 
and Clinical Evaluation of Medical Devices) and ISO/TC 276 (Biotechnology);  
• In the UK, further guidance is provided by regional British Standards Institute (BSI), 
Publicly Available Specifications (PAS) 83, 84 and 93 to provide specifications 
covering cell-based medicinal products regulated as ATMPs or US biologics under 
351 HCT/Ps. 
  
  
    
Page 30 of 289 
 
Table 1 Example of lot-release specifications (Carticel™) adapted from [37]. Bacterial, fungal and 
mycoplasma contamination tested at various points during manufacturing. * LAL - Limulus amebocyte 
lysate (test). 
Specifications Methods Range 
Microbiological Sterility Direct inoculation (72 hr prior to 
assembly). 
No growth by direct 
inoculation. 
Endotoxin LAL* ≤ 3 EU/mL. 
Viability Trypan Blue ≥ 80% dye-
excluding cells. 
Morphology Microscopy examination. ≥ 80% typical 
chondrocyte 
morphology. 
General Safety Test Alternative. 
(Alternative is 3 parts; all criteria 
must be met) 
Trypan Blue. ≥ 80% dye-
excluding cells. 
Microscopic Exam ≥ 80% typical 
chondrocyte 
morphology. 
Elution assay for cytotoxic on 
indicator cells (48-72 hr prior to 
assembly). 
Score of 0: No cell 
death above 
background. 
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In the case of biologics a quality target product profile (QTPP) includes the following CQA:  
• Identity/purity - presence of starting cellular material, phenotype, embryonic body 
formation, adhesion to tissue culture plastic, morphology; 
• Safety – contamination with bacteria, fungi and mycoplasma, endotoxins, viral 
vectors;  
• Potency/Stability – cell number and viability, CFC, CFU-F, migration, proliferation, 
chromosomal stability; 
In 2006, ISCT release a set of criteria released aimed at harmonising standards for 
characterisation of MSCs based on surface marker expression, multi-lineage differentiation 
and proliferation on tissue-culture grade plastic [38]. The suitability of these standards may 
vary depending on tissue source, culture conditions and intended MSC MoA (i.e. 
immunomodulation)[39]. Standards and assays need to address attributes of the final 
intended QTPP. For example, in CAR-T cell manufacturing expression of T-cell markers 
together chimeric antigen receptor enables appropriate identification of viral transduced cells. 
In that respect the clinical efficacy of emerging monocyte-derived dendritic cells therapies, 
such as Provenge®, may be evaluated according to capacity for cross-priming of antigen-
specific CD8+ T cells [40].  
The mechanistic relationship between surface marker expression and identity/potency is 
partly understood[41]. On the other hand, certain cell therapy MoA require multivariate 
analysis which may present a challenge to in vitro characterization, especially within the 
scale and time frame of a typical CBT process. Such mechanisms could include the multi-
lineage differentiation MSCs aforementioned but also iPSC colony morphology, embryoid 
body (EB) formation and post-thawing plating efficiency.  
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Under physiological conditions, cells are continuously stimulated by mechanical forces 
originating from their outer environment (e.g. tension, shear, torsion, compression). A 
synergy of force actuations with spatial-temporal dynamics, creates complex interactions 
that modulate cell-specific behaviours and phenotypes [42]. This is best portrayed by the 
alignment of endothelial cells on the interior wall of blood vessels, parallel to blood flow 
induced by laminar shear stress [43] or the enhanced hESCs osteogenesis of hESCs 
modulated by oscillatory mechanical strain [44]. Mechanical stimuli are perceived by 
membrane mechanoreceptors (e.g. integrins) interacting with homologous proteins present 
on either the extracellular matrix (ECM) (e.g. fibronectin, collagen) or adjacent cells (i.e. 
cadherins) [45]. Transduction of mechanical stimuli (mechanotransduction) progresses 
through activation of intracellular signalling cascades largely mediated by the cytoskeleton. 
These events generally culminate in the regulation of gene expression, leading to phenotypic 
and functional alterations [46], [47]. The study of intracellular molecular events resulting from 
complex mechanical and physical stimuli is referred to mechanomics [48]. Figure 2 
summarizes some of the biochemical and mechanical parameters that could be measured to 
qualify product quality attributes. 
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Genomics
• DNA sequence
• Methylation pattern
• Chromosome 
stability
• Short tandem 
repeat (STR)
Transcriptomics
• RNA expression and 
sequencing
Secretomics
• Enzymes (i.e. metaloproteinase)
• Cytokines (i.e. IL-6)
• Growth factors (i.e. VEGF)
• Volatile organic compounds
• ECM elements (i.e. collagen)
• Exosomes
Metabolomics
• Surface marker 
expression
• Vesicles
• Ion transport
• [ATP], [NADH]
• Metabolites 
(>42,000)
Mechanomics
• Elastic modulus
• Granularity
• Membrane potential
• Membrane integrity
• Charge distribution
• Acoustic wave propagation
F
Figure 2 Examples of biochemical and mechanical parameters used in the study of cell function and identity. 
Metabolites number take from [49] 
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1.5.2. Population heterogeneity 
Independently of the variability source and the level of control, questions remain as to 
whether phenotypic drift arising from microenvironmental differences in manufacturing steps 
is unavoidable [50]–[52]. The level of population heterogeneity in the cellular material 
depends on the original tissue heterogeneity and the specificity of the enrichment step. 
Certain cases of subpopulation heterogeneity and temporal variations in marker expression 
have in fact led to revised immunophenotyping criteria [53]–[56]. This defies the general 
assumption that average measurements of cell populations reflect the dominant biological 
mechanism operating within individual cells in a population. The challenge is to determine 
which components of the measured cellular heterogeneity serve a biological function or 
contain meaningful information. This turns into a particularly sensitive issue from perspective 
of safety. Evidence suggests that low numbers (0.025%) of undifferentiated hESCs can form 
teratoma in vitro which can lead to tumour formation when injected in immunocompromised 
mice [57]. This therefore demands for very sensitive multistep procedures capable of 
removing undifferentiated cells while acceptable recovery efficiencies of target cells. 
This is often seen in the case of persister states within microbial populations of 
Staphyloccocus aureus and Escherichia coli and is linked with capabilities to confer antibiotic 
resistance [58]. Low numbers of dormant stem cells in haematopoietic populations are 
capable of reactivation upon bone marrow injury or in the presence of stimulating factors[59]. 
The topic of heterogeneity within cell populations is carefully analysed by Altschuler and Wu 
(2010).  
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1.5.3. Safety 
Safety is the primary quality assurance concern since possible contamination with 
pathogens and/or other cell sources (i.e. pooling and mixing) could lead to fatal treatment 
outcomes. Moreover, levels of media components such a serum have to be kept at low 
levels (see FDA 21 CFR 610.5b). Sakamoto and colleagues (2007) reported adversary 
antibody responses in patients treated with cell-based therapies cultured in the presence of 
foetal calf serum and that bovine apolipoprotein B-100 is the predominant target of the 
antibody response [61], [62]. Because CBT cannot be sterilized by heat and radiation, 
maintaining aseptic conditions throughout the process avoids contamination  
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1.6. Process monitoring and control 
1.6.1. Design 
PAT is described as a system for designing, analysing and controlling manufacturing through 
timely measurements of critical quality and performance attributes of raw and in-process 
materials [5]. PAT implementation within a cGMP environment has important considerations 
regarding several operational aspects from health and safety to potential environmental 
influences on the system’s performance [63]. Provided a certain level of human intervention 
is warranted, ease of training and use whilst capable of running without human intervention 
would also be beneficial in cases of lack of trained personnel. Sensor life-time will be 
dependent on maximizing operation wear and tear on components that can be easily 
replaced and validated (sample interfaces, fluidics). This is particularly crucial under the 
pretext that many branches of biopharmaceutical manufacturing are increasingly switching 
from conventional glass and stainless steel vessels to disposable, single-use bioreactors 
[64]. Examples include Hyclone™ and Xcellerex XDR (GE Healthcare), BIOSTAT® STR and 
Wave Bioreactor (Sartorius Stedim Biotech) as well as Mobius® CellReady (Millipore). 
Therefore, any sensor component capable of being produced at high volumes will ultimately 
result in an affordable disposable unit capable of being integrated in a closed loop fluid 
system, interfacing with the process without breaching aseptic conditions.  
A noteworthy case study by Codgdill and colleagues (2005) covers various aspects of 
development and implementation of near-infrared (NIR) spectroscopy method to function as 
a PAT tool for real-time release of drug tablets [65]–[67]. 
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1.6.2. Sampling 
In the case of CBT, characterisation would ideally require a low sample volume as well as 
rapid and inexpensive methods in order to lower QC costs and shorten product shelf-life [68]. 
The subject of sampling is a nontrivial aspect of quality monitoring and yet often overlooked 
in R&D. Sampling lots can be categorized in four dimensions based in the special nature of 
the material under test: 0-D (i.e. truckloads), 1-D (i.e. conveyor belt), 2-D (i.e. stratigraphic 
section), 3-D (i.e. reactor) [69]. The effects of cross-sectional as well as longitudinal 
heterogeneity on representative sampling can be minimized by following Theory of Sampling 
(TOS) principles [70]. This includes correct was homogenization (mixing and blending), 
composite sampling, transformation of lot dimensionality, mass reduction and probe location. 
Moreover, the presence of dead volume areas in the fluidic stream may result in suboptimal 
mixing due to stagnation while also trapping impurities. In the case of a bioreactor sampling 
(3-D lot), Esbensen and Paasch-Mortensen (2010) suggests that only upward flux sampling 
with the longest possible upward pipeline segment before sampling co-operated butterfly 
valves is in agreement with TOS and reduces variability through self-mixing caused by both 
gravitational and frictional forces.  
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On- and in-line sampling methods are the more amenable to incorporation into closed 
automated systems. Although a generalized suspension cell culture system is presented in 
Figure 3, sampling may occur at substantially different operation units (i.e. harvest, 
packaging). In the case of adherent cell types both in- and on-line sampling could take place 
during passaging (medium exchange). Each sampling strategy comes with its own benefits 
and shortcomings. At-line and off-line carry a higher risk of contamination and results may 
lag behind sampling to an extent that renders them inapt for feedback control. On the other 
hand, in-line probes are required to be adapted to fit the design of the equipment which may 
represent a challenge to certain low-volume static expansion systems (e.g. T-flasks) [71]. In-
line monitoring is the most suitable solution to avoid breaches in aseptic conditions, although 
Figure 3 Schematic representation of process measurement systems for monitoring of 
process parameters in mammalian cell culture. 
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both sensor and interface need to retain integrity and performance (calibration) upon 
sterilisation and cleaning in place (SIP/CIP). A compromise is found in skid-based 
configurations also enable transportation of analytical instruments into close proximity with 
the process unit, which would be more amenable where continuous or frequent 
measurements are not necessary.  
The frequency of sampling is an important consideration and the right balance takin cost and 
risk into account. Here the use of the term ‘‘real-time’’ measurement indicates the minimum 
amount of time required to carry out process control step based on measurement feedback. 
Since the idea behind continuous process monitoring is to identify failed batches early on, 
quality checkpoints should be based on risk analysis. Figure 5 demonstrates some risk 
factors associated with each unit operation. Tools for risk analysis include failure mode 
effects analysis (FMEA), Pareto analysis and risk ranking (ICH Q9).  
The subject of representative sampling becomes extremely complex in the case of 
cellularised component of TEC, appropriate characterization of fluid mechanics and mass 
and heat transfer in the scaffold can help evaluate the expected degree of sample 
homogenization [72]. 
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Figure 4 Generalised schematics of CBT process flow and potential risk factors associated with the different unit operations. 
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The use of FDA-cleared or approved sterile connecting devices and microporous filters (cut-
off, 0.2 μm) should form the fluidic connections between cell culture vessels, analytical 
apparatus and assay reagents. Continuous use  should also withstand biofouling (deposition 
of proteins, cells and biological material), photobleaching and baseline drift arising from 
exposure to heat and salt precipitation on parts in contact with the sample[73]. In the case of 
non-destructive sampling, sensor constituents and mode of operation must meet standards 
of biocompatibility to avoid product damage (see ISO 10993). 
 
1.6.3. Performance and validation  
ICH’s Q2(R1) and Q6B guidelines cover validation and specifications of analytical 
procedures in for biological and biotechnological products. Validation is required for every 
step deemed critical to the quality and purity of the active product ingredient (API)(MHRA, 
2014). Further guidance can be found in ASTM D6122 – 09 and D3764 – 09, US Ph <1210> 
and <1034> specific to biological assays. Re-validation may be necessary whenever 
changes to chemistry, manufacturing, and controls (CMC) of the product occur [74]. For this 
reason, it is imperative to demonstrate and document how procedure performance 
characteristics meet the requirements for the intended analytical application. The same 
principle extends to ancillary equipment and any data-acquisition-software involved.  
Manufacturers are obliged to validate the test method under actual conditions of use, yet 
data previously obtained to validate the methods performance against the product in 
question must be presented (FDA 21 CFR 211.165(e) and 211.194(a)(2)). This not only 
involves accounting of unexpected changes in biological material but also changes in assay 
reagents (i.e. antibodies, buffers) and potential interference of sample matrix interference. 
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The latter example is the reason for why spectroscopic tools (e.g. near-infrared [75], mid-
infrared [76], Raman [77]) are utilized due to the specificity toward molecular groups that are 
common not found in solvents and formulation excipients (e.g. solvents, excipients) [78].  
Finally, although prior knowledge of product attributes is required for successful validation, 
manufacturers should consider it as an opportunity to increase that same knowledge is line 
with a QbD approach to manufacturing. Moreover, regulatory scrutiny of PAT implementation 
considers around model development, validation, and lifecycle management [63].  
 
1.6.4. Data handling 
The continuous data acquisition and processing demands for controlled and secure 
communication between process analysers. This is particularly important when programmed 
interventions as part of a control loop, where electromagnetic disturbances from other radio-
frequency sources could result in time-delayed transmissions. Requirements for electronic 
records are covered in 21 CFR part 11, becoming relevant to process analysers and other 
PAT tools such as multivariate analysis algorithms. Moreover data management solutions 
are being developed for the pharmaceutical industry such as SIPAT50 and Optimal 
SynTQ51[63]. The FDA has regulated the use of radiofrequency (RF) wireless technology 
(47 CFR Part 15) and published a guidance document outlining safety and efficiency issues 
in relevant to its use in medical devices. 
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1.7. Cost evaluation and impact on business strategy 
Regulatory assessment of PAT tools is expected to delay approval, discouraging 
development and subsequent implementation. The time and resources expenditure 
expected of this activity could also be channelled to the development of new strategies to 
yield regulatory or financial advantages, such as process capabilities (e.g. serum-free culture 
systems). Moreover, high process variability, poor controllability and automatic inspection 
may further discourage process control and value productivity performance [79]. Logic 
follows that PAT implementation during development stages creates a redundancy in its use 
later as process understanding increases as a by-product, leading to better development of 
the process itself. 
In such relatively new industry as regenerative medicine, it may be challenging for both 
manufacturers and investors to initially estimate return on investment, when potential gains 
(e.g. reduced CoGs) arising from enhanced process control cannot be predicted with 
accuracy at early stages of PAT development. Where economies of scale do not apply (e.g. 
autologous), QC can incur up to 50% of CoGs [80]. Altogether characterisation, monitoring, 
CoG and QC-associated costs in cell therapy contrasts with conventional biopharmaceutical 
manufacturing and cell characterisation methods require consideration of technical aspects 
as well as their compliance with cGMP. However, similarly to other challenges in 
biomanufacturing, potential collaborations between industry and academia, under close 
regulatory guidance and IP protection, could help spread cost and risk by pulling resources 
and multidisciplinary expertise, conducting pilot-scale studies on specific cases of PAT 
implementation. Outsourcing development to contract manufacturing organizations (CMOs) 
could de-risk capital and time investment (Shaw, 2014).  
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PAT implementation should take the form of a gradual process where tools are temporarily 
integrated off-line within a manufacturing environment to avoid interference with the cycle 
time of the main line during the ramp-up phase. Once the process is made stable, the 
technologies can be developed as on-line integrated operations. 
 
 
  
Sensor
Design
On-line/ in-line
Wireless communication
Disposable
Re-usable
Analytical performance
Response time
Seneisitivity and specificity
Linearity
Implementation
Staff training
Validation
Approval delays
Standards
Ph. Eur, USP
ASTM E55
ISO 10993
Regulatory requirements
21 CFR part 11, 210, 211
Operation
Automated vs. semi-
automated
Destructive sampling
Sample requirements
Figure 5 Summary of important factors in the development of PAT sensors according to different areas of 
development and implementation 
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1.8. Instrumentation 
Analytical tools for CBT process monitoring have been predominantly inherited from 
recombinant protein production. The impact of parameters such as pH, oxygen tension, 
temperature, biomass and off-gas composition in cell homeostasis is well characterized [2]. 
Systems like Micro-24 miniature bioreactor system (Pall) and ambr miniature bioreactors 
(TAP Biosystems) demonstrate how far sensor miniaturization has reached to enable scale-
out process control. Further advancements in inline optical reading of process parameters, 
like PreSens Shake Flask Reader (SFR) system (Precision Sensing GmbH) and 
SENSOLUX stand-alone version (Sartorius Stedim Biotech). Their application is still 
predominantly confined to monitoring of fermentation processes and their performance in a 
cGMP context is yet to be evaluated. As refereed previously, spectroscopy tools have also 
been thoroughly used in the context of bioprocess monitoring, owing to their non-destructive, 
non-invasive and reagent-free nature [81]. The diagram presented in Figure 6 summarises a 
wide breath of commercially available analytical instruments employed in analysis of cell or 
process parameters, according to a categorization based on the transduction principle – 
electromechanical, optical and acoustic impedance. 
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Figure 6 Commercially available analytical instruments used categorized against CQA addressed. Blue lines represent measurement of medium parameters while red lines 
denote direct measurement of cell parameters. Generated in MindJet MindManager 15. 
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The most candid example of single-cell analysis is found in fluorescence-activated-cell-
sorting (FACS). In a conventional flow cytometry setup, particles are aligned into a single file 
via hydrodynamic focusing, enabling direct analysis of individual cells (events). As the 
particle travels through the stream, an incident laser beam is focused on the flow cell, 
interrogating parameters such as probe fluorescence, absorption and scattered light at a 
single-cell level (Figure 7). The light emitted/transmitted is filtered and finally collected by 
sensitive photodetectors [82]. Forward scattered (0.5-20o of laser beam axis) is often 
correlated with cell size, although it can also be modulated by other parameters such as the 
cell’s refractive index. Side/orthogonal scatter (SSC) (~90o of laser beam axis) is in turn 
related to the cellular granularity. 
 
 
Figure 7 Schematics of flow cytometry showing a single-cell 
interrogation of light scatter and fluorescence intensity from 
membrane-bound probes (e.g. antibodies, aptamers). 
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High-end flow cytometers offer throughput speeds of up to 50,000 particles per second, 
capable of simultaneous measurements of up to 50 fluorophores (organic dyes or quantum 
dots), as well as other 19 optical parameters relating to cell size, morphology and granularity 
[83]. Even though such features are highly valued in R&D and clinical diagnostic labs, they 
increase instrument complexity to an extent that renders FACS incompatible with process 
monitoring requirements. With respect to cell sorting capabilities, the efficiency and 
specificity of this method is dependent on the existence of appropriate antibodies for the 
target combination of markers [84]. Furthermore, there are certain limitations when 
combining multiple fluorophores (measuring multiple surface markers) relating to fluorescent 
crosstalk due to spectra overlapping [85]. Mass cytometry addresses this limitation by 
staining the cells with antibodies tagged with heavy metal isotopes which can then be 
separated according to their mass-to-charge ratio in a time-of-flight mass spectrometer [86], 
[87].  
Finally, the standard isolation processes involved in F/MACS are not considered sterile and 
further testing concerning sterility of the product may be required for implementation in 
online bioprocess monitoring [88].  
1.8.1. Microelectromechanical systems (MEMS) 
Developments in microelectromechanical systems (MEMS) design and fabrication have led 
to innovative solutions that facilitate high throughput cell screening, integrating speed, 
accuracy and reproducibility into conventional benchtop assays (e.g. real-time polymerase 
chain reaction) [89]. Moreover, MEMS also provide reproducibility, reduction of reagent 
consumption, automation, parallelization, precision and multiplexing capability required 
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within a point-of-measurement context (El-Ali, Sorger, & Jensen, 2006; Adam K White et al., 
2011). Some examples of commercially available platforms integrating full process flows for 
single-cell genomic analysis, can be found in C1 single-cell Auto Prep System (Fluidigm, US) 
and DEPArray NxT (Menarini Silicon Biosystems, US). Government-led initiatives like 
Japan’s Single-Cell Surveyor, the International Human Cell Atlas and NIH (US) $2M to 
support single cell profiling materialize the importance of sensor development in this area. 
Moreover, future MEMS advancements nature could drive the development of low cost 
smart packaging with integrated sensors [92].  
The future of mechanobiology has been previously referred to in Section 1.5 as holding the 
promise for rapid and more informative cell identity and potency assays [48]. Such gap for 
rapid and more informative analytical methods is driving the new generation of point-of-care 
diagnostics based on mechanical cell properties [93]–[95]. A recently published study by 
Guzniczak et al., (2017) demonstrates tracking of in vitro maturation of hematopoietic stem 
cells (CD34+) based on single-cell hydrodynamic deformation. The technique enabled 
differentiation between enucleation stages thereby offering simultaneous cell sorting and 
analysis capabilities. In fact several additional examples of single-cell hydrodynamic 
deformation methods can be found for both pathologic [97], [98] and physiologic cell states 
[99], [100]. Finally, methods have been reported capable of high throughput and rapid 
screening of other mechanical parameters, including dielectrophoresis [101], [102], acoustic 
impedance [103] and electric impedance [104]–[106]. In the context of high throughout, 
single-cell level mechanic characterization, MEMS integrate both actuator and transducer 
elements, providing quantifiable force stimuli to cells while simultaneously measuring the 
response. Several examples of MEMS development are discussed throughout this work but 
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the author would like to refer the reader to the work of Loh and colleagues for a more in-
depth discussion[107]. 
Finally, in the case of tissue-engineered constructs, development of compact and purpose-
built magnetic resonance imaging (MRI) setups could enable informative and non-invasive 
measurements of both scaffold and cellular components simultaneously. After all, the use of 
MRI for post-engraftment evaluation of tissue integration and potential signs of 
immunorejection is well established [108]. Moreover, research into biocompatible tags has 
led to MRI signal resolution capable of capturing a multitude of parameters relating to 
cellular activity including apoptosis and gene expression[109]. 
1.8.2. Biosensors 
Analytic methods in biosensor development can be broadly categorized into three basic 
groups according to their underlying transduction principle – optical, acoustic, 
electrochemical and thermal. Like FACS, some transduction principles require samples to be 
first labelled with a reporter molecule, such as a fluorophore, quantum dot or an enzyme 
substrate. The reporter is in turn attached to a recognition element such as an antibody, with 
affinity towards the target of interest (e.g. cell surface marker, glucose). The combination of 
reporter and recognition element is referred to as “label”, “probe” or “tag”, and it signals the 
presence of the analyte of interest in the sample. Labelling samples prior to detection is 
considered to be a laborious, costly and often highly-skilled process, which is does not agree 
with the high levels of throughput and automation required for applications such as POC 
detection or online process monitoring [110]. These applications require fast turnaround 
times designed to obtain timely information that could direct treatment options or process 
changes. Label-free methods should therefore aim to deliver real-time measurement of 
  
    
Page 51 of 289 
 
unlabelled samples at a level of throughput appropriate for the application in question.  
provides a summary of a subset of studies employing label-free analytic methods for 
characterization of cell-surface interactions.  
The following sections review a selection of surface-sensitive methods employed to study 
cell-surface interactions and cell morphology via microscopy/interferometry methods. The 
aim is to provide the reader with contextual information rather than an in-depth review of the 
transduction principles.
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Table 2 Brief review of optical and electromechanical transduction methods implemented in the study of cell identity/function.  
Cell type (species) Culture Technology Object of interest References 
L929 fibroblasts (mouse) Adherent QCM Polymer–cell interactions [138] 
DH82 macrophage (dog) Adherent QCM 
Cytotoxicity induced by single-walled carbon nanotubes (SWCNT) 
cytotoxicity 
[144] 
NIH3T3 fibroblast (mouse), HS 483.T 
fibroblasts (human) 
Adherent QCM Cell-adhesion to collagen and fibronectin [141] 
Jurkat T lymphocyte ,  K-562 lymphoblast 
(human) 
Suspension QCM Cell adhesion mediated by protein–carbohydrate interactions [146] 
Thyroid epithelial cells (human) Adherent QCM Cell-substrate interactions [147] 
B-lymphoblastoid LG2 (human) Suspension SAW Cell-membrane interactions [148] 
Ovarian surface epithelium, mesothelial 
cells (human) 
Adherent SPR Exosome surface proteins screening [149] 
Primary mouse embryonic fibroblasts 
(human) 
Suspension Mass cytometry Progression analysis of cellular reprogramming [150] 
MCF-7, HeLa (human) Suspension SAW device Acoustic separation of circulating tumour cells (CTC) [103] 
HEK-293 (human) Adherent SPR Real-time monitoring of chemical-induced cell morphology [151] 
Adipose-derived stem cells Adherent ECIS Changes in cell membrane capacitance induced by differentiation [104] 
MCF-7, HCT116, and 
PC3 (human) 
Adherent QCM, ECIS, CV Specific cell number detection on aptamer-modified electrode [152] 
Mesenchymal stem cells (human) Adherent  ECIS Neural differentiation  [153] 
HeLa and H9c2 (human) Adherent Digital holography microscopy Cytotoxicity-mediated morphological changes  [154] 
Airway smooth muscle; endothelial cells 
(human) 
Adherent 
Fourier-transform traction 
microscopy 
Cell contractile force [155] 
Red blood cell (human) Suspension/Adherent Optical tomography Morphological, chemical (hemoglobin content) and mechanical parameters [156] 
Fibroblast (human) Adherent Interferometry Cell viscoelastic properties  [157] 
QCM- Quartz crystal microbalance; SAW- Surface acoustic wave; SPR- Surface plasmon resonance; ECIS – Electric cell-substrate impedance spectroscopy; CV – Cyclic voltammetry.
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1.8.3. Electrical Impedance Spectroscopy (EIS) 
Often referred to as electric-cell substrate impedance spectroscopy (ECIS) in this context, 
electrical impedance spectroscopy is a technique that measures the electrical impedance of 
cells in contact with a conductive substrate. Commercially available ECIS apparatus include 
xCELLigence (Roche) and Model 100/1600R (Applied BioPhysics Inc.), founded by Nobel 
laureate Ivar Giaever and Charles Keese, who co-invented the technology. 
ECIS has been mostly employed to monitor attachment, growth and spread of cells on 
conductive substrates in response to administered compounds. As cells attach, spread and 
multiply on a surface separated by two electrodes (d≈250 µm), fluctuations on the applied 
alternated potential (≈1 µA, 1-40 kHz), enable the characterization of cell-surface and cell-
cell interactions based on complex impedance (Z) [111], [112]. This technique has been 
implemented in the study of cell proliferation and differentiation [104] and cytotoxicity [113]. 
The phospholipid bilayer displays the properties of passive electronic components (resistor 
and capacitor), polarizing cell membranes and thus impeding current flow [114]. This is the 
same principle underpinning dielectrophoretic cell sorting which has also been used for [115], 
[116]. When the electrode surface is fully covered with cells, small fluctuations in the 
electrical signal are caused by cellular micromotion, a characteristic of particular importance 
in the study of malignant cells [117]. As a function of frequency, complex electrical 
impedance can provide information at different structural levels, from molecular (>1 GHz) to 
cell-membrane (<100 Hz). At even lower frequencies, at the so called β-dispersion region, 
EIS is able to provide information relative to the cellular arrangement and spacing which has 
been already adapted for characterization of neoplastic tissue [106], [114].  A relevant 
example in the context of cytomechanic characterization includes the recent work by El 
Hasni et al (2017), which describes an EIS method to assesses the integrity of the zona 
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pellucida of an oocyte, an important success indicator of in vitro fertilization (IVF) treatments. 
Several EIS studies have reported the use of microelectrode arrays for single-cell EIS 
measurements [105], [118]–[120]. 
1.8.4. Surface Plasmon Resonance (SPR) spectroscopy 
In SPR spectroscopy a noble metal film (~50 nm thick) deposited on a glass plate is 
irradiated from the bottom with a polarized light. At a given angle of incidence (resonance 
angle) the light induces oscillation of the metal free electrons (surface plasmons) generating 
an evanescent electromagnetic wave that propagates into the sample medium. The angle of 
the reflected light is dependent on the extent of the plasmon resonance, which in turn is 
modulated by the optical density of the sample medium. In this way, kinetics of the 
biomolecular interactions at the metal surface are monitored in real-time as the amount of 
adsorbate increases. For example, in a conventional SPR setup a change of 0.1o in the 
reflectance angle corresponds to of a surface mass density of 1 ng.mm-2 protein [121]. The 
high mass sensitivity of SPR has been widely explored to determine kinetics of biomolecular 
complex formation. A modified version called SPR imaging (SPRi), compatible with high-
throughput screening applications, is capable of scanning an array of localized chemistries 
(spots) on a single metal surface. In a similar way SPRi could be used to assess cell 
morphology based on two-dimensional refractive index distribution of the sensor surface 
when imaged by a charge-couple device (CCD) camera. Horii and colleagues (2011) real-
time imaging of individual tumour cells on a commercial 2D-SPR imager, enabling detection 
of changes in cell contact area induced by antigen stimulation  [122].  
Although SPR systems such as Epic® system (Corning) and BIND© technology (SRU 
Biosystems) have been successfully commercialized for cell-based assays, the study of cell-
surface interactions is a niche research area. As cells attach and spread on the 
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biofunctionalized metal film, the refractive index of the plasma membrane changes the signal 
response [123]. Conventional setups generate an evanescent electromagnetic field with a 
penetration depth of a few hundred nanometers (100-200 nm), significantly smaller than 
typical cell dimensions. In long-range SPR (LRSPR) spectroscopy, the metal film is 
embedded between two dielectric materials with similar refractive indices with the surface 
plasmons propagating along opposite interfaces [124]. This enhances the intensity of the 
electromagnetic wave by an order of magnitude and thereby increasing the sensitivity of the 
technique to cell coverage [125]. Yang et al (2014) reported for the first time a LRSPR 
system capable of detecting cellular micromotion [126]. In contrast, this is something that 
had been achieved with ECIS over a decade earlier [111], [127].  
Finally, LRSPR can also be used in imaging mode although to the author’s knowledge there 
are no studies reporting intercellular resolution imaging, even though this has been 
previously hypothesised [123]. Mammalian cells are intrinsically heterogenous, with a 
difference in refractive index between the membrane and the cytoplasm of 0.1 units, for 
example, so one can expect these differences to be detected in this case. LRSPR imaging 
has however been developed to study spatial-temporal variations in protein secretion of a 
single cell, detected by an array of lithographically-patterned gold plasmonic nanostructures 
on the SPR sensor surface [128].  
1.8.5. Acoustic wave devices 
Piezoelectric resonators are used as precise frequency references of important application in 
clocks and telecommunications. The technology was first patented at Bell Telephone 
Laboratories in 1918, thirty-eight years after piezoelectricity had been first discovered by 
Pierre and Jacques Curie [129]. Certain materials acquire electrical charge when under 
mechanical stress. Conversely, under an electrical potential, the same materials undergo 
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reversible crystal lattice polarization, a phenomenon termed inverse piezoelectricity. 
Piezoelectricity occurs in many anisotropic materials whose internal structures lack a centre 
of symmetry. These materials include quartz (SiO2), lithium tantalite (LiTaO3), lithium niobate 
(LiNbO3), sapphire (Al2O3), Aluminium nitride (AIN) and zinc oxide (ZnO2) [130].  
Most acoustic wave devices rely on the piezoelectric properties of quartz crystals to detect 
changes in mass, density, and viscoelasticity of fluids (gases and liquids) [131]. They can be 
classified into three groups according to the respective mode of wave propagation: Bulk 
Acoustic Wave (BAW), Surface Acoustic Wave (SAW) and Acoustic Plate Mode (APM) 
devices. The latter two examples can be further categorized into Surface Generated 
Acoustic Wave (SGAW) devices. In this case, generation and detection of longitudinal 
acoustic waves on the piezoelectric substrate is carried out with interdigital transducers 
(IDTs) [132]. On this matter, the author invites the reader to refer to the work of Fu and 
colleagues (2017) which presents a wide review of acoustic wave devices. 
Quartz crystal microbalance (QCM) is arguably the most widely-known type of BAW device 
in biosensor applications, stemming largely from its simple and inexpensive operation. QCM 
devices operate at resonance frequencies of about 5–20 MHz and it is designed according 
to a general configuration of a thin quartz disk crystal, cut from mineral quartz at a 35.25o 
orientation to its optical axis (AT-cut), sandwiched between two gold electrodes. The type of 
cut specifies the mode of oscillation and in the case of QCM resonators undergo thickness-
shear displacement (TSM) when excited by an alternating electrical potential. The electrodes 
are deposited by electron-beam evaporation or sputtering onto a titanium, chromium or 
nickel substrate, acting as adhesion between gold and quartz. Furthermore, unlike standard 
SGAW devices, shear acoustic waves have low attenuation and more energy is conserved 
in the resonator.  
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Arrays of quartz resonators can be fabricated in array fashion on a single (monolithic) quartz 
substrate, enabling different surface chemistries and/or frequencies in a single setup [134], 
[135]. Moreover since these are all fabricated on the same substrate, their frequencies would 
be closely matching. This could also improve mass sensitivity by cancelling out the 
environmental and matrix effects, thus decreasing noise and nonspecific interactions at the 
sensor interface [136], [137]. 
Similarly to SPR and ECIS, several studies using anchorage-dependent cell lines have been 
carried out with commercially available QCM platforms to monitor energy dissipation (Q-
sense, Biolin Scientific). The majority of QCM studies in this area have targeted adherent 
cell types, which naturally interact with bioactive surfaces via glycoproteins present on the 
outer part of the plasma membrane. Spreading and mobility of adherent cells, monitored via 
oscillation frequency and energy dissipation, has been looked at with interest in cytotoxicity 
[144], cellular activation [158], tumour cell screening [146], [147], [159] and paracrine 
signaling [160] and in-line cell growth monitoring [161].  
During oscillation, energy is dissipated due to the oscillatory motion induced by internal 
friction in the cell membrane and cytosol. This is particularly prominent at low drive 
frequencies where the effect of mass loading is significantly overshadowed by that of 
viscosity [268]. A viable solution to this problem is simultaneously monitoring energy 
dissipation (ΔD) as a function of resonance frequency as reported by Watarai et al. 2012 
when trying to differentiate between three stages of material-cell interactions. Cell coverage 
of quartz crystal correlates linearly with changes in resonant frequency, as cell population in 
contact with the electrode reaches confluence (Janshoff, Wegener, Sieber, & Galla, 1996; 
Saitakis & Gizeli, 2012). Cytoskeletal changes have also been studied in response to 
cytomorphic drugs [141], [142], growth factors [143] and cytotoxic materials [144]. Chung et 
al. 2012 quantified adhesion of fibroblasts onto the surface of TSM crystal, coated with 
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different combinations of biopolymers. Frequency shifts associated with cells adherence 
(change in mass) was compared to more standard and laborious cell-counting or cell viability 
assay (MTT or MTS).  
1.9. Discussion and Conclusion 
The increasing number of market-approved cell-based therapies demands for in-process 
characterization of cell quality attributes in an effort to reduce the risks associated with 
supply, cost, safety and efficacy cell-based therapeutic products. In this chapter a number of 
aspects related to implementation of process analytical technology were discussed, while 
providing an overview of manufacturing of cell-based therapies. Destructive methods are 
commonly used to study important cellular processes and phenotypes, either via direct 
staining of cellular structures (e.g. von Kossa staining) or by studying cell components (e.g. 
Western blot, FACS). These methods however lack the flexibility and speed required for 
release testing and process control, suggesting that CBT manufacturers along with 
regulatory and standards authorities, ought to consider alternative CQA. In line with 
developments in POC diagnostics, mechanic and morphological parameters could be 
exploited as proxy parameters, provided there is an underlying mechanistic relationship with 
relevant biological processes.  
Several analytic methods capable of characterising cellular mechanic and morphological 
parameters were reviewed in this section within the context of processes relevant to CBT 
manufacturing, like multilineage differentiation with ECIS, blood genotyping with SPR and 
cell viability with QCM. These methods provide direct label-free measurements which 
significantly reduce the extension of human intervention and, as result, decrease the need 
for skilled and time-consuming sample preparation procedures. These methods have been 
further enhanced via integration with microelectromechanical systems, conferring high-
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throughput as well as low sample volume and handling requirements. This facilitates 
analysis of large sample sizes within a time frame where process changes and early batch 
rejection could occur. Ultimately implementation of PAT within CBT manufacturing would 
facilitate a safe, efficacious and continuous supply of CBT at reduced costs.  
Acoustic wave devices, namely QCM, are the main focus of this work as they can 
simultaneously act as force transducers and actuators. Despite being predominantly used for 
microgravimetric measurements, QCM has found applications in cell biology studies through 
measurement of dissipative energy losses induced by the viscoelasticity of cells. Moreover, 
thickness-shear mode vibration is a prerequisite for low loss operation in liquids and the 
viscoelastic nature of the cell membrane is predicted to further contribute to this effect. The 
principle of QCM operation and startegies for enhanced sensitivity and applicability in the 
context of CBT manufacturing will be covered in the following section. 
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2. Chapter II 
Quartz crystal resonators: analysis of operation and applications in biosensing . 
 
2.1. Introduction 
Quartz crystal resonators (QCR) have been widely used for label-free quantification of 
biomolecular interactions [198], [269], leading to the development of commercial platforms 
operating at a range of frequencies (5–20 MHz) with interchangeable flow modules and 
automatic data acquisition. Popular commercial apparatus include Q-Sense (Biolin Scientific) 
and Attana A100® C-Fast (AttanaAB), as shown in Figure 8.  
The objective of this section is to review the fundamental principles of QCM operation, 
including advancements in hardware and theoretical models that support measurement 
analysis. Attention is also given to methods and developments in biochemical interfaces and 
thermodynamic analysis relevant to QCM operation. Finally, this section introduces the 
concept of anharmonic acoustic transduction, which underpins the experimental component 
of this work. 
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Figure 8 Exemplars of commercialised QCM instruments. On the left Q-Sense Pro (Biolin Scientific) and on the 
right Attana Cell™ A200 System (Attana AB). Permission to include these images was granted by the respective 
brand representatives. 
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2.2. 
2.2. Quartz crystal microbalances 
2.2.1. Principle of operation 
Cyclic shear tangential deformation of the quartz crystal lattice propagates an acoustic wave 
through the bulk of the crystal, with antinodes situated at the opposite electrodes (Figure 9). 
The crystal resonance frequency at any given harmonic order (𝑛), can be found through the 
shear acoustic wave velocity (𝜈), expressed as √
μq
ρq
  - 3328 m/s for AT- cut quartz - and the 
thickness (𝑡𝑞) of the crystal substrate, expressed as: 
𝑓n =
nν
2tq
 (1) 
Where, ρq is density of quartz (2.648 g.cm
-3), μq is the shear modulus of quartz (2.947x10
11 
g.cm-1.s-2). Since the electrodes are antinodes of the acoustic wave, only odd integer 
overtones (n = 1,3,5, … ) can be excited [162].  
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The mass-sensitive behaviour of QCM can only measure the contribution of uniform and 
rigidly attached thin-film deposits (height below penetration depth). In this context, a 
biomolecular complex can be described as a point mass (ligand) connected by a linker 
rigidly attached to the crystal. The resonance frequency of the attached particle (𝜔𝑝) 
depends on the stiffness of the link, mechanically represented as a Hookean spring of 
stiffness (k), and a dashpot with a drag coefficient (ξ) [163]. These elements represent 
storage and dissipation of oscillation energy by the particle-link system, respectively. 
Following Sauerbrey (1959) relation, deposited rigid uniform films represent an extension of 
the resonator’s own thickness, hence their  linearly proportional to the change in resonance 
frequency as given by: 
Figure 9 Schematics of a quartz crystal resonator vibrating in thickness-shear 
mode driven by a sinusoidal potential (Vf). 
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Δ𝑓 = −(
2n𝑓0
2
A√ρqμq
) ∙ Δm (2) 
where 𝑓0 is the fundamental resonance frequency of the unloaded crystal and 𝐴  is the 
effective electrode area. The latter parameter is not easy to derive and often it does not 
necessarily correspond to the actual electrode due to the effect on energy trapping.  Details 
of its approximate calculation can be found in Arnau (2008). The term in brackets in 
Equation 2 represents the sensitivity factor (Cf) and it is purely dependent upon the quartz 
crystal properties. Because of this fundamental relationship between the crystal properties 
and mass coupling, this type of sensor does not require any calibration. The effects of 
specific mass coupling are isolated from the contribution of liquid loading by establishing a 
reference (baseline). The additional contribution of liquid loading at the electrode interface 
changes the resonance frequency of the crystal [166], [167]. This is predicted by Equation 3, 
where ρl and ηl are the respective density and viscosity of the liquid layer in contact with the 
electrode.  
Δf = −𝑓0
3
2
√
ρlηl
πρqμq
 (3) 
Mass sensitivity of QCM is expressed in Hz.ng-1·cm2, that is, the absorbed mass per unit 
area required to change the resonance frequency by 1Hz. The detection limit of a 
conventional QCM sensors is 100 ng.cm−2 which is significantly outperformed by that of most 
advanced surface plasmon resonance setups (10 pg.cm-2) [168].  
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Impedance (or network) analysers sweep a range of frequencies close to resonance and 
measure the electrical admittance. Resonance frequency (ƒ0) is in this way characterized as 
the point when the frequency of the sinusoidal excitation potential matches that of the 
fundamental frequency, presenting least resistance to current flow (maximum admittance). 
 The series resonance frequency and the full width at half max (bandwidth) are obtained by 
fitting the admittance spectrum to the Butterworth-Van Dyke (BVD) equivalent circuit, 
describing the behaviour of unloaded QCR operating near resonance. The acoustic branch 
is composed of three parameters: the motional capacitance (𝐶𝑚), representing the stored 
oscillation energy due to crystal elasticity, motional resistance ( 𝑅𝑚 ) corresponding to 
dissipation of acoustic energy to the medium and mounting structures (i.e. fluidic cell, O-ring). 
The third parameter, motional inductance (𝐿𝑚), represents energy storage due to inertial 
effects of mass displacement. The electrical branch of the BVD contains a parallel 
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Figure 10 Butterworth-Van-Dyke equivalent circuit and admittance spectrum of a 14.3MHz QCR around 
resonance with one electrode immersed in water (a). Real (conductance) and imaginary (susceptance) 
parts of admittance (b). The resonance frequency is determined as the maximum conductance (real part 
of the admittance) or at the zero-crossing frequency of susceptance. 𝜖22 and  2 correspond to dielectric 
and piezoelectric constants of an AT-cut quartz crystal, respectively. 
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capacitance (𝐶0), termed shunt capacitance, accounting for the dielectric energy stored sue 
to the generated electric field (Figure 10a) [129], [169]. The term 𝛤 is the bandwidth or full 
width at half maximum (FWHM) of the admittance spectrum [129]. 
Resonance parameters can also be interrogated with short radio-frequency-pulse (RF pulse) 
excitation of a frequency that closely matches resonance (opposed to broadband sweep). In 
this approach, named ring-down, the amplitude decay rate of the freely oscillating resonator 
is obtained by fitting the current-versus time trace with a decaying cosine. Most QCM cell 
studies look at energy dissipation using commercially available QCM-D (Q-Sense), operating 
on ring-down. This method has a faster data acquisition rate than impedance analysis while 
at the same measurement of acoustic parameters on a free oscillating is not interfered by 
the supporting electronic network [129].   
𝑄−1 = 𝐷 =
2𝛤
𝑓
 (4) 
Energy dissipation (D) is a dimensionless quantity defined as the ratio of energy lost and 
energy stored in the system during oscillation. The propagation of the acoustic wave into the 
liquid layer in contact with the resonator is characterized by a standing wave with 
exponentially decaying amplitude and penetration depth (𝛿), given by: 
𝛿 = √
𝜂𝑙
 𝑓𝑛 𝑙
 (5) 
The penetration depth is defined as the distance over which the acoustic wave decays to 1/e 
(~37%) of its maximum intensity. In the case of a 14.3 MHz AT-cut quartz crystal in water, 𝛿 
is approximately 150nm. 
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2.2.2. Improving sensitivity 
From Equations 1 and 2, it can be deduced that the sensitivity of QCM is inversely 
proportional to the square of the resonator thickness and inversely proportional to the 
effective electrode area (A). Because reducing the sensing area causes the amount of 
adsorbed proteins to decrease, efforts to improve sensitivity have been mainly focused on 
decreasing the oscillator’s thickness, thus increasing its fundamental resonance frequency. 
Alternatively, working with overtones requires appropriate band-pass filters, a strategy to 
overcome significant attenuation in liquid and interference of anharmonic side bands with 
fundamental resonance at high overtones (Goka, Okabe, Watanabe & Sekimoto, 2000).  
High fundamental frequency (HFF) quartz crystals require an inverted mesa design, which 
requires thinning of the central area of a quartz crystal substrate, leaving a thicker and more 
rigid surrounding frame. This confers mechanical stability and facilitates handling of a 
resonator, which would otherwise be too fragile to withstand the mechanical pressure that 
would experience when mounted [171]. Understandably, there is a limit to the minimum 
obtainable quartz thickness and other strategies must be explored.  
FBAR devices are able to operate at a fundamental resonance frequency within a range of 
sub-GHz to tens of GHz. Contrary to QCM, FBAR devices are comprised of a thin (~1-7 µm) 
film of piezoelectric material, typically of aluminium nitride (AlN) or zinc oxide (ZnO), 
sputtered on a silicone substrate. When compared to quartz, these piezoelectric materials 
have higher acoustic velocity, lower acoustic loss and higher electromechanical coupling 
[172]. The latter parameter is a measure of the energy conversion efficiency of a 
piezoelectric substrate [173]. 
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This type of BAW device was first described in the early 80s, although the longitudinal mode 
of operation rendered it unfit for biosensing applications due to high-loss operation in liquid 
[174], [175]. A novel method developed by Bjurström and co-workers enabled reactive 
sputter deposition of highly textured AlN thin films with uniform tilted c-axis was that enabled 
shear mode vibration [173]. The resonator must be isolated from the substrate completely or 
else the acoustic waves generated by the piezoelectric film will radiate into the substrate, 
leading to no standing waves and hence no resonance. For this reason different designs 
have been proposed for energy confinement of the acoustic wave using a supportive 
substrate with an air cavity (e.g. back-trench membrane) [176]. On the other hand, solid 
mounted resonators (SMR) trap acoustic energy by supporting the resonator on an acoustic 
mirror structure (e.g. Bragg reflector), composed of alternated layers of high and low 
impedance materials, each half the thickness of the piezoelectric film [177]. The resonator 
can also be supported on a low-impedance polymer layer, enabling simplification of the 
fabrication process in irregular surfaces [176]. 
  
Figure 11 A schematic of a solidly mounted resonator (SMR). In red is 
represented the c-axis angle of the of the hexagonal AlN columns in relation to 
the substrate. 
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Several studies have reported significant improvements in protein detection in liquid with 
sensitivity the 0.3 ng/cm2 to 7.5 ng/cm2 [178]. For example, DeMiguel-Ramos and 
coworkers (2017) report the development of a AIN-based FBAR sensor with a sensitivity 
factor (Cf) of 1.8 GHz.ng-1·cm2, representing a staggering improvement over a 5MHz QCM 
(0.057 Hz.ng-1·cm2) under similar conditions. Immunodetection of thrombin concentrations 
as low as 4 nM. FBARs can be made on any solid substrate, even on irregular surfaces, 
using standard CMOS processing, reducing  significantly the size and the fabrication cost 
[172], [180]. The fragile nature of QCM-HFF and FBAR devices means that these have to be 
housed in low-volume flow chambers, in the nanoliter range [181]. In the context of 
mammalian cell studies this would undoubtedly constitute a problem since cell diameters are 
an order of magnitude greater.  
2.2.3. Electrodeless QCM 
Since the density of gold (19.3 g.cm-3) is much larger than that of quartz (2.65 g.cm-3), the 
mass of a QCM sensor is heavily comprised of the electrodes and thus, heavily factored in 
the design of HFF-QCM sensors. Due to high damping of metals, the electordes increase 
inertial resistance as well as mechanical loss [182] and such influence increases with the 
resonance frequency [183]. Reducing the thickness of the electrodes increases the electric 
resistance, in turn requiring more sensitive amplifiers and/or higher operating potentials 
which could introduce heat and generate additional vibration modes [129]. On the other 
hand reducing the electrode’s area restricts the active sensing area. For this reason, 
resonators operating through electromagnetic (noncontact) excitation of the crystal lattice 
have been proposed [184].  
Electromagnetic acoustic transducers (EMATs) have been implemented to carry out non-
destructive testing of stress, corrosion cracking and unbound coating in metals [185], 
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[186]. EMATs are capable of simultaneously exciting and detecting ultrasonic waves, 
through a process entitled magnetic direct generation. The EMAT uses electro-magnetic 
forces to introduce acoustic waves into the test object through a combination of Lorentz 
force and magnetostriction mechanisms. When a coil-generated high radio frequency (RF) 
pulse interacts with a magnet-generated low frequency (or static) field, alternating Lorentz 
forces radiate into the material generating acoustic waves. These forces are applied over the 
whole skin depth of the bulk material and as result, the generated frequencies can be as low 
as 1-2 MHz due to the high amplitudes potentials required to offeset the high conversion loss 
[187]. Stevenson and Lowe (1998) demonstrated that these forces could instead be confined 
to a thin metallic film on a glass substrate through a continious current, significanlty 
enhancing transduction efficiency [184]. Moreover, this can be reproduced on a variety of 
inexpensive low loss materials such as glass, metallic disks and polymer foils. Magnetic-
acoustic-resonant sensor (MARS) have already shown promising results in the development 
of implantable glucose sensors [188]. The response signal can be also be remotely 
measured with an amplitude modulation diode detector or an RF coil.  
 
2.3. Anharmonic acoustic transduction 
When excited at high electrical potentials (drive levels), linear mechanical oscillators 
generate components of frequencies that are multiple integers of its fundamental resonance 
frequency (harmonic excitation). This phenomenon arises due to intrinsic nonlinearities 
caused by crystal lattice deformation by the propagated wave [189]–[191]. Dultsev and 
colleagues (2000) have shown excitation of third overtone mode of an AT-cut quartz crystal 
driven at linearly increasing amplitude. Moreover, this work demonstrated mechanical forces 
exerted on biomolecular complexes at high oscillation amplitudes are capable of rupturing 
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chemical and physical bonds. The rupture event is represented by sudden change in the 
overtone current, which manifests as a peak after a numeric differentiation of the current, 
referred to as acoustic “noise”. This method, entitled rupture event scanning (REVS), has 
since been reported for detection of viral particles [193], bacteria and DNA unwinding [194]. 
Large excitation at fundamental frequency interferes with noise detection, affecting to lesser 
extent higher order harmonics. However bond rupture has also been reported based on 
analysis of fundamental frequency QCR response [195]–[197]. 
Third harmonic excitation may not necessarily result from an abrupt bond rupture event. 
Ghosh et al. (2010) reports detection of adsorbed streptavidin-coated polystyrene 
microparticles by recoding third harmonic amplitude of a QCR driven by a harmonic 
excitation. The principle behind this technique relies on interactions at the surface of a TSM 
AT-cut quartz crystal resonator, causing a nonlinear oscillation that introduces distortion in 
the harmonic or purely sinusoidal electric current. This is measured from change in 
magnitude of third Fourier harmonic (3f) current, which is at three times the drive frequency 
(3f) (Figure 72). Significant deviations in higher odd harmonic responses (3f, 5f, 7f…) as 
function of oscillation amplitude are strongly dependent on the force-extension characteristic 
of the molecular tether formed by the recognition element, as well as the size of the analyte 
under study. The same principle was further developed to discriminate between non-specific 
and specific (antibody-antigen) surface interactions, while enabling quantitative 
measurements of bacterial spore numbers at a detection limit of approximately 430 spores 
[199]. This transduction principle is entitled Anharmonic Detection Technique (ADT) and it is 
the transduction principle underpinning the experimental work presented in this thesis. As 
such, further theoretical and experimental insights will be discussed in depth throughout 
Chapter III and IV. 
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Figure 72  Diagram depicting the principle of anharmonic detection technique (ADT). 
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2.4. Biochemical interfaces 
2.4.1. Self-assembled monolayer (SAM) 
Characterization of receptor-ligand kinetics often involves the formation of a molecular 
complex on a solid substrate such as in the cases of QCM, SPR and atomic force 
microscopy (AFM). The spontaneous and thermodynamically stable organization of 
disulphides on a gold substrate was first reported in 1983 by Nuzzo and Allara [200]. Since 
then the study of self-assembly of organosulfur compounds on different oxide-free metal 
substrates (e.g. Au, Ag, Pt and Cu) on different substrate geometries. Self-assembled 
monolayers (SAMs) of alkyl thiols contain a thiol (sulphide or disulphide) headgroup (-SH) 
with a hydrocarbon backbone and a reactive group terminus. 
The inert nature of gold enables self-assembly under atmospheric conditions instead of at 
ultrahigh vacuum (UHV). The kinetics of SAM formation follows two distinct stages: (1) fast 
physisorption characterized by a disordered (gas-like) layer arrangement, characteristic of 
Langmuir films, followed by (2) a chemisorption stage lasting several hours [201]. During the 
latter stage, alkyl thiols lose a proton to form gold-sulphur bond (∼50 kcal/mol), assembling 
into a highly ordered configuration (1015 molecules/cm2) [202]–[204]. The density and 
orientation of the monolayer results from the balance between lateral interactions (van der 
Waals, hydrogen bonds). Therefore, this process can take 2-24 hours depending on the 
length of the hydrocarbon chain and the type of end group [205] while other important factors 
include incubation temperature, chain length, thiol concentration, solvent and surface 
roughness [206]. 
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Alkyl thiols are commonly solvated in ethanoic solutions although other common organic 
solvents are DMSO and hexane [207]. Moreover co-adsorption of different thiol species 
allows for a mixed SAM composed of molar ratios relating to their concentration in solution, 
depending on certain factors [208]. For this reason, SAM co-adsorption has been widely 
explored owing to their ability to regulate the concentrations of functional groups on those 
surfaces. One of the greatest advantages of mixed SAM is the reduction of lateral steric 
hindrance effects. Huang et al. (2005) found the optimum ratio of 16-mercaptohexadecanoic 
acid and 11-mercapto-1-undecanol to be 1:9, yielding the highest density of anti-prostate-
specific-antigen-antibody complexes on a gold surface. The optimum ratio will vary 
according to the reactive group [208], [210]. 
 
 
 
Figure 113 Schematics of QCR surface functionalization based on thiol-Au 
bonds. The receptors can be displayed on the surface as a monolayer (2D) or 
embedded in a matrix (e.g. dextran layer) 
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2.4.2. Patterning 
Patterned formation of monolayers can enable immobilization of multiple ligands on a single 
substrate offering multiplexing capabilities. A variety of lithographic methods are able to 
achieve this at the nanometer scale, including e-beam lithography [211], dip-pen 
nanolithography and microcontact printing [212]. Mechanic deposition or even removal of 
alkyl thiols onto a gold surface can be controlled with an AFM tip. In the case of tips made of 
conductive material, can also be used to activate reactive groups via oxidation/reduction 
[213], [214].  
A lower degree of control and accuracy3 albeit with higher throughput can be achieved with 
alkyl thiols terminated with photo-switchable groups. An example is the reversible cis↔trans 
isomerization of azobenzene derivatives by light or temperature induction [215], [216]. The 
groups to react can be controlled with the use of a mask (photoresist) of desired geometry 
and size. Similar approaches have used magnetic fields [217], DNA [218] or spin-coating 
[219] to create nanomasks. Finally, Kankate et al. (2017) presents an elegant approach 
combining electron beam  photolithography with vacuum vapour deposition to replace one 
type of SAM with the other.  
2.4.3. Cleaning 
Exposure of gold substrate to ambient conditions leads to an immediate accumulation of 
contaminants that prevent thiol bonds from forming. Common strategies include rinsing with 
organic solvents such as chloroform or acetone and strong oxidative solutions like hot 
piranha solution (7:3 98% H2SO4 :33% H2O2) and aqua regia (3:1:16 HCl:HNO3:H2O). The 
combination of the latter two treatments leads in fact to a favourable recrystallization of the 
                                                
3 This is greatly due to light diffraction which in turn is dependent on wavelength (Huygens principle) . 
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Au surface [208]. Plasma and ultraviolet light/ozone treatment are also very effective 
although the latter requires a  wet cleaning step with water or ethanol to remove by-products 
[221], [222].  
Because QCM can be integrated in a electrochemical flow cell as the working electrode 
(eQCM) [223], it also means its surface can be cleaned by electrochemical desorption [224], 
[225][226]. Here an anodic or cathodic potential is applied to the electrode providing enough 
energy to dissociate the Au-S bond. The advantages of using electrochemical desorption is 
that it can be carried out online electrochemically (sensor refreshment) and the efficiency of 
the cleaning process can also be characterized [226]. Conditions for electrochemical 
desorption must be optimized for any given system in order to concurrently achieve efficient 
removal of alkyl thiolates and prevent delamination of Au substrate. 
To conclude, Fischer et al., 2009 looked at nine combinations of reported chemical and 
electrochemical methods of gold cleaning. The most effective method was found to be 
potassium hydroxide–hydrogen peroxide treatment (10 min in a solution of 50mM KOH and 
25% H2O2 before) with single potassium hydroxide potential cycling (-200 to -1200 mV (vs. 
Ag/AgCl)) at 50 mV/s scan rate), followed by water rinse [228].  
2.4.4. Controlling nonspecific adsorption (NSA) 
Non-specific interactions between sample components and the sensor interface can 
detrimentally affect the detection specificity (refer to Chapter IV and V). Addition of 
poly(ethylene glycol) (PEG) to the alkyl thiol chains has shown to reduce non-specific protein 
adsorption[208]. Choi and Chae (2010) present a study looking at the impact of surface 
roughness, SAM incubation time and using mixed SAMs composed of hydrophilic resist film 
such as tri- and hexa-polyethyleneglycol (PEG) or OH-terminated SAMs. The results show 
that long-chain SAMs suffered from NSA even after 24 h SAM formation time, while short-
  
    
Page 77 of 289 
 
chain SAMs showed little NSA after just a 3 h formation time. In fact, true surface area 
(accounting for roughness) can be determined electrochemically by through integration of 
gold oxide reduction peak in the cyclic voltammogram [226]. Work by Bolduc and Masson 
(2008) has also shown the impact different amino acid head groups on NSA. Their 
conclusion was that lowest degree of NSA was seen on self-assembled monolayers of N-3-
mercaptopropyl-amino acid with small polar and negatively charged amino acids (Asp, Asn, 
Ser). 
2.4.5. Molecular recognition elements 
Antibodies  
The earliest exemplars of antibody-based sensors date back to 1987 [230] and since then 
immunoglobulin G (IgG) is the most common choice of receptor for biosensor applications. 
Such popularity could be accredited to a thorough understanding of their structure and 
generation in vivo. The Y-shaped IgG is formed of light and heavy chains containing 
constant and variable regions (Fab) which mediate antigen binding. The Fc portion (Y “leg”) 
is responsible for recruiting components of the immune system. In mammals a large and 
diverse antibody repertoire is generated by B cells through recombination and somatic hyper 
mutation of the genes encoding for the variable regions This process is capable of 
generating up to 1012 different binding sites which increases the likelihood of displaying 
sufficiently strong affinity to initiate an immune reaction upon binding a foreign object [231].  
Antibodies can be conjugated with other molecules (e.g. fluorophores, enzymes, biotin) by 
precise modification of carbohydrate, amine and sulfhydryl residues, located away from the 
binding regions. The same methods can be carried out to immobilize antibodies on solid 
substrates [232]. Moreover, the slow off-rate of molecular complexes such streptavidin-biotin 
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(~10-14M) [233] and protein G/A-antibody4 (~10nM) [234] means that in theory, antibodies 
can be bound to a surface-immobilized proteins in a specific orientation for the standard 
duration of immunoassays. Antibody-surface immobilization is a non-trivial aspect of sensor 
development. The orientation and density dictate the number of available binding sites, thus 
contributing to the overall sensor sensitivity. Immobilization occurs via covalent 
immobilization to surface groups is subject to electrostatic and hydrophobic interactions, 
modulated by surface charge and ionic strength. Therefore, it appears to be possible to 
predict, and thereby control, the orientation of antibodies without resourcing to the use 
intermediate linkers [235]–[237]. Alternatively, immobilization via native thiol groups at the 
Fab′-SH fragment hinge has been shown to improve antibody affinity due to controlled 
orientation and stability. Fab portion can be separated from Fc portion by reduction of the 
disulphide bond of F(ab)2 fragments [238]. Moreover, such reduction in the receptor spatial 
dimensions may result in higher immobilization spatial density.  
One of the claimed advantages of label-free techniques is that the modification of receptors 
with for purposes of reporting or immobilization (e.g. fluorophores, enzymes, quantum dots) 
may alter the affinity of the receptor itself, even if bespoke modifications target non-binding 
sites (Fc portion) [182]. Indicator-displacement assay presents an elegant solution to this 
problem. A reporter molecule of weaker affinity toward the receptor binds to the antibody. 
The complex is then reversed when the target competes for binding to the receptor, causing 
the displacement of the indicator from the receptor, which in turn modulates an optical signal 
[239].  
Despite being well-established antibodies present several disadvantages concerning to 
development costs, requirement for low-temperature storage, batch-to-batch variability and 
                                                
4 Protein G also contains a binding site for albumin which is highly present in serum and used to 
passivate the surface (discussed in Section 5.1)[234] 
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poor performance in non-physiological conditions [240], [241]. These characteristics limit the 
operation and reliability of immunosensors. This can be tackled by reducing the complexity 
to only the elements required for ligand binding and recognition of a receptor one is also 
decreasing the chance of non-specific binding.   
Synthetic receptors 
Single-stranded DNA or RNA oligonucleotides are capable of adopting a three-dimensional 
conformation that confers high affinity and specificity to specific molecular targets. These 
molecules termed aptamers, are selected through an inexpensive and scalable in vitro 
process with a high degree of accuracy and reproducibility. In systematic evolution of ligands 
by exponential enrichment (SELEX), a randomly generated nucleic acid library is repeatedly 
exposed to the solid-phase analyte, washed and subsequently amplified [242], [243]. The 
structures contained in the pool of final sequences can be further modified to improve the 
aptamer affinity, specificity and stability [244]. Unlike antibodies, generating aptamer libraries 
in vitro represents an inexpensive, scalable and automated method, while also mitigating the 
need to use animal models for development. Furthermore, oligonucleotides are stable at 
room temperature. The speed and throughput conferred by current aptamer selection 
procedures is crucial to tackle rapidly evolving epitopes such as the cases of seasonal virus 
or antimicrobial resistance [245]. Moreover, aptamers can be precisely modified with 
different compounds, so to facilitate substrate-immobilization via biotin-streptavidin 
interactions, thiol-gold bond or –NH2 cross-linking, amongst other strategies. 
The gap created by the overwhelming advantages of aptamers over antibodies does not 
however reflect in the number of publications in sensor development. As per Figure 4, the 
annual number of publications on aptamers has increased 15-fold in the last seventeen 
years. These include not only sensor development in diagnostics/theranostics but also in 
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medical treatments. Notably, sensor-related publications account for half of the total and 
have increased 42-fold since the turn of the century.  
 
Figure 14 Cumulative volume of search hits on Google Scholar relevant to aptamers and antibody used in 
sensor development.  
Finally, it is worthwhile a brief mention of imprinted polymers as an alternative class of tailor-
made receptors, holding the promise to solve the drawbacks of antibodies. Polymer curation 
around molecules or cells, produces cavities containing both structural and chemical 
blueprint required for specific chemical recognition [137], [240]. The use of imprinted 
polymers in sensor development has been widely reported in the literature, including 
detection of mammalian cells [246], viral particles [247], small molecules [248], yeast [137] 
and bacteria [249]. Interestingly, the last two examples involve analyte recognition on a 
quartz crystal microbalance. Currently however, the application of imprinted polymers in 
sensor development is dependent on the complete characterization of the binding 
mechanisms, as well as homogenization of binding site distribution, which would otherwise 
lead to high of non-specific binding [250].  
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2.5. Reaction kinetics 
2.5.1. One-dimensional kinetics 
The reaction between a ligand (A) and its receptor (B) to form a molecular complex (AB) is 
generally described as a second order reaction. This is characterized by an exponential 
signal change from a reference state (no ligand) of which the exponent describes the 
concentration of analyte and the sensitivity of the assay. As number of available binding 
sites decreases the reaction approaches a state of equilibrium where the rates of complex 
association 𝑘𝑜𝑛 and dissociation 𝑘𝑜𝑓𝑓 equalize.  
 
 
Figure 125 Schematics of sensor response with progressive analyte association. 
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The second-order rate constant (k) for both association and dissociation is given by the 
Arrhenius equation:  
k = Ae−∆G/kbT (6) 
Where A  is the pre-exponential factor, kb is the Boltzmann constant (1.3 ×
10−23m2kgs−2K−1) constant and T  is temperature in Kelvin. The exponent numerator ∆G 
denotes the free energy change required to transition reaction states. The association phase 
in QCM experiments, characterized by an exponential decay in resonance frequency is thus 
expressed as: 
𝑓(t) =
[L]
[L] + KD
(1 − e−([A]kon+koff)t) 
(7) 
The pre-exponential factor denotes the fraction bound at equilibrium (Req) which relates to 
the Langmuir isotherm (θ) for surface coverage [251], [252]. Because [B] is limited by the 
density of binding sites and [A] remains constant ([L] ≫ [R]) due to constant delivery by the 
flow system, this reaction is more suitably described as pseudo-first order. In the case of 
QCM the Sauerbrey relation, predicting linear decrease in resonance frequency with change 
of coupled mass, also has be satisfied. The exponent constant rate, 𝑘𝑜𝑛 = [L]kon + koff (M
-
1s-1) can be derived by fitting Equation 7 to the data [253]. The dissociation constant Kd =
koff (s
−1)
kon (M.s−1)
, expressed in molarity units (M), is proportional to the complex affinity (binding 
strength): 
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∆G = ∆H − T∆S = −kbT lnKeq (8) 
The association constant K𝑎 on the other hand is given by the inverse of Kd. Higher sensor 
sensitivities, faster response times and lower sample volume requirements are related to the 
optimization of the reaction thermodynamic parameters and analyte transport to the sensing 
area. Several strategies have been reported revolving around flow cell geometry, decreasing 
area and geometry of sensing area as the use of mixing components upstream the sensing 
area [254]–[257].  However when reducing the chamber volume in QCM applications, it is 
important to take into consideration the generation of coupled resonances as compressional 
waves reflect of the top of the flow chamber [258], [259].  
2.5.2. Two-dimensional kinetics 
Receptor-mediated colloid-surface interactions under flow is influenced by ligand density, 
receptor number, temperature, shear stress, affinity as well as its radius [260], [261]. 
Moreover, interactions between cell-membrane ligands and surface cannot be modelled on 
three-dimensional (3D) kinetics as previously mentioned. Contrary to free ligands in solution, 
the surface-immobilized ligands are restricted in space by the surface [262], [263]. Therefore 
in this context, kon and Keq are expressed in area units, µm
2 s-1 and µm-2 respectively [148], 
[264], [265]. Thermodynamic parameters are more accurately derived from a liner plot of the 
reaction rate against the pre-exponent factor (𝑅𝑒𝑞)[148], [265], [266]: 
Δ (
Δ𝑅
Δ𝑡 )
𝑅𝑚𝑎𝑥
 = 𝑘𝑜𝑓𝑓 + 𝑘𝑜𝑛 ([L]
𝐶𝑖
𝑐𝑒𝑙𝑙𝑠
𝐶𝑓𝑢𝑙𝑙
𝑐𝑒𝑙𝑙𝑠) 
(9) 
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The term in brackets represents total analyte concentration (C), which is governed by two 
parameters of interest: available membrane ligand (A) for surface interaction and (2) cell-
surface contact area (𝐴𝑐) [148], [267]. Whereas C is represented as the concentration of 
soluble analyte in 3D kinetics, here it reflects the density of ligands present on the portion of 
membrane available for binding. The latter parameter is dependent on cell diffusion based 
on mechanical parameters (e.g. shear stress) used by other methods. The kinetics constants 
Ka  and Kd  can then be derived from the slope and the intercept of the plot 𝐶(
Δ(
Δ𝑅
Δ𝑡
)
Δ𝑅𝑚𝑎𝑥
) , 
respectively.  
 
2.6. Discussion and Conclusion 
Enhancements in QCR mass sensitivity have enabled detection of minute amounts of free 
biomarkers in solution. This has been attained via different energy trapping strategies or by 
reducing the thickness of the piezoelectric substrate to reach high fundamental resonance 
frequencies. Other advancements have also facilitated wireless (and electrodeless) 
excitation and detection of acoustic waves, which could in the future enable this technology 
to be used for in-/on-line process monitoring. Improvements in sensitivity have been mostly 
benchmarked with respect to formation of rigid uniform films, where mass loading can be 
predicted from Sauerbrey’s equation. However, large colloidal particles (like cells) are much 
larger than the penetration depth of the acoustic wave and under this scenario, energy 
dissipation dominates over mass loading due to viscoelastic effects. For this reason, 
evaluation of cytomechanical parameters with quartz crystal resonators must be carried out 
according to a different approach. 
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Anharmonic acoustic detection technique is a relatively novel acoustic transduction principle 
with potential to be developed for study of cell-surface contact mechanics. The force-
extension characteristics of the interactions between a particle and the resonator were 
discussed in the context of improved specificity and sensitivity, whereas ADT will be 
explored to study cell-surface contact mechanics This represents new research venue where 
with the potential to not only study cell mechanics but also membrane surface-marker 
expression. 
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3. Chapter III 
Probing particle-QCR interactions via the acoustic response of a quartz crystal 
resonator. 
 
3.1. Introduction 
In QCM studies, the thickness (mass) and softness (viscosity) of uniform rigid films (e.g. 
protein, liposomes, virus particles) are conventionally estimated from changes in resonance 
frequency and energy dissipation measured at the drive mode. The models predicting QCR 
behaviour, namely Sauerbrey relation, for homogenous thin films fail to explain adsorption of 
micron-sized colloid particles (e.g. bacterial cells), at which point the QCR response behaves 
less like a microgravimetric device and more like a force balance (coupled resonance)[270]. 
When relatively large and more flexible adsorbates bind to the quartz crystal via small 
contact points, it forms a coupled oscillator with the quartz crystal resonator. Such particles 
clamped in space by inertia are unable to follow the MHz thickness-shear QCR oscillations, 
thus contributing with a restoring force that ultimately increases the effective stiffness of the 
quartz crystal resonator. In such case, a more dominant elastic (stiffness) load causes an 
increase in resonance frequency that is proportional to the stiffness of the particle-resonator 
contact [271]. 
In this section, a coupled resonance system is studies via simultaneously measuring of the 
third Fourier harmonic component of the output current. A 14.3 MHz AT-cut quartz crystal 
resonator functionalized with biotin-terminated SAM is driven close to its fundamental 
resonance frequency at a range of potentials. Adsorption of magnetic streptavidin-coated 
  
    
Page 87 of 289 
 
microparticles (mSCMP) is transduced via linear and nonlinear QCR response, at a range of 
surface-displacement amplitudes and different extents of energy-trapping. This involves 
simultaneous characterization of variations in fundamental resonance frequency (𝑓0) and 
energy dissipation, as well as measurement of third Fourier harmonic response as described 
by the principle of ADT. The underlying rationale for the choice of quartz crystal resonator is 
two-fold. First the underpinning ADT work carried out by Ghosh and colleagues was carried 
out on an AT-cut (TSM) quartz crystal with the same fundamental resonance frequency as 
the one used here. Hence the objective is not only to confirm these findings but also build 
upon the original work. Secondly, high electric potentials would be required to excite 
nonlinear modes in HFF-QCR to a level that satisfactory signal-to-noise ratio (in liquid). At 
this power levels the effect of temperature and other spurious vibration modes are expected 
to have a detrimental effect on the signal. 
The aim of this section is to investigate how the nonlinear QCR response is modified by a 
coupled resonance system, comprised in this case by a micron-sized colloid attached to the 
resonator’s surface through biotin-streptavidin interactions.  
 
3.2. Materials and methods 
3.2.1. Reagents 
All buffer reagents and biomolecules were procured from Sigma-Aldrich (UK) and prepared 
in ultrapure water (16 MΩ.cm) (Milli-Q Integral system, Millipore, US), unless specified. 
Phosphate buffered saline solution (PBS) was prepared from tablets: 8.1 mM Na2HPO4, 1.1 
mM KH2PO4, 1 mM MgCl2, 2.7 mM KCl, and 138 mM NaCl, pH7.4. Ethanoic alkyl thiol 
solutions, HS-(CH2)11-EG6-Biotin and HS-(CH2)11-EG3-OCH3, were procured from Prochimia 
  
    
Page 88 of 289 
 
(Poland). Streptavidin-coated magentic microparticles (mSCMP) - Dynabead M280 
Streptavidin - procured from ThermoFisher Scientific (US). These polystyrene microparticles 
with are iron oxide core, 2.8 m in diameter and with a density of 1.6 g.cm-3. Streptavidin-
coated polystyrene microparticles were procured from Bangs Laboratories, Inc (US). 
3.2.2. Instrumentation 
Nonlinear network analyser 
The novelty of this work stems greatly from the development of a nonlinear network analyser 
(NVA) by Victor Ostanin (University of Cambridge, UK). The instrument was designed to 
operate a wide range of drive amplitudes (0-27.5 V) and frequencies (RF 0.1 to 300 MHz) 
while recording the complex (in-phase and quadrature) current and voltage sensitively (noise 
~1 µV/Hz½) and synchronously at three frequencies (1f, 3f, 5f). The microvolt level odd 
harmonics signals are separated from powerful driving signal applied near fundamental 
resonance frequency by appropriate highly linear passive filtering network.  
 
Figure 136 Schematics of experimental setup. NVA – nonlinear network analyser; DUT- Device under test; PC- 
Laptop. 
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Calibration 
A “3-term calibration” using short, open and loaded (100Ω resistor) was used to find the 
value of the current flowing through the electric circuit composed of the amplifier, DUT, 
nonlinear vector analyser and RF connect cables.  
Control software 
The control software (SendAND) was programmed in LabWindows/ CVI by Mr. Victor 
Ostanin and Dr. Alex Zhukov at the University of Cambridge (UK). The graphic user interface 
displays four functional tabs - one for the settings and one for each of three scan modes. In 
the settings window, the channels (recorded frequencies) and their respective gains can be 
specified for each type of scan while the drawing options allow the user to choose which 
parts (real, imaginary, absolute) of the recorded signal are to be displayed on the screen. 
The available scan modes are named Frequency Mode Scan (FMS), Amplitude Mode Scan 
(AMS) and Constant Mode Scan (CMS). In frequency mode, the frequency of the feed AC 
signal is adjusted by the user central frequency of the feed sinusoidal potential is set along 
with the sweep span and the duration. In amplitude mode, the drive frequency is fixed by the 
user and the scan duration and the final amplitude of the applied potential are varied. In the 
constant mode the amplitude and frequency remain constant as the scan duration is varied. 
In the general settings window, mainly the signals to be displayed in the different scan 
modes and the measured signals to be saved can be chosen. Decimation factor was set to 
record approximately 800 data points in a 0.1s scan. 
Device under test (DUT) 
A FR4/Cu/Au printed circuit board (PCB) was designed and fabricated by Dr. Niklas 
Sandström at KTH Royal Institute of Technology to provide electrical connection between 
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the ADT instrument and the QCR but also to provide an alignment guide for the microfluidic. 
The flow cell was fabricated by N. Sandström through precision milling of polycarbonate 
substrates using a Protomat S62 printed circuit board plotter (LPKF, Germany). The top of 
the flow cell was polished to enable direct microscopic observation of the QCR surface. An 
UPS class VI EPDM O-ring (Trelleborg, Sweden) helped without considerable damping of 
the crystal vibrations. The QCR and flow cell were aligned on the PCB aligned with the help 
of vertical pins. The electrical connection and an air-tight seal between the flow cell and the 
QCR were secured by clamping everything together with paper clips. The flow cell was 
designed with a height of 240µm to optimally reduce the effect of interference between the 
resonator and compressional acoustic waves in liquid that are generated out-of-plane by the 
shear wave oscillation of the crystal. The flow cell was connected via tubing, which was 
inserted into the fluidic inlet and outlet ports, to a syringe pump procured from Harvard 
Apparatus (UK). When the flow cell was filled with aqueous liquid, the resonator featured a 
quality factor of ~2000. Between experiments, the flow cell and O-ring were cleaned by 
sonication in 1% Tween-20 and double-distilled water. 
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Microscopic imaging 
Imaging was carried out with a Nikon stereomicroscope SMZ18. Final cell count was carried 
out using ImageJ software (v1.8), a freeware developed by the US National Health Institute. 
Micrographs of QCR surface were only acquired at the end of the assay so bright field light 
did not interfere with acoustic signal due to temperature fluctuations. The optical 
transparency of the flow cell allowed for in situ imaging without need for removing 
disassembling the QCR. 
  
Figure 17 Schematics of device under test with window enabling in situ imaging of the QCR surface. IP - inlet 
port; OP – outlet port. 
  
    
Page 92 of 289 
 
QCR functionalization 
AT-cut quartz crystal resonators, with 14.3 MHz fundamental resonance frequency 
(tq~115µm), were custom-made for this work by Laptech Precision Inc (Canada). This type 
of quartz resonators oscillates along the crystallographic x-axis (cut on the side) as denoted 
in Figure 8, having a theoretical sensitivity factor (Cf) of approximately 463 Hz.µg-1.cm2. 
Typical equivalent circuit values for a 14.3 MHz crystal with only one immersed electrode are 
𝐶𝑚 = 27 f𝐹, 𝐿𝑚 = 4 𝑚𝐻, 𝑅𝑚 = 200 𝛺 and 𝐶0 = 9 𝑝𝐹. 
Some quartz crystals used for this work were customised by the manufacturer with extra 
thermally evaporated gold layer on the bottom electrode for energy trapping. These circular 
gold layers were 2.5mm in diameter and were provided at thicknesses - 50,60,70,80 and 90 
nm. These modified quartz crystals are referred to as “energy-trapped”. 
 
Figure 18 Representative diagram of 14.3 MHz QCR design (a) together with modified bottom electrode for 
energy trapping (b).  
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Immediately before use, quartz crystal resonators were individually cleaned in acetone and 
isopropanol sonication baths for 5 min, followed by argon plasma treatment at 250 W for 90s 
(Harrick Plasma, US). The cleaning procedure described was performed multiple times on 
the same crystal after experiments, in an effort to reuse them and in that way reduce 
variation across experimental replicates. The cleaned crystals were immersed for 24 h in 1 
mM ethanoic solution of 1:10 biotin to methoxy-terminated alkyl thiols. A single crystal is 
mounted in a fluidic cell and cleaned by flushing pure ethanol followed by copious amounts 
of water. Streptavidin diluted in PBS [16 ug.ml-1] is injected for 20 min until surface saturation 
is reached, as monitored in real-time with the QCR. Finally, removal of unbound streptavidin 
interacting with the QCR surface is carried out by flushing copious amounts of PBS.  
In this assay the QCR is driven close to its fundamental resonance frequency by taking short 
frequency sweeps. Resonance frequency and frequency are derived from impedance fitting 
at fundamental resonance. On the other hand, 𝐼3𝑓 values are obtained from measurement of 
the third Fourier harmonic current and should not be confused with the measurement of third 
overtone mode resonance frequency, which is commonly employed in quartz crystal 
microbalance studies.  
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3.3. Results 
3.3.1. Harmonic excitation 
Figure 19 shows the magnitude of I3f around resonance in water. Discrete linear increases 
in feed-through voltage (0.5-12.5 V) induce higher I3f magnitudes as the quartz crystal 
behaves more nonlinearly. The peak value corresponding to maximum 𝐼3𝑓  amplitude 
( 𝐼3𝑓𝑚𝑎𝑥 ) is plotted against the respective piezoelectric current at fundamental ( 𝐼1𝑓 ) 
demonstrating a cubic dependence (𝐼3𝑓 ∝  𝐼1𝑓
3   .   
The asymmetry of the I3f impedance spectrum is characterized by the presence of a 
“shoulder” at frequencies slightly higher than resonance, could be explained by coupling of 
vibration modes as result of anharmonic side bands or standing compressional waves [129]. 
It is important to note that this phenomenon is only observed at 3f and 5f and not in the 
Figure 19 Dependence of third Fourier harmonic current magnitude on oscillation amplitude. A 
quartz crystal resonator (f0 = 14.3 MHz) is intermittently oscillated in liquid at increased drive 
potential (0.5V to 12.5 V) for 0.1 s. Full I3f spectrum around resonance is shown in (a) and 
respective peak values are plotted against respective piezoelectric current, showing a cubic 
relationship.  
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admittance spectrum of fundamental frequency where the magnitude of these effects might 
be simply masked by the large excitation at fundamental resonance. 
3.3.2. Monitoring particle-surface adsorption 
In order to isolate contributions of viscous drag of mSCMP adsorption on the QCR response, 
continuous flow was carried out for 10min at 10uL.min-1 and stopped for 5min. Frequency 
sweeps (0.1s) were then taken at the end of the cycle allowing the particles to settle on the 
surface. The change in resonance frequency and bandwidth (energy dissipation), before and 
after injection of streptavidin-coated microparticles (107/mL), are shown in Figure 21.  
  
 
Figure 20 Schematics of mSCMP adsorption mediated by streptavidin-biotin interactions. 
The first three cycles correspond to baseline in PBS (no microparticles) to evaluate the level 
of drift arising from non-specific interactions from ubiquitous medium constituents as well as 
any potential source noise arising from external thermal or electrical sources. The standard 
in QCM studies is to stabilize the baseline so the signal variation is close to 5 Hz. It should 
however be noted that, conventionally QCM is driven linearly (low electrical potentials), 
which should in itself confer more stability.  
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In this assay both frequency and energy dissipation increase monotonically with cumulative 
microparticle adsorption (Figure 1621). Even though an equilibrium stage (saturation) is not 
observed for this experiment, exponential interpolation of the association phase for the 
dataset corresponding to 0.5V predicts equilibrium phase for resonance frequency shift of 
1.1 kHz. This value obtained close to linear drive in turn agrees with the value reported 
previously [272] with a 16 MHz quartz crystal in an identical assay.  
Figure 151 Adsorption kinetics mSCMP measured by frequency and energy dissipation. A quartz crystal 
resonator (f0 = 14.3 MHz) is intermittently oscillated in liquid at increased drive potential (0.5 - 15 V) for 0.1 
s. Here, a “cycle” is defined by an initial stage where sample is continuously injected at 10 µL.min-1 for 
10min, followed by stage of static conditions (no flow) for 5min at which point short (100 ms) frequency 
sweeps at increasing drive level. Streptavidin-coated microparticles (𝜙 = 2.8um,   = 1.6 g.cm-3) were 
injected after cycle 3 at 107 MP/mL. 
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The relative change in the peak 3f current normalised by the respective 1f current, here 
defined as Δ𝐼′3𝑓𝑚𝑎𝑥/𝐼
′
3𝑓𝑚𝑎𝑥, was also recorded for the same range of amplitudes (Figure 
2). The change was normalized accounting for the cubic dependence of 𝐼3𝑓  on drive 
piezoelectric current. Note that in this fashion, taking the peak of 3f resonance is not 
analogous to deriving bandwidth from real part of 𝐼1𝑓 at resonance. Figure 22 shows the 𝐼3𝑓 
magnitude at 1.25V close to fundamental resonance frequency, where increasing surface 
coverage streptavidin-coated microparticles increases the nonlinear response of the, 
resulting in a positive shift in Δ𝐼′3𝑓𝑚𝑎𝑥/𝐼
′
3𝑓𝑚𝑎𝑥.  
  
Figure 22 Increase in third harmonic current amplitude induced by chemisorption of mSCMP to QCR. The 𝐼3𝑓 
magnitude increases with cumulative microparticle adsorption (a) and the respective maxima (peak value) is 
plotted for each cycle of mSCMP injection.  
Heat generated from oscillation due to electric resistance dissipates into the liquid medium 
and can change the reaction kinetics molecular complexes forming at the sensor substrate. 
For this reason, the reaction rate of mSCMP adsorption was studied in relation to scan 
duration for single amplitude (Figure 173). In this case, despite only a slight difference in 
reaction kinetics, Δ𝐼′3𝑓𝑚𝑎𝑥/𝐼
′
3𝑓𝑚𝑎𝑥  decreased exponentially reaching a value around 50% 
lower than baseline level.  
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Figure 173 Influence of frequency sweep time on binding kinetics. 
The dependence of particle mass and contact point area was studied with polystyrene 
streptavidin-coated microparticles (ρ=1.05 g.cm-3). In this case, adsorption to the QCR 
surface was carried out under continuous flow (10µL.min-1) so the scale is in time units. The 
change in resonance frequency is presented in positive scale values for ease of 
interpretation. 
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Figure 24 Association of polystyrene microparticles (ρ=1.05 g.cm-3) coated with streptavidin monitored by ∆𝑓, ∆𝐷 
and Δ𝐼′3𝑓𝑚𝑎𝑥/𝐼
′
3𝑓𝑚𝑎𝑥. Baseline signal in PBS is presented up to t=10min, at which point a concentrated mSCMP 
solution is spiked in the buffer reservoir to a final concentration of 106 mSCMP.mL-1. 
As demonstrated in Figure 4 the QCR surface adsorption was followed by a pronounced 
negative frequency shift for 0.99um microparticles (300Hz), yet a low (albeit significant) shift 
of 50 Hz for 3 µm microparticles. In both cases change in energy dissipation was close to 
baseline level whereas the nonlinear response at 12.5 V changed slightly on opposing 
directions for the different sizes.   
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3.3.3. Influence of elevated amplitudes on QCR response 
The voltage-normalized Δ𝐼′3𝑓𝑚𝑎𝑥/𝐼
′
3𝑓𝑚𝑎𝑥  was taken between baseline and the last time 
point in Figure 9 (cycle 8). The amplitude value was derived based on the linearly 
relationship between drivel level and the amplitude of motion of the quartz crystal surface 
(Equation 1). Here 𝑑2  is the experimentally-derived piezoelectric strain coefficient (3.1 
pm/V), 𝑄  is the dimensionless quality factor at the amplitude of the applied electric 
potential(𝑈𝑒𝑙) [273], [274].  
𝑎𝑚𝑎𝑥 =
4
( 𝑛)2
𝑑2 𝑄𝑈𝑒𝑙 
(10) 
Amplitude of surface displacement decreases with distance from the centre of the crystal 
(𝑑𝑐) in a Gaussian distribution with coefficient (𝐶𝐺) [275], [276]. It is important to note that 
even though it is assumed that I3f (peak value) is in very close to maximum electrical 
excitation and therefore only the amplitude at the centre will be considered. The amplitude 
distribution with respect to electrode centre is given by: 
𝑎(𝑟) = 𝑎𝑚𝑎𝑥 
−(
𝑑𝑐
𝐶𝐺
)2
 
(11) 
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Figure 25 Dependence of normalised I3f peak shift on drive amplitude. Scans were taken before (in PBS) and 
after injection of streptavidin microparticles (ø=2.8µm, ρ=1.6g.cm-3) and the shift in signal calculated accordingly. 
Figure 5 shows the effect of oscillation amplitude (derived from Equation 10) on the change 
between in all the three parameters. In this experiment, Δ𝐼′3𝑓𝑚𝑎𝑥/𝐼
′
3𝑓𝑚𝑎𝑥  is the only 
parameter varying non-monotonically. The almost symmetrical distribution of Δ𝐼′3𝑓𝑚𝑎𝑥/
𝐼′3𝑓𝑚𝑎𝑥 as a function of oscillation amplitude is caused by the fact that lower drive potentials 
do not excite nonlinear modes and therefore cannot be accurately measured.  
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The plot of I3𝑓 /I1𝑓
3  versus 𝐼1𝑓 presented in Figure 26 was obtained from a single experiment 
where two amplitude mode scans (AMS) where taken in PBS, followed by another two scans 
after successive mSCMP injections (107/mL). In this case drive frequency was fixed at 
resonance and the amplitude was linearly increased from 0 to 12.5 V for 0.1 s, similarly to 
what was originally reported by Ghosh and colleagues (2011). Given 𝐼3𝑓 ∝ 𝐼1𝑓
3 , in the 
absence of third harmonic excitation by particle attachment, one expects 𝑓(𝐼1𝑓 ,
𝐼3𝑓
𝐼1𝑓
3 ) to take 
the form of an approximately linear function, as it is the case for the baseline scans in Figure 
29. The difference in maximum value suggests that these values suggest that 𝑓(𝐼1𝑓 ,
𝐼3𝑓
𝐼1𝑓
3 ) is a 
function of the number of microparticles attached to the surface since this increases with 
subsequent samples injections (Appendix A3).  
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Figure 26 Amplitude-mode scan at 12.5V (0.1s) showing I_(3f )/I_1f^3 
versus I_1f. Two baseline scans (red and black) and two scans for 
magnetic streptavidin-coated microparticles (green and yellow). 
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3.3.4. Energy trapping 
When the free propagating wave within the crystal lattice reflects back from non-oscillating 
areas of the crystal it gives rise to spurious modes of oscillation. This translates into the 
appearance of anharmonic sidebands in the vicinity of resonance. The suppression of these 
vibration modes can be achieved by reducing electrode area or changing design with 
keyhole-shaped electrode, bevelling [275] or by mass loading (simple mass loading by 
electrodes in the centre portion on flat surfaces).This is of particular importance when the 
QCR supporting structure that can significantly dampen the oscillation at the contact regions 
by confining mechanical energy to the central area (i.e. through bevelling, mass load or 
convex crystal design) trapping has long been described by W. S. Mortley (1957). Energy 
trapping is a well-established strategy to increase the overall mass sensitivity of QCM [278].  
Figure 27 Circular gold layer centrally plated on the top electrode of a 
14.3 MHz QCR for energy trapping. 
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In this work, an extra gold layer was plated on top of the bottom electrode to increase the 
energy trap effect (see Section 3.3.3). This is expected to increase amax and decreases the 
Gaussian coefficient as presented in Equation 1, resulting in a sharper distribution in surface 
displacement amplitude around the centre of the crystal. The effect of different layer 
thicknesses on 𝐼1𝑓 magnitude is demonstrated in Figure 28 for several drive potentials. 
 
Figure 28 I3f responses of energy-trapped quartz crystals. Data was acquired by taking short frequency sweeps 
(0.1s) at increasing amplitude in water.  
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The same plot is presented for a 60nm-energy trapped QCR in water along with a 𝐼3𝑓 vs 𝐼1𝑓 
plot showing a hysteresis effect. The theoretical model developed by Mr. Victor Ostanin, Dr. 
Igor Efimov and Dr. Sourav Ghosh, is described in detail in [279], the parametric plot of the 
third overtone resonance current against the 1f current, both being functions of f, showed a 
loop feature (Figure 29b). The loop is expected considering the asymmetry of third overtone 
resonance and this anisotropic effect is attributed to the fact that the third overtone 
resonance frequency is slightly higher than three times the fundamental resonance 
frequency.  
 
 
Figure 29 The magnitude of I3f at resonance increases with I1f in 60nm stepped crystal. Inset plots show 
upscaled magnitude of I3f against drive frequency (left) and against current at fundamental frequency (I1f) (right) 
when the quartz resonator is excited at 2.5V. Black plots correspond to experimental data while blue plots show 
fit obtained in [279]. 
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A comparison of ΔI3f induced by mSCMP adsorption is provided in 30 for the different layer 
heights (60-90nm) and uniform crystal (no step). Association constants (𝑘on) derived from 
fitting with an exponential function could be used instead of last values (t=70 min). However, 
a poor exponential fit is obtained for higher drive-levels which cross zero I3f axis to the 
positive range of the scale.  
Despite the larger I3f magnitude of energy-trapped crystals the highest shift was observed for 
the uniform crystal. Moreover, the shift for f upon MP binding is greater for uniform than it is 
for any of the step heights (data not shown). Contrary to spattered crystals, the expected 
signal dependence on mSCMP number, as predicted in the case of first order reactions, 
appears to extend only to lower drive potentials (≤1.4V). Higher drive levels display ΔI3f 
values in the negative scale, an observation common to all step heights including uniform. 
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Figure 180 Comparison between different gold layer heights and drive voltages on mSCMP (107.mL-1) adsorption. Each chart corresponds to a separate experiment. 
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3.3.5. Density-dependent transition 
The observation of negative 𝛥𝐼′3𝑓𝑚𝑎𝑥/𝐼
′
3𝑓𝑚𝑎𝑥 was not exclusive to energy-trapped crystals 
and it was also observed in Figure 191, showing mSCMP adsorption at a concentration of 
106.mL-1. In order to further investigate this phenomenon, an experiment was carried out 
increasing mSCMP concentrations where flowed across the surface. As predicted, the initial 
concentrations resulted in a decrease of I3f magnitude with a transition point beyond which, 
the same value starts increasing. In-situ imaging of the QCR surface enabled counting of the 
microparticles on the crystal surface. The micrographs were imported into ImageJ (NIH) and 
microparticle counts were obtained using an in-built function (see appendix A8). These 
results show a transition point at mSCMP surface densities equal or lower than 1200 
mSCMP.mm-2. Such transition is characterized by a distortion of the 𝐼3𝑓  curve symmetry, 
highly pronounced in Figure 191 corresponding to 2x107 mSCMP.mL-1. 
 
Figure 191 Variations in magnitude and shape of I3f spectrum induced by mSCMP adsorption. Frequency 
sweeps (0.1s) were taken at 2.5V. Values in legend correspond to mSCMP concentration flowed.  
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
f (MHz)
 pbs_1
 pbs_2
 pbs_3
 5x10
6
 SCMP
 10
7
 SCMP
 2x10
7
 SCMP
 3x10
7
 SCMP
I 3
f 
(a
.u
)
  
    
Page 109 of 289 
 
The values of three acoustic parameters for the different concentrations were divided by the 
actual mSCMP surface density, as calculated based on the micrographs (see appendix A3). 
From the micrographs is also possible to confirm the progressive and monotonic mSCMP 
adsorption. The normalized values were plotted in Figure 202 as a function of drive voltage. 
The different number of data points in 𝛥𝐼′3𝑓𝑚𝑎𝑥/𝐼
′
3𝑓𝑚𝑎𝑥  is due to the fact lack of distinct I3f 
distinct resonance at 0.5V.  
 
 
Figure 202 Δf/θ, ΔΓ/θ and ΔI3f/θ as a function of drive voltage. 
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3.4. Discussion 
In this work, particle-surface interactions were probed by studying changes in resonance 
frequency (Δf) and energy dissipation (ΔΓ) at fundamental frequency (~14.3 MHz) and the 
peak magnitude of the third Fourier harmonic current (𝐼3𝑓). Additionally, the association of 
streptavidin-coated microparticles on a biotin-functionalised QCR electrode was monitored 
as a function of drive-level, which translates into variations in amplitude of the QCR surface 
shear displacement. 
For the experiments carried out with a uniform crystal, resonance frequency and energy 
dissipation increase in a monotonic fashion with progressive adsorption of streptavidin-
coated microparticles on the QCR surface. This behavior defies classic Sauerbrey relation 
predictive of mass coupling as described in Section 2.2. When micron-sized particles bind to 
the quartz crystal resonator via small contact points (Hertzian contact), they form a coupled 
oscillator with the quartz crystal resonator. Such particles are clamped in space by inertia 
and are unable to follow the MHz surface displacement, thus contributing with a tangential 
restoring force that increases the effective stiffness of the quartz crystal resonator. In such 
case, a more dominant elastic (stiffness) load increases the resonance frequency, 
proportionally to the stiffness of the particle-resonator contact [163], [271]. Cases of coupled 
resonance in QCR experiments have been already reported for bacteria [280], diatoms [281], 
oocysts [282] and possibly in the case of mammalian cells [283], which demonstrates its 
relevance in biosensing.  
The results obtained for polystyrene microparticles show that the acoustic response differs 
between microparticles of approximate diameters, albeit differing in material density, 
possibly due to the contribution of the elastic properties of the material to the contact 
stiffness. However, polystyrene and magnetic microparticles used here were obtained from 
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different suppliers, which could reflect differences in surface density of immobilized 
streptavidin. Nonetheless the differences between ø = 0.99 μm  and ø = 3 μm  pSCMP are 
significant and can only be explained by different contact point areas. For this reason, it is 
important to carry out further experiments to better understand the effect of contact area on 
the transition between elastic and inertial loading. 
To the author’s knowledge, this work reports the first case of a coupled resonance system 
on QCR, characterized by measuring 𝐼3𝑓. An increase in 𝐼3𝑓proportional to the number of 
adsorbed microparticles even at modest amplitudes (1.25 V), at which 𝐼3𝑓 is weak and noisy, 
suggests that microparticles adsorption induce nonlinear behavior of the quartz crystal 
resonator. Ghosh and colleagues (2010) suggest that the lateral component of the force 
(tangential stiffness) exerted on the resonator surface via the contact point modifies the 
shear forces within the crystal lattice itself. This in turn translates into modulation of electrical 
charge and by extension, current flow through the resonator. The different association rates 
of mSCMP across all three acoustic parameters (𝑓, Γ and 𝐼3𝑓) demonstrated to some extent 
a dependence on the shear oscillation amplitude. Moreover, an asymptotic limit is observed 
for ∆𝑓 and ∆𝐼3𝑓 at high drive levels where the relative shift in 𝐼3𝑓 is equal to zero. Such limit 
could be attributed to a significantly higher contribution of quartz nonlinearities to 𝐼3𝑓 at high 
amplitudes, thus overshadowing the contributions of particle-surface interactions. A similar 
limit was observed within the same amplitude range in the plot of I3𝑓 /I1𝑓
3  versus 𝐼1𝑓. In the 
latter case the signal value starts relatively high and rapidly decreases to a transition stage. 
This behaviour resembles the force-distance plot of a typical force spectroscopy experiment. 
In this case, the anharmonic signal is a measure of the transduced force exerted by the 
particle-linker system on the resonator. However, in this case an abrupt change denotive of 
bond rupture is replaced by a gradual increase in 𝐼3𝑓 /I1𝑓
3 , approximating an asymptotic limit 
established by the reference state (no microparticles). The force-extension relation of a 
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molecular bond is nonlinear in its own right due to potential energy barriers representing 
smaller free energy changes that confer stability [285]. A gradual change in force-extension 
of biotin-avidin complexes has been by Wong et al. (1999) and also in the case of biotin-
streptavidin complexes by [287]. This phenomenon could be thus explained by an 
overcoming of multiple energy barriers gradually leading to complete bond rupture. An 
alternative explanation could be formulated in light of mechanic model of an elastic element 
(spring) and a dashpot in series pinned to a solid substrate . In this case, extension of the 
streptavidin-biotin bond will increase as streptavidin uncoils, until a stage at which the 
stiffness of the linker matches that of the thiol bond, when weaker interactions dissipate 
energy until rupture takes place.  
The possibility of bond breakage as underlying explanation for drive-dependence of 𝐼3𝑓  as 
seen in Figure 25 and Figure 26 warrants further analysis. Microscopic examinations of the 
crystal surface during mSCMP adsorption did not present any indications of concentric 
microparticle displacement caused by high oscillations (see [288]). Moreover, the reported 
scan durations in both REVS literature and the work published by [199] on anharmonic 
acoustic transduction (30-600 s) are substantially large comparing to this work. A deeper 
discussion on this topic is provided in Chapter V, so the possibility of irreversible bond-
rupture is excluded from this analysis for simplicity. 
In the case of coupled resonance, the particle-surface contact stiffness is derived from the 
linear relationship between ∆𝑓 and the complex load impedance (Z𝑙), defined as the ratio of 
the area-averaged tangential stress and the tangential velocity at the crystal surface 
(represented in angle bracktes) [163]: 
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∆𝑓 + 𝑖∆𝛤
𝑓
=
𝑖
 𝑍𝑞
〈
?̃?0
?̃?0
〉 𝑎𝑟𝑒𝑎 
(12) 
represented by the area-averaged ratio between tangential stress (?̃?0) and velocity (?̃?0), 
where the latter is given by 𝑖ωamax . The acoustic impedance of quartz (𝑍𝑞)  is  . ×
10 𝑘𝑔 𝑚−2𝑠−1 for an AT-cut quartz crystal. Johannsmann (2016) and Olsson et al. (2012) 
both present studies looking at coupled resonance, where the tangential stress exerted by 
the oscillations on the particle-surface contact is modulated by overtone drive s as a function 
of overtone drive (for 𝑛= 1..13), as opposed to drive potential. Interestingly, both studies 
report a transition from negative to positive ∆𝑓, as a function of drive overtone. Olsson et al. 
(2012) extends this comparison to different inonic strenghts modulating the stifness of 
particle-surface contacts, concluding that such transition is indicative of bond stifness as well 
as other interface characteristics.  
Energy trapping resulted in an increase in magnitude of 𝐼3𝑓, together with suppression of 
spurious vibration modes in comparison to uniform crystals. This has however negatively 
impacted the signal profile of mSCMP adsorption across all measure responses. The most 
likely explanation could be the expected increase in surface-displacement amplitude induced 
by energy trapping. In this case however, the modified amplitude distribution of energy-
trapped crystal would have to be derived experimentally by, for example, direct imaging of 
the surface displacement as function of applied potential with atomic force microscopy, for 
example [274]. It is important to note that in neither case, uniform or energy-trapped crystals, 
particle displacement was observed on the surface which would denote irreversible bond 
dissociation. Microscopic observations of the QCR surface showed that the number and 
distribution of mSCMP on the QCR surface were not altered after flowing buffer at high flow 
  
    
Page 114 of 289 
 
rates (100-500 µl.min-1), however no harsh treatments with hypotonic or acidic dissociation 
solutions were tried.  
Only one DUT signal could be processed in every experiment meaning that only one set of 
conditions could be tested in a period of approximately of five hours. For this reason, the 
level of confidence in these findings stems from the confirmation of result trends across 
different experiments, such as the significant positive frequency shift caused by specific 
mSCMP adsorption. The next two chapters aim to reinforce the assumptions made here on 
the basis of reproduced experimental results.  
  
3.5. Conclusion  
The aim of this work was to study the effect of microparticle adsorption on the QCR surface 
on its nonlinear acoustic response, 𝐼3𝑓 . In this section, it was demonstrated that the 
nonlinear acoustic signal increases above a certain microparticle surface density threshold. 
Moreover, such transition from negative to positive 𝛥𝐼3𝑓 was not observed for fundamental 
resonance frequency and energy dissipation shifts. Nevertheless, at high concentrations of 
streptavidin-coated microparticles (107.mL-1), all three acoustic parameters increased 
exponentially with progressive adsorption under controlled sample flow, showing sensitivity 
towards surface coverage.  
The 𝐼3𝑓  magnitude of a bare quartz crystal in liquid was shown to increase with energy-
trapping, while the mSCMP detection sensitivity - simply characterized by the maximum 
signal shift - was shown to be higher for normal crystals. This was hypothesised to happen 
due to the dependence of higher oscillation amplitudes, as demonstrated by controlling the 
surface-displacement amplitude. The actual phenomenon is yet to be fully understood, 
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although it is probable that such dependence stems from a higher contribution of material 
nonlinearities to 𝐼3𝑓, over that of mSCMP adsorption. 
This study has therefore concluded that all three acoustic parameters (𝑓, 𝛤 𝑎𝑛𝑑 𝐼3𝑓 ) are 
modulated by the surface density of adsorbed microparticles as well as the scan drive level. 
This suggest that further QCR studies of coupled oscillators require an optimization of drive 
potential, which in certain cases might be dependent on the nature of the particle-surface 
interactions under study.  
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4. Chapter IV 
Characterization of weak affinity particle -surface interactions via anharmonic 
acoustic transduction. 
 
4.1. Introduction 
Several strategies have been employed to study the effect of different contact stiffness in 
coupled resonance systems, including subjecting the particle-QCM contact to a range of 
centrifugation forces [290], ionic strength [289] and dehydration levels [291].  
This section aspires to formulate an understanding of how the stiffness of particle-surface 
contacts, modulated by different extents of multivalent interactions, affects the nonlinear 
acoustic response of a quartz crystal resonator. To achieve this objective, the contact 
strength between superparamagnetic microparticles (MP) and the QCR surface is modulated 
by varying the ligand-receptor densities and characterized by monitoring both linear (∆𝑓 and 
∆Γ) and nonlinear (Δ𝐼3𝑓) changes in QCR response. Human immunoglobulin E (IgE) was 
chosen as ligand due to its clinical relevance but most importantly, due to the fact that it is 
naturally found on the surface of mast cells at moderate densities (103-105 molecules/cell) 
[292]. Moreover, here particle-surface interactions are mediated by low-affinity molecular 
complexes (mM>KD>μM), contrasting with that characteristic of streptavidin-biotin 
interactions (KD =10-14M).   
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4.2. Materials and methods 
4.2.1. Reagents 
Human immunoglobulin-E (ab65866) and goat immunoglobulin-G were purchased from 
Abcam (Cambridge, UK). The 37-mer IgE-binding aptamer (D17.4), with the sequence (5’-
GGGGCACGTTTATCCGTCCCTCCTAGTGGCGTGCCCC-3’), was extended with 24 
thymidine bases (D17.4ext) and biotinylated as at the 3’ end as previously described[293]. A 
prediction on the tertiary structure of D17.4ext at [Na+]=138mM, [Mg2+]=1mM and 95oC was 
obtained using the Mfold algorithm [294]. The single stem-loop conformation predicted was 
in conformance with previously reported  [295] structure of ΔG = -10.55 kcal.mol-1 (see 
Appendix A4). The results from this simulation were used to estimate the length of D17.4ext 
based on an average base-pair distance of 0.63nm [296].  
 
4.2.2. Functionalisation of superparamagentic particles 
A monodispersed solution of superparamagnetic particles (Carboxylic Acid, M270, 2.8um 
diameter), acquired form ThermoFisher (UK), was repeatedly washed in 10 mM MES buffer 
(pH5.0) followed by surface activation with a 1:1 solution of 0.4M EDC and 0.1M NHS for 
20min. A volume equivalent to 2x107 microparticles (0.3 mg) was then re-suspended in 
respective protein (IgE or IgG) solutions, at final concentrations of 40, 20, 10, 2, 0.2 and 
0.02µg per mg of MP and incubated for one hour. Unreacted esters were quenched with 
50mM ethanolamine-HCl (pH8.0). Particles were re-suspended in PBS containing 0.1%BSA 
and 0.05% Tween 20 and the final microparticle concentration measured with a Countess 
Automated Cell Counter (ThermoFisher, UK). 
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4.2.3. QCR aptamer assay 
Clean AT-cut quartz crystal resonators (f0=14.24 MHz) were immersed for 24 h in 1mM 
ethanoic solution of 1:9 biotin to methoxy-terminated alkyl thiols. The crystal was then placed 
in a fluidic cell and cleaned by flushing pure ethanol followed by copious amounts of water. 
Streptavidin, diluted in PBS to 16ug/mL, was injected until saturation. DNA aptamers diluted 
(1µM) in PBS (138mM NaCl, 5mM MgCl2) and heated to 95°C for 5min before being added 
to the gold resonator surface. After several washes, PBS was flowed at 20uL/min for 30min 
to stabilize the baseline. Concentrated microparticle solution was added to the buffer and 
mixed, achieving a final concentration of 106 MP/mL. 
 
 
Figure 213 Schematics of detection of IgE immobilized on microparticles. Quartz crystal resonator is 
functionalized with a mixture of biotin- and methoxy-terminated thiolated PEG chains. Streptavidin is bound to the 
biotin-terminated thiols thereby facilitating the orientation of the biotinylated aptamer stem loop (receptor) away 
from the electrode (I,II). Microparticles displaying molecules of interest with high affinity toward the surface 
receptor are injected and allowed to come in contact with the resonator under continuous flow. The resonator is 
driven by a pure oscillating potential close to its fundamental resonance frequency (f) and the amplitude of third 
Fourier harmonic current (I3f), is recorded together with fundamental frequency (f0) and energy dissipation (D) (III, 
IV). 
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4.2.4. Fluorescence assay 
Plate wells were pre-blocked with 150μL of 5%BSA in PBS overnight at 4oC, followed by 
several washes with 150 μL of PBS supplemented with 0.05% Tween 20. Each well was 
filled with 50 µL of D17.4ext [1.25 µM] and immunoglobulin-coated magnetic particles (106 
particles.mL-1) and left to incubate for 60 min at RT under moderate rotation. Microparticles 
were then separated from solution and washed twice in PBS using magnetic plate holder 
(Bio-Plex, BioRad) for 2.5 min. MP were then re-suspended in 50 µL of streptavidin [1 µM], 
labelled with fluorescein isothiocyanate (FITC), and left to incubate for 30 min at RT under 
moderate rotation. MP were washed twice a re-suspended in 90 µL of PBS. The final 
solution was analysed with a BMG FLUOstar Omega microplate reader (Germany) with 
preinstalled filter set for an excitation and emission wavelengths of 485 nm and 520 nm, 
respectively. 
 
4.3. Results 
4.3.1. Fluorescence assay 
Checkerboard titration 
In order to quantify the relative density of IgE coated on the surface of the magnetic 
microparticles a fluorescent-label assay was developed based on a previously reported 
procedure [297]. The proportion of IgE immobilized on the surface of the MPs can be 
determined based on a pre-established linear correlation between the concentration of 
reporter (streptavidin-FITC) in solution and the respective fluorescence intensity. IgE 
covalently immobilized onto microparticles was first labelled with D17.4ext, followed by 
attachment of FITC-labelled streptavidin, with strong affinity toward the 3’-end biotin label on 
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the aptamer. After washing, the fluorescence intensity of remaining labelled complexes is 
measured with a spectrophotometer. 
In order to arrive at an optimum concentration of both aptamer and FITC-labelled 
streptavidin conjugate, a checkerboard titration experiment was carried out. The results 
show that lowest concentration of aptamer (1.25 µM) and the highest concentration of FITC-
labelled streptavidin (1 µM) yielded the highest fluorescence response, however no plateau 
was reached which suggests the range of concentrations for both aptamer and reporter 
should be extended (Figure 34). This combination was nevertheless used to further 
characterize MPs functionalized separately with different concentrations of IgE, or IgG.  
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Figure 224 Checkerboard titration. Heatmap showing recorded fluorescence intensity corresponding to IgE-MP 
labelled with different concentrations of fluorescent reporter (streptavidin-FITC) and D17.4ext. 
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Relative quantification of MP-immobilised IgE 
Four concentrations of IgE (1.6, 0.16, 0.016, 0.0016 and 0 µM) were used to functionalize 
the surface of microparticles. Figure 235 shows the average fluorescence intensity for the 
five IgE concentrations as well as IgG (1.6 µM). The limit of detection of this assay is less or 
equal than 0.16 µM since this was the maximum concertation detectable that significantly 
differs from the negative control (p < 0.0001). The actual IgE concentration is very likely to 
be lower given the considerable level of background noise measured by the fluorescence 
values measured for the negative control (IgG). This could be explained by nonspecific 
binding of the aptamer to the MP surface or IgG pointing to the need for a more thorough 
washing procedure.  
The objective of this experiment was to confirm the efficacy of the IgE immobilization 
protocol while providing an estimate of the concentration range to be tested on QCR 
experiments. Furthermore, more accurate approximations can be made if one excludes 
differences and normalizes fluorescence response against number of beads. This can be 
achieved by running the same fluorescently-labelled beads on a flow cytometer calibrated for 
FITC. Alternatively, the amount of free protein in the functionalization supernatant can be 
quantified, either through a Bradford assay or by measuring absorbance at 280 nm. The 
amount of immobilized protein could hence be estimated by subtracting this value to the 
initial amount of protein.  
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Figure 235 Average fluorescence response from the different samples off functionalized MPs. Error bars 
correspond to standard deviation (n = 3). Averages for lower IgE concentrations and IgG were compared in a 
two-sample T-test for a difference significantly greater than zero (**** p ≤ 0.0001; ns – not significant). 
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4.3.2. IgE-aptamer QCR assay 
Monitoring microparticle adsorption  
The QCR was driven with a pure sinusoidal potential of 2.5 V at a range of frequencies 
around its fundamental resonance (𝑓0 ≈14.24 MHz), and recorded complex (in-phase and 
quadrature) current and voltage synchronously at the drive frequency (1f) and at three times 
the drive frequency (third Fourier harmonic or 3f). The currents measured at the drive 
frequency and the third Fourier harmonic frequency are denoted as 𝐼1𝑓 and 𝐼3𝑓 respectively. 
The fundamnetal resonance frequency ( 𝑓0 ) and dissipation (𝐷 ) were estimated from 
impedance data of 0.5V frequency sweeps (0.1 s). For controls, we used non-functionalised 
microparticles (referred to as blank) and microparticles functionalised with goat 
immunoglobulin-G (IgG) to model non-specific interactions with the anti-IgE functionalised 
sensor. 
Figure 246a and b show the cumulative effect of binding of IgE-microparticles on 𝐼3𝑓-f and 
𝐼3𝑓-𝐼1𝑓 graphs, respectively, for a drive potential of 2.5 V. The progressive decrease in peak 
value of the anharmonic response equivalent to that reported for streptavidin-biotin assay at 
identical microparticle concentration (106.mL-1).  
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Figure 246 Magnitude of I3f before (dashed) and after (solid) injection of IgE-coated microparticles, as a function 
of (b) frequency and (c) I1f. Spectra correspond to scans taken every ten minutes, going from dark to light grey 
with increasing microparticle surface coverage on the QCR surface.  
The time evolution of the relative decrease in the peak 𝐼3𝑓 normalised by 𝐼1𝑓 (−∆𝐼
′
3𝑓𝑚𝑎𝑥/
𝐼′3𝑓𝑚𝑎𝑥) at 2.5 V, increase in dissipation (∆𝐷)and increase in resonance frequency (∆𝑓0) 
relative to the reference state at (t = 0-20 min), were analysed for baseline and microparticle 
flow stages. The stability of baseline is typically affected by the quality of surface 
functionalisation and changes in non-gravimetric parameters, such as temperature, viscosity 
and pressure. The challenge of establishing a stable baseline of a quartz resonator before 
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introducing the sample is well known. In certain cases, significant drifts during baseline were 
observed for the resonance frequency and dissipation shift graphs (Figure 37b and c). 
Interestingly, such drifts were not observed for the 3f current shifts (Figure 37a) measured 
from the same assay simultaneously. It is plausible that loosely bound biomolecules are 
removed of the surface during the 3f current measurement scans, which are at relatively 
higher amplitude than the other two acoustic parameters, giving better baseline stability. The 
baseline noise was also comparatively lower (Table 1) and the association curves followed a 
typical exponential progression more closely for −∆𝐼′3𝑓𝑚𝑎𝑥/𝐼
′
3𝑓𝑚𝑎𝑥 (Figure 37a). 
The 3f current was found to decrease with binding, while the dissipation increased due to 
losses at the liquid-particle interface [270]. The resonance frequency increased as elastic 
loading dominates over mass loading for microparticle binding to QCR [272]. 
 
Figure 37  Relative response for I3f, f0 and D. Time-dependent signal progression under continuous flow of 
running buffer (20µl/min), showing baseline in the first twenty minutes followed by injection of microparticles 
(denoted by arrow). A low volume of concentrated microparticle solution in running buffer was spiked into the inlet 
reservoir and homogenized, resulting in a final concentration of 106 MPs/mL. Exponential fit for the I3f response 
(solid lines) show expected response of pseudo-first order kinetics. Data points represent averages calculated 
from replicate experiments (n=3).  
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A dramatic increase in resonance frequency and dissipation is observed for the lowest IgE 
concentration (0.016 µM) and the blank (no IgE or IgG). We anticipate this could be due to 
non-specific interactions coming into play and start dominating as the bare polystyrene 
surface gets increasingly exposed at lower IgE concentrations. However, the 3f current is 
found to be negligibly affected by the growing non-specific interactions. This also means that 
the lowest concentration of microparticle-bound IgE that can be reliably readout is 
comparatively lower for 3f current measurement than the traditional acoustic parameters. It 
is possible that weaker electrostatic bonds of the non-specific interactions are dissociated at 
relatively higher amplitude at which the 3f current measurements are taken. 
When binding takes place on the QCR, there is a change in its nonlinearity coefficient (𝛽) 
and dissipation factor (𝐷). Since the relative change in 𝜔0 is negligible (~7×10
-6), we treat it 
as constant. The amplitude of the oscillatory drive (𝑎𝑚𝑎𝑥) is constant in our experiments. 
Since the shift in the third overtone frequency (∆𝜔3 ) and three times the shift in the 
fundamental resonance frequency (3∆𝜔0) are equal according to Sauerbrey equation, 𝜖 =
𝜔3 − 3𝜔0 also remains constant. Therefore, the normalised 3f current varies only with the 
nonlinearity coefficient (directly) and the dissipation factor (inversely to the second order). 
Equation 13 as derived in [279], gives the relationship between the relative decrease in the 
normalised 3f current, the relative decrease in the nonlinearity coefficient and the relative 
increase in the dissipation factor close to resonance due to binding of microparticles on the 
QCR. 
 
−
Δ𝐼′3𝑓𝑚𝑎𝑥
𝐼′3𝑓𝑚𝑎𝑥
= −
Δ𝛽
𝛽
+ 2
Δ𝐷
𝐷
 
(13) 
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4.3.3. Effect of drive amplitude 
The effect of drive amplitude on the IgE-MP adsorption kinetics was studied for a drivel level 
range (0.5-15V) on a 60nm-step QCR, similarly to Section 3.3.3. The relative changes of the 
three parameters, taken between the last time point and the reference state, are plotted in 
Figure 38.  
 
Figure 38 Effect of drive amplitude on adsorption of IgE-MP (3.2µM). Data points represent difference between 
the values at baseline and at the end of the assay (t=70min). 
A negative I3f shift was observed for IgE-microparticle binding, contrasting with the 
observations made with mSCMP adsorption at 107/mL. This means that as the amplitude of 
∆𝐼′3𝑓𝑚𝑎𝑥/𝐼
′
3𝑓𝑚𝑎𝑥 decreases as result of IgE-MP binding, the signal becomes noisier. This 
explains the choice of drive voltage (2.5 V) for the experiments described in Figure 37, even 
though it may not yield the highest shift from baseline. 
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A comparison of −∆𝐼′3𝑓𝑚𝑎𝑥/𝐼
′
3𝑓𝑚𝑎𝑥 is provided fin Figure 9 for 0.8 µM and blank (no IgE or 
IgG). The values were normalized so they are represented as relative shifts from 2.5 V (6 
nm). The shift along the amplitude axis seen for mSCMP binding is due to the higher Q 
factor, resultant of lower mas coupling required to achieve the appropriate functionalization 
of the crystal.  
 
 
Figure 39 Effect of drive amplitude on binding kinetics for different particle-surface interactions. 
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4.3.4. Effect of particle-surface adsorption strength  
A linear correlation is observed between the signal and the highest four concentrations of 
IgE (3.2-0.16 µM solutions) for all the three acoustic parameters. However, the relative 
decrease in the normalised peak 3f current has the strongest linear correlation (𝑅2 = 0.997), 
and almost a direct linear proportionality with the IgE concentration, as suggested by the low 
y-intercept value of the interpolation function (40). Microscopic observations showed 
comparable surface coverage of the QCR with microparticles by the end of the 70-minute 
assay for the different concentrations of IgE, particularly for the highest four concentrations 
corresponding to 3.2-0.16 µM IgE solution.  
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Figure 250 Signal response for different IgE concentrations and the estimated nonlinear coefficient (β). Average and 
standard deviation (n = 3) taken at the end of assay (t = 70 min) for all parameters. Linear interpolation for nonlinear 
coefficient (β) shows the extent of linear detection range (0.16 µM - 3.2 µM). The lower detection range is limited for f0 
and D due to higher non-specific background at lower IgE concentrations. 
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Figure 261a and b show microparticle coverage on the QCR for IgE concentrations 
corresponding to 1.6 µM and 0.16 µM IgE respectively. The surface coverage was also 
comparable for microparticles with similar concentrations of IgE and IgG, corresponding to 
1.6 µM of the respective protein solutions, although clustering was noticeable for non-
specific binding of IgG-microparticles (Figure 261a and c). 
Interestingly, the surface coverage was found comparatively lower for blank or non-
functionalised microparticles than IgG-microparticles (Figure 261c and d). However, all the 
three acoustic parameters recorded (𝐼′3𝑓𝑚𝑎𝑥 , 𝑓0  and 𝐷 ) showed greater signal for blank 
compared to IgG-coated microparticles. We anticipate this could be due to greater non-
specific interactions between bare polystyrene and QCR. This could arise from impurities in 
the functionalization mixture which could be passively adsorbed into the polystyrene mesh. A 
greater negative value for the relative decrease in the nonlinearity constant (-Δ𝛽/𝛽) makes 
this clear. Hence, we can interpret that for the range of IgE concentrations explored, the 
relative decrease in the normalised peak 3f current is linearly proportional to the ligand (IgE) 
concentration on the microparticles, which is a measure of the strength of microparticle-
resonator interaction. 
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Figure 261 Micrographs of the quartz crystal resonator electrode at the end of the assay (t = 70 min). Pictures 
show microparticles bound on the anti-IgE functionalised gold electrode. (a) IgE-microparticles (1.6 µM IgE) 
bound via specific interactions. (b) IgE-microparticles (0.16 µM IgE) bound via specific interactions. (c) IgG-
microparticles (1.6 µM IgG) bound via non-specific interactions. (d) Blank or non-functionalised microparticles 
bound via non-specific interactions.  
a b 
c d 
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4.3.5. Deriving specificity of particle-surface interactions 
For similar concentrations of IgE and IgG on the microparticles, corresponding to 1.6µM of 
the respective protein solutions, the increases in resonance frequency and dissipation for 
non-specific binding of IgG-microparticles are found to be 2.9 and 9.4 times lower 
respectively than those for specific binding of IgE-microparticles, both measured at the end 
of the assay (Figure 272a and b). The relative ‘attenuation’ in the normalised peak 3f current 
for non-specific binding of IgG-microparticles is found to be even more remarkable (51.7) 
(Figure 272c) – more than one order of magnitude greater than similar attenuation in 
resonance frequency shift (2.9). This preferential transduction of specific interactions and 
decrease of non-specific background without any washing steps or assay optimisation is 
encouraging for real-time measurements, particularly as microscopic images show nearly 
similar levels of coverage for IgE- and IgG-microparticles albeit with noticeable clustering for 
the latter (Figure 261a and c). The results demonstrate an ability of the ADT transduction 
method, based on driving a quartz crystal resonator near one of its resonance modes 
(fundamental mode in this study) and measuring the current at three times the drive 
frequency (referred as the third Fourier harmonic current), to differentiate between specific 
and non-specific interactions. 
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Figure 272 Specificity comparison across all three measured parameters and the estimated nonlinear coefficient 
(β). Average and standard deviation (n = 3) taken at the end of assay (t =70 min) for all parameters. The relative 
decrease in β is found to be negative for non-specific binding i.e. IgG-antiIgE and polystyrene-antiIgE. 
4.3.6. Effect of energy trapping 
As described in , the effect of energy trapping on the particle adsorption kinetics was studied 
for the following step heights: 0, 50, 60, 70 and 80 nm. IgE-functionalised microparticles (0.8 
µM) were injected after establishing a baseline for 20 min. No significant impact on 
resonance frequency and energy dissipation was seen as result of energy trapping (Figure 
283). On the other hand, the highest 𝐼3𝑓  shift from baseline was seen for uniform quartz 
crystal. However, when divided by respective 𝐼1𝑓 the signal became noisy suggesting that 
drive amplitude may have to be increased to obtain a clear peak value as result of this 
normalization step. 
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Figure 283 Effect of energy trapping on IgE-aptamer binding kinetics. 
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4.4. Discussion 
The values of relative decrease in the nonlinearity coefficient (−∆𝛽/𝛽) (Table 3), show a 
linear correlation with the IgE concentration. Earlier it was noted that as the concentration of 
IgE on the microparticles decreased (corresponding to less than 0.16 µM IgE solution), Δ𝐷 
reversed its trend and started increasing because of dominating non-specific interaction 
between the bare polystyrene and the resonator. We note the same trend for Δ𝐷 in Table 1. 
However, interestingly, we find −Δ𝛽/𝛽 continues decreasing without any change in trend 
and changes in sign to grow in negative value for the lowest IgE concentration explored in 
this study and for blank microparticles (no IgE) (Table 3, 7)Consequently, −∆𝐼′3𝑓𝑚𝑎𝑥/𝐼
′
3𝑓𝑚𝑎𝑥 
reduces to a small value for these cases governed by Eq.13. A negative value of −Δ𝛽/𝛽 is 
also noted for non-specific IgG-QCR binding (Table 3, Figure 272) while Δ𝐷 is positive, 
which also reduces −∆𝐼′3𝑓𝑚𝑎𝑥/𝐼
′
3𝑓𝑚𝑎𝑥 to a small value according to Eq.13.  
These observations collectively suggest that the nonlinearity coefficient (𝛽 ) of the QCR 
decreases due to microparticle-resonator (ligand-receptor) interaction, and the decrease is 
higher for stronger interaction, linearly correlating with the concentration of the ligand on the 
microparticle. The nonlinearity coefficient also depends on the type of interaction (specific or 
non-specific), i.e. the interaction strength, and the direction of its change is reversed 
(increases) when non-specific interaction starts dominating. This characteristic dependence 
of the nonlinearity coefficient on the interaction strength underpins the quantitative 
correlation and transduction specificity of the 3f current measurement governed by Eq.13.  
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Table 3 Average values and standard deviations (n = 3) taken at the end of assay (t = 70 min) for all three 
measured parameters and the estimated nonlinear coefficient (β). 
 -Δβ/β -ΔI’3fmax/I’3fmax ΔD (x10-6) Δf0 (Hz) 
 
𝑥 σ 𝑥 σ 𝑥 σ 𝑥 σ 
IgE (3.2µM) 0.292 0.013 0.396 0.016 27.138 1.438 109.222 6.673 
IgE (1.6µM) 0.116 0.010 0.188 0.014 18.725 1.190 91.935 4.554 
IgE (0.8µM) 0.057 0.007 0.098 0.010 10.929 0.953 51.240 3.364 
IgE (0.16µM) 0.010 0.003 0.033 0.003 6.057 0.192 45.339 0.968 
IgE (0.016µM) -0.013 0.001 0.041 0.002 13.990 0.560 94.126 4.489 
Blank -0.014 0.003 0.036 0.002 13.383 0.350 20.870 1.193 
IgG (1.6µM) -0.004 0.002 0.004 0.003 2.017 1.214 31.754 2.809 
IgE:IgG (1.6µM) -29.4 51.7 9.3 2.9 
 
The directionality in the change of 𝛽, which helps differentiating non-specific interactions, 
also allows resolving lower concentrations of microparticle-bound proteins compared to the 
widely used acoustic parameters of resonance frequency and dissipation. It may be noted 
that increased non-specific background from measurements of resonance frequency and 
dissipation shifts restricts their limits of detection of microparticle-bound IgE in this study to 
concentrations corresponding to 3.2 µM and 1.6 µM of initial IgE solution respectively. 
However, due to attenuated non-specific background analysed using 𝐼′3𝑓𝑚𝑎𝑥  and 𝛽 
readings, the detection limit corresponds to 0.16 µM of initial IgE solution, which is one order 
of magnitude or more lower than the detection limit obtained with the traditional acoustic 
parameters - resonance frequency and dissipation. We did not measure the concentration of 
IgE on the beads directly. We can estimate 0.16 µM IgE solution corresponds to 
0.16 attomole IgE per microparticle, equivalent to 9.6x104 IgE molecules with a molecular 
weight of 190 kDa, assuming full immobilization efficiency. Such value lies within the 
physiological range (103-105 molecules) of common lymphocyte cell-surface antigens [292]. 
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It is worth mentioning that the assay was not optimised here and that reference to IgE 
concentrations made throughout this document only serves as term of comparison between 
the three acoustic parameters. Moreover, no temperature regulation or flow optimisation of 
the microfluidic cartridge was carried out with the intent to improve analyte delivery and 
capture. 
The size of microparticles used lies within the size range where elastic loading dominates 
over mass loading in quartz crystal resonator resulting in positive shift in resonance 
frequency. As elastic loading from the bound microparticles is responsible for the nonlinear 
distortion, which causes the shift in third Fourier harmonic current of a quartz resonator, it 
would be interesting to investigate the lowest size limit of microparticles for which particle-
resonator interactions may be measured for a given drive frequency.  
A significant difference with the results obtained in the previous section warrants a thorough 
analysis. The consistent negative 𝛥𝐼3𝑓  with no observable transition event could be 
explained by two reasons. First, the intentional difference in affinities of approximately 6 
orders of magnitude between IgE-D17.4ext5 and biotin-streptavidin and its intuitive effect on 
contact stiffness. The second reason could be attributed to the differences in microparticle 
concentrations used, which may have been below the level required to observe the transition 
discussed in Section 3.3.5. Furthermore, similar exponent coefficients (rate of decay) as 
well as asymptotic limits (approximately zero) were estimated for the two concentrations of 
IgE and the blank control. Such observations contradict the theory of a possible relationship 
between strength of contact stiffness and the rate of decay of 𝑓(𝐼′3𝑓𝑚𝑎𝑥 , 𝑎𝑚𝑎𝑥). However, 
such theory was formulated on the basis of a positive (and not negative) I3f shift as result of 
microparticle adsorption. The estimated lengths of the particle-surface link also differed and 
                                                
5 KD= 10-8M as per Wiegand et al., 1996 
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by consequence should change the force exerted by the particle on the surface at any given 
amplitude.  
Finally, highly sensitive microparticle-based assays, relying on either enzyme-substrate 
conversion or fluorescence read-out, have reported detection limits in the attomolar (aM) 
range [298]–[300]. Examples of commercially available platforms relying on microparticle-
based capture can also be found (e.g. Luminex® xMAP and Quanterix™ SiMoA). Future 
endeavours should therefore explore the analytical performance of anharmonic acoustic 
transduction on an established microparticle-based assay.  
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4.5. Conclusion 
This study presents a label-free anharmonic acoustic transduction (ADT) method, which 
reads out ligand-receptor binding in real-time based on the strength of interaction between 
bound microparticles and a quartz crystal resonator. The elastic loading due to binding of 
microparticles to the quartz resonator causes a nonlinear distortion of the pure sinusoidal 
oscillation, which modifies the nonlinearity coefficient of the resonator (β). Combining 
experiments with polystyrene microparticles, functionalised with human immunoglobulin-E, 
and theoretical modelling, we show that the change in the nonlinearity coefficient is 
proportional to ligand concentration on the microparticles, which is a measure of the strength 
of microparticle-resonator interaction. The change in β is measured by actuating the 
resonator close to one of its resonance modes (fundamental mode in this study) and 
recording the third Fourier harmonic current (at three times the drive frequency 3f). The 3f 
current is directly proportional to the nonlinearity coefficient. On the other hand, the current 
at the driven (resonance) frequency, typically measured in a network analyser and it does 
not depend on the nonlinearity coefficient. The transduction method discussed here also 
facilitates preferential readout of stronger (specific) interactions and attenuation of weaker 
(non-specific) interactions without resorting to extensive washing or assay optimisation.  
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5. Chapter V 
Controlled acoustic-driven surface regeneration using a quartz crystal resonator.  
 
5.1.  Introduction 
The problem addressed in this chapter relates to both sensor reusability and capture 
selectivity. One of the major challenges in sensor development is the existence of non-
specific interactions (NSA) between the molecular recognition elements and ubiquitous 
medium components [202], [298]. This situation is particularly limiting when the 
concentration of say, a specific target protein, is two orders of magnitude lower than the total 
sample protein concentration. Such effects are augmented in the case of unprocessed 
samples like blood, urine and culture media, due to biofouling [301]. The effect of NSA on 
analytical performance has been estimated elsewhere, both mathematically [94] and 
experimentally [229], [302].   
Such challenges can be solved in practice through extensive assay development and 
chemically-assisted molecular dissociation. However, to do so would require skilled 
operators and additional reagents, rendering such methods impractical outside controlled 
laboratory environments. Additionally, differential measurement schemes involving the use 
of a reference sensor help account for the contribution of non-specific interactions as well as 
other sources of background noise (e.g. pH, salt concentration, electric noise). This could be 
achieved with a multichannel monolithic quartz crystal microbalance array [135], [303], [304]. 
However, specific and non-specific adsorption kinetics differ significantly which impacts the 
estimation of thermodynamic parameters as a result of subtracting the reference signal[305].  
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Molecular dissociation is an effective method to determine the energy required for bund 
rupture and thereby offering the means to distinguish specific and nonspecific molecular 
complexes. However, dissociation constant is hard to derive from association phase due to 
the excess of analyte amongst other factors, while dissociation measurements rely solely on 
temperature [306].  
The combination of transduction and actuation capabilities offered by acoustic biosensors 
has been widely explored in the context of selectivity and sensor regeneration. Hirst et al. 
(2008) reviews the concept of bond-rupture assays in QCM sensors. Moreover, this topic 
has been previously covered in Section 2 in the perspective of REVS and measurement of 
overtone current. The mechanisms of bond rupture in thickness-shear mode vibrations will 
be further discussed later in this chapter. However, there are examples of acoustic 
biosensors used for disruptive sensing worthy of mention, operating at vibration modes other 
than thickness-shear. For example, Cui and colleagues (2016) reports generation of 
microvortexes induced by liquid attenuation of thickness extensional mode vibrations at 
gigahertz frequencies. The same principle was later adapted by Pan et al. (2017) to remove 
non-specifically absorbed IgG and biofouling removal using a longitudinal acoustic wave 
(LAW) device. Hsu et al., (2013) also shows nonspecific binding removal on a glass slide 
thanks to longitudinal wave propagation generated by an adjacent piezoelectric substrate.  
In force spectroscopy, molecular dissociation rate (koff) varies exponentially with applied 
external force according tp Arrhenius kinetic models [260], [311]: 
𝑘off(𝐹) = 𝑘𝑜𝑓𝑓
∗ e
(
𝐹𝑥β
kβT
)
 
(14) 
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where 𝑘𝑜𝑓𝑓
∗  is the natural dissociation rate and the exponent nominator represents the work 
required to break the bond, where 𝑥β (nm) is the potential distance between  energy 
minimum and transition state [312]. Thus, a force-induced bond rupture is simply a 
thermally-assisted transition from the bound state into an unbound state over a potential 
energy modified by an external force. In the case of a TSM quartz crystal resonator, the 
force exerted on the particle at maximum surface displacement is given by [193]: 
F =
2
7
𝑚amax(2π𝑓)
2 
(15) 
where, the factor 2/7 corresponds to the distance moved by the surface with respect to the 
spherical particle’s centre of mass attached by a single pivot point. 
This section aims to describe and evaluate a novel acoustic dissociation assay for study of 
affinity of multivalent particle-surface interactions. The results offer a potential point-of-use 
measurements that can be applied in both bioprocess monitoring and clinical diagnostics 
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Figure 294 Assay schematics depicting surface association and dissociation of micropartilces. A step-wise 
thermomechanical dissociation of particle-surface interactions is carried out through intermittent 30s frequency 
sweeps (30s) at increasing drive potentials.  
Here is described a method of acoustic dissociation of IgE-coated microparticles adsorbed 
on the surface of a quartz crystal resonator. The resonator is excited intermittently at 
increasing amplitudes for a period of 30s, to encourage disruption IgE-aptamer interactions. 
The state of the crystal surface was monitored in real-time via direct microscopic observation 
of the QCR surface as well as monitoring its acoustic parameters (Δf0, ΔD, ΔI3f). Upon 
microparticle removal, the resonator was re-used without further cleaning, showing that up to 
a certain extent, acoustic dissociation can maintain the quality of the sensor interface. The 
results of this work show the suitability of acoustic dissociation to probe particle-surface 
interactions at high sensitivity in an elegant and inexpensive method.   
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5.2. Materials and Methods 
5.2.1. Thiolated D17.4 immobilization 
IgE-binding aptamer with 24-thymidine extension (D17.4ext) was modified with an alkylthiol 
group (C3H6SH) at the 3’-end, to enable self-assembly on gold. Disuldfide bonds were 
reduced by treatment with 20 mM Tris(2-carboxyethyl) phosphine hydrochloride (TCEP) for 
one hour at room temperature. The 3' thiol-modified oligonucleotides were heat-treated and 
allowed to react with the QCR electrode as described in Section 4.2.1. 
5.2.2. Cyclic voltammetry  
Principle 
Cyclic voltammetry is one of the most commonly used electrochemical techniques to study 
the kinetics of monolayer self-assembly [205], [225], [313]. In the experimental work here 
described, the immersed QCR electrode (19.63 mm2) acts as the working electrode in a 
typical three-electrode electrolysis cell configuration (Figure 38). A cyclic potential is applied 
between the working and counter electrode by a power source (i.e. potentiostat) resulting in 
subsequent reduction and oxidation of reversible redox couple species in solution.  
During an anodic voltage sweep, the working electrode drives oxidation of 
ferrocyanide (Fe(CN) 
4−) into ferricyanide (Fe(CN) 
3−), as represented in half reaction above 
(Equation 16). As the concentration of ferricyanide increases above the working electrode 
surface, it slows down the rate of diffusion of ferrocyanide from the bulk solution and with it 
the rate of electron transfer [314]. The reverse reaction occurs when the potential is scanned 
Fe(CN) 
4− ⇌  Fe(CN) 
3− + e− (16) 
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in the opposite direction (cathodically). Figure 45 presents a schematic reprensentation of 
the setup used. 
 
The current is proportional to the flux of electrons towards the electrode and amount, it will 
also depend on the interfacial properties of the working electrode (QCR top electrode in this 
case), such as the thickens of the self-assembled monolayer [205]. In an ideal case, SAM 
will block electron transfer between the electrolyte solution and the top electrode. However, 
defects in the monolayer such as pinholes and grain boundaries will increase the electron 
transfer rate, making this an extremely useful technique to study SAM integrity [205], [313]. 
Procedure 
All voltammetric scans were produced with a PalmSens3 potentiostat acquired from 
PalmSens (Netherlands). Data was analysed with proprietary software PSTrace v 5.1 
(PalmSens). An Ag/AgCl reference electrode was procured from IJ Cambria Scientific Ltd 
Figure 305 Schematics of electrochemistry setup where the 
QCR electrode acts as the working electrode (WE) with a 
counter electrode (CE) and reference electrode (RE) 
integrated in the flow cell. 
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(UK) while a platinum wire functioned as a counter electrode and the top QCR electrode as 
the working electrode (WE). Voltammetry measurements of the gold QCR electrode were 
recorded in the presence of a 1:1 mixture of 2.5 mM ferri/ferro-cyanide [Fe(CN)6]3-/4- redox 
couple in 0.01 M phosphate buffer (0.1M KCl, pH 7.0). Potassium ferrocyanide solutions 
were kept stored in the dark to slow oxidation[315]. Potential sweeps were cycled between 
−0.2 V and 0.6 V vs. SCE at a scan rate of 25 mV/s as reported. Measurements were 
performed at room temperature and shielded from light in a grounded Faraday cage. The 
integrity and shielding capacity of the cage were tested for GSM frequencies with a mobile 
phone and with the calibration circuit. See supplementary information for pictures of the 
electrochemistry setup. 
 
5.3. Results 
5.3.1. Acoustic dissociation of particle-surface interactions 
Figure 3 provides a schematic representation of a two-phase assay with sequential 
adsorption and desorption of magnetic microparticles on the surface of a quartz crystal 
resonator (𝑓0 = 14.3 MHz). The interaction between the microparticles and the resonator is 
mediated via binding between human IgE on the surface of the microparticles and aptamers 
(D17.4ext) immobilized the QCR gold surface. The QCR response to IgE-microparticle 
adsorption and desorption is monitored by taking two short frequency sweeps, at 0.5 and 2.5 
V, every 2 min. Changes in resonance frequency (Δf) and energy dissipation (ΔD) are 
derived from impedance fit at fundamental frequency (𝑓0) and low amplitude (0.5 V). The 
peak value of i3f is by measuring the third Fourier component of the current at relatively high 
potential (2.5 V). 
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After a period of baseline stabilisation, a solution of IgE-coated microparticles (106/mL) in 
PBS is injected at 20  L.min-1. As the signal plateaus, denotive of surface saturation, the 
solution is replaced with PBS and flowed at 50  L.min-1 to help remove loosely bound 
microparticles of the surface. A series of long duration (30 s) frequency sweeps are taken 
every 10min, at increasing electrical potential, from 2.5 V to 12.5 V. At high amplitude and 
scan durations above ten seconds, a progressive radial displacement of microparticles was 
observed. When the drive level increases above a certain point, IgE-coated microparticles 
adsorbed on the QCR surface move away from the centre towards the periphery of the 
crystal, leaving a circular clear out area as shown in Figure 6. The diameter of the clear out 
area (yellow dashed circle in Figure 6) is approximately that of the 2.5 mm-diameter extra 
gold layer deposited on the bottom QCR electrode for energy trapping. The elliptic outline 
shown in red demonstrates a preferential displacement of the microparticles along the 
crystal’s own oscillation axis. This elongation of the vibrating area along is attributed to 
anisotropic characteristics of quartz crystals[129]. Interestingly, diffraction of the shear 
waves at non-vibrating parts of the crystal results in microparticle agglomeration in areas of 
lower vibration energy (nodal patterns). The spacing between nodes should be about twice 
the resonator thickness, a characteristic of keyhole-shaped electrodes [129].  
A comparison between uniform and different energy-trapped crystal was established in 
relation to the extent of microparticle displacement on the QCR surface, as observed under 
the microscope (Figure 7). In this case, microparticles coated with IgE (0.8  M) were flowed 
across the sensor functionalized with biotinylated D17.4ext as described in Section 4.2.3. A 
dissociation process was carried out as described above, revealing clear differences not only 
between successive oscillation amplitudes but also between uniform and energy-trapped 
crystals. The latter as expected, was characterized by a large clear out area better perceived 
at amplitudes generated above 5V. Moreover, the formation of nodal patterns appears to be 
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more accentuated for the 80nm-energy-trapped crystal. Such characteristics were however 
not observed in the case of uniform crystals, where the greatest central area of the crystal 
was still in its majority covered with microparticles after scanning at 15 V. 
Figure 46 Microscope image showing the top electrode of an energy-trapped quartz crystal resonator 
(60nm) This figure shows the radial displacement of IgE-coated microparticles adsorbed via 
aptameric interactions (gold colour) after a constant mode scan 15 V constant mode scan 
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Figure 47 Microphraphs showing a top view of the top QCR electrode coated with IgE-MPs (0.8 µM). Pictures show the whole area of the 
the electrode (ϕ = 5mm) and each row represents a separate experiment. 
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Independently the oscillation amplitude, a fraction of surface microparticles remains bound at 
the centre of the crystal, aligned with the direction of the flow at which they were injected. 
This could be an artefact introduced by the supporting structure, generating a node normal 
to the oscillation axis. The comparison between surface fractional coverage after 
microparticle displacement arising from different energy-trapping extents, not excluding 
uniform crystals, demonstrated that the fraction as well as the extent by which microparticles 
move toward the edge of the crystal, depends heavily on the magnitude of the applied 
potential. For this reason, it was important to develop an understanding of the forces arising 
from the thickness-shear horizontal displacement of the crystal generating microparticle 
momentum.  A self-assembled monolayer of single alkyl thiol composition (HS-(CH2)11-EG3-
OCH3) was prepared overnight on the surface of an energy-trapped (60 nm) quartz crystal 
resonator.  Magnetic microparticles with carboxylic surface groups (hydrophilic) were flowed 
across the sensor’s surface and allowed to settle under static flow conditions. Figure 5 
shows the distribution of microparticles on the surface, generated by oscillating the crystal at 
fundamental (top row) or third overtone drive (bottom row) frequencies. In contrast with the 
observations made with microparticles adsorbed via IgE-aptamer interactions, the extent of 
microparticle displacement in the absence of such interactions is intuitively greater. These 
results thus suggest a possible link between contact adhesion and the extent by which 
microparticles displace as distance travelled by the particles from the centre of the QCR 
under oscillation. Since the amplitude of oscillation is proportional to the inverse square of 
the harmonic order, the radial displacement of the microparticles also decreases with 
effective area. Interestingly, the appearance of concentric rings at overtone drive (𝑓3 =
42.9 MHz) could be due to coupling of harmonic modes [316]. The third row in Figure 48 
shows a three-dimensional rendering of the particle distribution after successive acoustic 
dissociation scans at overtone drive.  
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Figure 48 Micrographs of carboxy-coated microparticles on a 14.3MHz QCR surface coated with methoxy-terminated alnkanetiols (OCH3). Radial displacement 
is shown for fundamental (top) and third overtone drive (middle). The third row shows a three-dimensional rendering, produced with ImageJ, of the middle row 
with an area of 7mm2 to help visualise the vibration pattern. 
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5.3.2. Dissociation kinetics 
The experiments described in Chapter IV, where microparticles were coated with different 
concentrations of IgE, revealed yet another interesting remark relating to strength of surface-
particle interactions. As the aforementioned acoustic dissociation process was applied on 
these microparticles, the extent of microparticle displacement differed across the different 
IgE concentrations tested. The clear-out area substantially increased beyond the diameter of 
the extra gold layer for lower concentrations (0.16 and 0.016 µM), while microparticle 
displacement was observed even at lower drive potentials. Note that as discussed in 
Section 4.3.1, a decrease in concentration translates into a decrease in density of IgE on 
the surface of the microparticles. As the density decreases, so does the likelihood of 
interaction between IgE and the aptamer on the QCR surface. It was therefore important to 
capture these observations analytically by studying the QCR response upon microparticle 
dissociation.  
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Figure 319 Micrographs of energy–trapped QCR surfaces after acoustic dissociation scans. The values expressed in molarity units relate to the 
concentration of IgE used to functionalize the microparticles. 60nm 
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Provided that the extent of micorparticle displacement is a characteristic of both oscillation 
amplitude and strength of particle-surface adhesion, the method here discussed could be 
used to the same effect as REVS. Here the fraction of microparticles removed as function of 
drive level is presented as relative change in signal from the saturation point (approximation 
of 𝑅𝑒𝑞) . However, given that sensitivity to number of adsorbed microparticles is inversely 
proportional to the oscillation amplitude at high drive potentials, the surface was monitored 
by low potential frequency sweeps (0.5 and 2.5V).  
Provided that the dissociation process does not damage or alter the structure of the 
biointerface, a second association phase can be performed on the same sensor. Figure 320 
shows surface regeneration achieved by acoustic dissociation of IgE-microparticles bound to 
D17.4. Interestingly, ΔD and ΔI3f do not restore to baseline levels upon acoustic dissociation, 
whereas the same does not apply for Δf. During the second association phase in (Figure 
320 (IV)), all three parameters plateau at values lower than the initial Rmax. Molecular films, 
including functionalization molecules contribute predominantly to frequency shift. The 
desorption of molecules, rather than microparticles, can explain the shift in resonance 
frequency below baseline levels. It is important to know if this includes desorption of 
receptors or impurities. The fact that the extent by which the signal changes in the second 
cycle could be explained by possible disruption of receptors or the fact that the majority of 
microparticles are not completely removed from the surface of the crystal.  
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Figure 320 Real-time raw acoustic response of a quartz crystal resonator functionalised with DNA 
aptamers with affinity towards IgE coated on microparticles. The assay is composed of five 
phases: baseline stability stage (I), association phase (II), acoustic dissociation (III) and a 
repetition of phase I and II. 
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In order to establish an accurate comparison between the three parameters, these were 
normalized according to their respective𝑅𝑚𝑎𝑥 value. Figure 1 shows an acoustic dissociation 
process for microparticles coated with IgE (1.6 µM). Four monitoring scans (0.5 and 2.5 V for 
0.1 s) are taken every two minutes after each disruptive scan. The change in 𝑅𝑚𝑎𝑥for all 
three parameters was normalized to facilitate comparison. Since 𝑅𝑚𝑎𝑥 represents maximum 
surface coverage (θ), any decrease from this value should be interpreted as microparticle 
removal. Both ΔD and ΔI3f appear to decrease almost exponentially as function of frequency-
sweep potential. A small number microparticles remained bound at the centre of the 
electrode even at higher amplitudes. This may explain why ΔD and ΔI3f do not reach baseline 
levels (θ = 0) after acoustic dissociation. This unlikely to be due to heat generation since the 
difference between first and fourth monitoring scans does not seem to change with 
increasing potential. It is possible however that some microparticles in suspension are being 
carried by flow onto the effective area of the crystal and thereby contributing to a signal 
increase. The rationale behind performing a dissociative process under flow is twofold. The 
continuous hydrodynamic shear stress on the resonator surface would help remove loosely 
bound particles and carry them out of the fluidic system. Secondly, the flow helps dissipate 
heat, preventing therefore potential signal interference especially in the case of high 
amplitude scans.    
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The effect of scan duration on the efficiency of microparticle removal was also investigated 
at different potentials. Instead of one disruptive scan at a given potential, five intermittent 
scans are taken with a five-minute interval in-between. In Figure 2, each data point 
represents an average of five scans taken in a space of 5min after applying a disruptive scan. 
These results reveal two important conclusions. Firstly, the signal remains stable at low 
potentials, such as 2.5 V, possibly due to low levels of microparticle unbinding. At 5 and 7.5 
V the signal decreases exponentially stabilising after four or five disruptive scans. At higher 
amplitudes however, the signal decreases linearly with number of dissociation scans 
displaying a linear trend.  
Figure 51 Decrease in microparticle coverage inside the effective electrode area monitored by 
acoustic parameters.  Dashed line corresponds to θ = 0. 
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Figure 332 Variation in energy dissipation (D) according to the number of disruptive scans at the described drive 
potentials.  
One of the aims of this experimental section is to try to understand if acoustic-driven 
microparticle dissociation could be used to discriminate between affinities of intermolecular 
interactions. This has been qualitatively demonstrated in Figure 319, where a possible 
relationship between the extent of particle displacement and IgE density was established 
based on micrographs of the QCR surface. Figure 343 shows the dissociation process 
monitored by energy dissipation for two IgE concentrations. Both concentrations exhibit an 
exponential signal change resultant of microparticle desorption. Interestingly however, while 
the highest concentration (1.6 µM) seems to approach an asymptotic limit for the range of 
potentials applied, the lowest concentration (0.8 µM) changes abruptly into a zero-
approaching linear trend. Even though only the change in energy dissipation (and not 𝐼3𝑓) is 
represented in Figure 343, both parameters behave similarly in this case. It is also important 
to note that the θ=0 corresponds to a detection limit and not the actual microparticle 
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coverage on the QCR surface. The exponential signal decrease as function of applied force 
can thus be described as:  
𝜃(𝐹) =  −𝑘𝑜𝑓𝑓𝐹 (16) 
 
 
Figure 343 Acoustic dissociation of IgE-mciroparticles based on energy dissipation change from association 
equilibrium stage. 
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5.3.3. Thiolate-aptamer assay 
Cyclic voltammetry 
In this section, the objective is to study the adsorption of thiolated D17.4ext onto the gold 
QCR surface. A self-assembled monolayer of thiolated D17.4ext was formed on the QCR 
gold surface and its capacitive behaviour was studied by cyclic voltammetry. Figure 354 
shows voltammograms of bare gold (Au) before and after functionalization with thiolated IgE 
aptamer (SH-D17.4). Several potential sweeps are applied between the QCR electrode and 
the counter electrode in a PBS solution containing 2.5 mM [Fe(CN)6]3-/4-. The resulting 
voltammograms in Figure 10 shows a duck-shape curve typical of reversible electrochemical 
reactions. The decrease in current after incubating the gold electrode with SH-D17.4 (1 µM) 
points to the formation of a surface monolayer. Likewise, after cleaning the crystal for a 
second round the same electrochemical characteristics of cleaned gold are achieved. The 
potential difference (ΔEP) between the anodic and cathodic peaks for single-electron transfer 
reactions on a perfect gold surface is theoretically given at 59mV, contrasting with a potential 
difference of 86mV obtained here. A small shift of the curve towards cathodic potential, with 
Epa/Epc between clean gold (0.185/0.271 V) and after treatment (0.19/0.276 V). Potential 
difference values above 58mV may be due to imperfections or contamination of the gold 
surface. It should also be noted that the strength of thiolate-Au bond (40-50 kcal.mol-1) in this 
context represents one the worse contamination scenarios.   
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Acoustic dissociation 
The dissociation assay was performed on a QCR functionalised with thiolated D17.4 (SH-
D17.4ext) with microparticles functionalized with IgE (0.8 µM). Figure 10 shows both 
association and dissociation phases as measured by the three different parameters. By 
analysing the dissociation phase it can be concluded that the relative signal decrease as 
proportion of Rmax is lower for all three parameters in comparison the same concentration of 
IgE count to biotinylated aptamer (Figure 365a and b). Microscopically the surface of the 
resonator appeared unaltered by the vibrations at a wide range of potentials. Unexpectedly, 
a large proportion of the particles remained bound to the surface even after frequency sweep 
at 22.5 V for 30 s. Figure 365c shows the presence of air bubbles (light-blue arrows) formed 
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Figure 354 Cyclic voltammograms of different stages of QCR electrode functionalization. (dash 
black) pre-treated gold surface; (red solid) after 45min incubation with thiolated D17.4 ( 1µM) 
solution; (blue dot) second round of cleaning treatment to remove aptamers from the gold surface. 
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during a frequency sweep at 22.5V (30s). It is not however clear whether this was generated 
due to heat accumulation, hydrolysis or surface hydrophobicity. 
 
Figure 365 Acoustic signal recorded at association and dissociation phases of IgE-MP (0.8 µM) on a thiolated 
D17.4 surface (a, b). A micrograph of the QCR surface taken after a dissociation scan (22.5 V for 30 s)(c). Light 
blue arrows denote air bubbles.  
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The dissociation process is captured in Figure 376, comparing the two different surface 
chemistries with the same IgE concentration (0.8 µM). Whilst the biotin-streptavidin 
mediated assay behaved like previously reported, a slower dissociation rate was observed 
for self-assembled D17.4. Given that the IgE density on the microparticles varies linearly 
between 0.8 and 3.2 µM (Figure 250), one can argue that  assembly of thiolated D17.4 on 
the QCR increases particle-surface interaction strength significantly compared to assembly 
via a biotin-streptavidin complex.   
 
 
  
Figure 376 Acoustic dissociation of IgE-microparticles based on energy dissipation 
change from equilibrium. A comparison of dissociation kinetics between two different 
extents of multivalent interactions.  
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5.4. Discussion 
The work here described presents an analytical method to investigate particle-surface 
interactions based on intermolecular dissociations mediated by surface of thickness-shear 
oscillations of a quartz crystal resonator. The inertial forces counteracting particle-surface 
interactions arise from both the horizontal displacement of the resonator as well as the 
propagation of standing waves into the sample medium [194]. Both these parameters vary 
linearly with the electrical potential applied to the resonator [259]. These forces combine to 
act on uniformly distributed microparticles on the surface of the resonator, displacing them 
towards parts of the crystal with lower vibration energy. This phenomenon has been long 
characterized for AT-cut (5-6 MHz) quartz crystals, though a non-interferometric laser 
speckle imaging method reported by Hertl et al. (1985). The results showed a confinement of 
the amplitude distribution at the centre of the electrode, where the central peak displacement 
decreases proportionally with the square of the harmonic order [317]. Finally, the same study 
reports the appearance of coupled vibration modes at higher amplitudes, also seen in this 
work.  
The existence of a critical oscillation amplitude capable of averting particle-surface contact 
has been previously reported [288], [318]. Because the sensitivity of a TSM quartz crystal 
resonator follows a Gaussian distribution [273], microparticles adsorbing away from the 
electrode centre (where sensitivity is highest) contribute to a lesser extent to modulation of 
the acoustic signal. In this work however, microparticle adsorption via IgE-aptamer 
interactions was carried out at low potentials to avoid perturbation of particle-surface 
contacts.   
The dissociation phase was characterized by a progressive exponential signal change as 
function of oscillation amplitude. While this contrasts with the concept of a single-rupture 
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event as reported in REVS literature [319], it is thought to be a result of the variation of 
immobilized IgE densities. Furthermore, it is possible that the microparticles remaining on 
the surface of the resonator at high potentials may indeed display the highest IgE surface 
densities. Since the linear flow velocity decreases with the distance from the center, 
microparticles travelling along the shortest path between the inlet and outlet carry more 
momentum [320]. The hydrodynamic drag force exerted on the microparticles provides a 
selective force for stronger adsorption. Indeed, the observation of an abrupt change in 
dissociation rate seen for 0.8 µM IgE (Figure 343) could be the result of disruption of highest 
valency interactions, thereby agreeing with previous observations [293], [321]–[323]. 
Furthermore, the reason for why this abrupt change did not immediately reach baseline 
levels could be explained by the short scan duration, thus failing to remove all microparticles. 
Indeed the disruptive scan duration used here falls close to the lower limit reported for REVS 
(30-500 s) [192]. Estimating the contribution of temperature in the absence of thermal 
imaging capability is challenging, especially under continuous flow. Although, the formation 
of air bubbles at high potentials points to a significant increase in temperature. On the other 
hand the Cooper et al. (2011) reports temperature increase lower than 1oC measured 
through thermal imaging at 10 V (8–10 min scan). Heat transfer into the liquid could be 
simply measured through the temperature dependence of the viscosity of Newtonian fluids, 
as shown in Equation 4 [324].  
Replacing the values in Equation 15 for a uniform 14.3MHz QCR driven at fundamental 
frequency with a 12.5V potential, the force exerted on the particle by the crystals is 
approximately 1.2 N. For comparison, the force required to break a single streptavidin-biotin 
bond depending on the load-rate is 0.3 nN [325] while the force required to disrupt IgE-D17.4 
is within the piconewton range [293], [312]. Finally, even though only two IgE concentrations 
have been explored here, Figure 319 shows that if such system could be quantitatively 
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resolved, it would represent a higher sensitivity than the association kinetics described in 
Chapter IV. 
  
5.5. Conclusion 
In this section, an analytical method is described for controlled molecular dissociation 
mediated by acoustic force. At high oscillation potentials, the steady flow of liquid normal to 
the QCR surface and the head generated, both consequences of oscillatory energy 
dissipation, forces IgE-MP to detach from the surface and displace towards areas of low 
vibration energy. This phenomenon was also shown to be more accentuated for energy-
trapped crystals. 
The density of IgE-D17.4 complexes was varied as described in Chapter IV, resulting in 
different strengths of particle-QCR contact stiffness. The extent of acoustic-mediated 
microparticle dissociation as function of drive potential of disruptive scans was shown to 
depend on IgE concentration. These observations were made qualitatively through 
microscopic examination of the QCR surface and analytically, by analysing its respective 
acoustic response after each dissociation step.   
The method described here allows for thermodynamic analysis of multivalent interactions 
between micron-sized particles and the QCR surface, applicable to bead-based assays as 
well as other particles like bacteria and mammalian cells. Moreover, this holds potential for 
future development of fully electronic and portable sensors, capable of point-of-need use 
without resorting to chemically-assisted molecular dissociation. 
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6. Chapter VI 
Investigating the acoustic response of a quartz crystal resonator for cellular 
phenotyping: a look at in vitro erythroid differentiation. 
 
6.1. Introduction 
Sensors capable of label-free estimation of cell-membrane ligand density are predominantly  
based on shear flow chambers [326]–[328], centrifugation [329], optical trapping [330], 
micropipette techniques [263], [331], [332]. Acoustic-based immunophenotyping has also 
been reported, relying on 2D kinetics to provide a relative quantification of membrane-ligand 
density [140], [333]–[335]. Saitakis and colleagues (2008) demonstrates that the time 
derivative of cell adsorption monitored by acoustic energy dissipation of a 110MHz Y-cut 
(flexure mode) correlates with density of membrane receptors on LG2 B-lymphoblastoid 
cells. Moreover, the authors claim that attempts to replicate the work on a surface plasmon 
resonance device were not successful. One of the drawbacks of studying cell-surface 
interactions with quartz crystal resonators is the overshadowing effect of the cell membrane 
on energy dissipation, challenging the study of contact mechanics. This has drawn attention 
toward other surface-interaction-sensitive techniques like surface plasmon resonance, which 
despite only being sensitive to the extent of surface coverage, derives two-dimensional 
thermodynamic parameters solely from shear stress exerted by laminar flow on the cell-
surface contact [148].  
Mammalian cells exhibit non-rigid viscoelastic properties (high loss modulus and low storage 
modulus) which cannot be explained by study of resonance frequency alone (Sauerbrey 
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relation) [336]. Their object of interest in QCM studies has instead shifted towards monitoring 
of frictional dissipative losses induced by a large range of viscoelastic properties, predictive 
of both pathological states, such as cancer and cytotoxicity, but also differentiation and 
immunomodulation [143], [337]. The oscillatory energy is primarily dissipated into the cell 
bulk and the liquid-cell boundary which extends to the cell-surface contact area [338]. In the 
absence of adhesion and spreading, a single focal contact point between the cell and the 
resonator surface mediated by antibody-antigen interactions, also dissipates a significant 
amount of energy (point contact) [339], [340].  
A straightforward example of a cell-based therapy product is in vitro generated erythrocytes. 
Artificial blood components represent a viable solution to worldwide homogenisation of 
quality, safety and availability of blood units [341]. The feasibility of this concept has been 
successfully demonstrated on multiple occasions, with a variety haematopoietic stem cell 
(HSC) sources, including peripheral blood [342], bone marrow [343] and cord blood CD34+ 
cells [344]. Nevertheless, production of artificial RBC units faces numerous hurdles to large-
scale formulation of blood units (1012 cells). Amongst the most pressing challenges is the 
level of control over expansion and enucleation [341], [345], attainable through in-process 
measurements of cell quality attributes [341], [345]. Erythropoiesis, the process whereby 
hematopoietic stem cells (HSCs) differentiate into mature erythrocytes, is characterized by 
distinct changes in mechanophenotype and surface-antigen expression changes which are 
used to study the dynamics of this process [346].  
This section analyses how QCR sensitivity to mass coupling and viscoelasticity of 
heterogeneous films (e.g. cells) can be explored to monitor changes in surface antigen 
expression of cultured erythroprogenitor cells.  
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Figure 57 Schematics of erythroblast adsorption mediated by antibody-antigen interactions. 
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6.2. Materials and Methods 
6.2.1. Reagents 
Phycoerythrin-conjugated antibodies anti-human CD36 Antibody (336205) and anti-human 
CD44 Antibody (338806) were procured from BioLegend (UK). FITC-conjugated anti-CD71 
was procured from BD Biosciences.  
6.2.2. X-ray photoelectron spectroscopy (XPS) 
Photoelectron spectroscopy has been extensively used to characterize both composition and 
orientation self-assembled monolayers. In X-ray Photoelectron Spectroscopy (XPS), also 
known as Electron Spectroscopy for Chemical Analysis (ESCA), the sample is bombarded 
with X-ray photons of fixed energy leading to the emission of a core electron, a process 
called photoionization (Figure ). Analysis of the kinetic energy (𝐾𝐸)  distribution of the 
emitted photoelectrons is based on Einstein relation (𝐾𝐸 = ℎ𝑣 − 𝐵𝐸), where ℎ is Planck’s 
constant (6.62 x 10-34 J.s), v is the radiation frequency (Hz) and BE (binding energy) is the 
energy difference between neutral and ionized atom. For every element there is an 
associated binding energy for each atomic core orbital which is detected in the photoelectron 
spectrum as a peak [347]. The intensity of the peaks their position in the photoelectron 
spectrum denotes the specific element and its concentration in the sample, respectively 
(Figure 8). Moreover, the depth of analysis for an XPS measurement is approximately 1-10 
nm while spatial lateral spatial resolution as small as 10nm.  
 
  
    
Page 172 of 289 
 
 
Figure 58 Simplified schematic representation of XPS analysis of QCR gold surface. 
In this experimental work, all XPS measurements were carried out at the Loughborough 
Materials Characterisation Centre located within the Materials Department, Loughborough 
University. Electrodes were functionalized at different with different ratios of functional and 
non-reactive groups (COOH:CH3) and thoroughly cleaned with 200-proof ethanol prior to 
analysis. Atomic composition of the self-assembled monolayer on the QCR electrode was 
carried out using a Al K-𝛼 Surface Analysis X-ray photoelectron spectrophotometer (Thermo 
Scientific, UK). Spectra were recorded with a 200 eV pass energy (400cμm spot).  
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6.2.3. Culturing CD34+ cells 
Fresh umbilical cord-derived mononuclear cells (MNC) were supplied by the Anthony Nolan 
Cell Therapy Centre (http://www.anthonynolan.org/clinicians-and-researchers/cord-blood-
services) with informed consent and NREC ethical approval. CD34+ cells were isolated via 
positive selection using CD34 antibody-labelled microbeads as per the manufacturer’s 
instructions (Miltenyi Biotec, Germany). Mixed donor CD34+ cells (>90% purity) were 
cryopreserved prior to cell culture. On thaw, CD34+ cells were cultured in accordance with a 
three-stage protocol as described previously by Griffiths et al. (2012)[348]. Briefly, cells were 
cultured in IMDM (Source BioScience) containing 3% (v/v) AB Serum (Sigma), 2 mg.mL-1 
human serum albumin (HSA) (Irvine Scientific, USA), 10 μg/ml insulin (Sigma), 3 U.mL-1 
heparin (Sigma), 500 μg.mL-1 iron saturated transferrin (R&D Systems). In the first stage 
(days 0-8) medium was supplemented with 10 ng.mL-1 SCF, 1 ng.mL-1 IL-3 and 3 U/ml 
erythropoietin (EPO); in the second stage (days 8-11) medium was supplemented with 10 
ng.ml-1 SCF, 3 U.mL-1 EPO and in the final stage (days 11-20) with 3 U.mL-1  EPO.  
Cells were cultured in tissue culture flasks at 37°C, 5% CO2; they were fed by addition of 
medium on day 3 of culture; they were fed daily to maintain density between 2-3 x 105.mL-1 
until day 8. At day 8, proerythroblasts are harvested, washed and set up in the second stage 
culture medium and maintained at 3-10x105 cells.mL-1 by daily addition of medium. On day 
11, cultured erythroblasts are washed in to tertiary medium for maturation and enucleation to 
form reticulocytes up to day 18-24, and maintained at 5-10 x 105 cells.mL-1, feeding every 
other day. 
  
  
    
Page 174 of 289 
 
6.2.4. Flow cytometry  
Cells were sampled (1x105/tube) into flow buffer (PBS containing 1% BSA) and centrifuged 
at 300g for 5 minutes. Cell pellets were re-suspended and mixed with 0.5 μg/mL of CD36 or 
CD44 antibody to a final volume of 50 μL. The same was also carried out with an IgG 
isotype control to measure the level of nonspecific background. Samples were incubated for 
30 minutes at room temperature, washed once and analysed using a BD FACSCanto™ II 
flow cytometer (BD Biosciences, USA) and gated against specific isotype controls. 
6.2.5. Functionalization of quartz crystal resonator 
For every experiment an AT-cut quartz crystal resonator (f0 ≈ 14.3 MHz) was sonicated in 
acetone and isopropanol sonication baths, followed by argon plasma treatment at 250 W for 
90 s (Harrick Plasma, US). The cleaned crystals were left immersed for ≥24h in 1 mM 
ethanoic solution of 1:9 carboxylic to methoxy-terminated alkyl thiols, respectively. The 
crystal was placed in a fluidic cell and cleaned by flushing though with ethanol followed by 
copious amounts of water.  
A freshly prepared solution containing equal parts of EDC (0.4 M) and NHS (0.1 M) 
dissolved in 25 mM MES (pH 5.0) is injected for 7 min at 20 µL/min to activate COOH 
groups. The surface was immediately washed with 0.1 M MES (pH 5.0) at 100 µl/min. 
Antibodies are diluted in 0.1 MES (pH 5.0) and injected at 10ul/min for 15min. Unreacted 
esters were quenched by flowing 50 mM Ethanolamine (pH 8) for 15 min followed by 0.1% 
BSA in PBS-T (0.05%) for 20 min. 
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6.3. Results 
6.3.1. Surface characterization 
X-ray photoelectron spectroscopy (XPS) 
The spectra obtained for all samples tested confirm the presence of the expected constituent 
elements of an alkyl thiol monolayer in the range of binding energies analysed. The element 
spectra of the different samples can be found in appendix A5. The double peak observed at 
84.0 eV commonly relates to thiolate species bonded to the Au surface. The S2p spectrum 
exhibited a single S2p doublet at ∼162 eV for the S2p3/2 component corresponding to 
thiolate species [349]. The signal intensity from this is very weak due to inelastic scattering 
of S2p electrons (see appendix A5). A distinctive peak at 284.8 eV is characteristic of 
aliphatic hydrocarbon chains with functional groups appearing at higher binding energies 
[350]. 
The atomic composition of surface layer is calculated by dividing the photoelectron intensity 
for a given element with the sensitivity factor of that element (Table 4). Increasing peak 
intensity of O1s (532 eV) with increasing ratios of reactive groups matches expected values 
arising due longer polyethylene glycol chains of thiol species containing reactive groups (-
COOH). A single sample (50% COOH:CH3) was analysed with angle-resolved XPS 
(ARXPS) in order to measure Au4f, C1s, O1s and S2p regions of the XPS spectra, as a 
function of angle over a 60° range (with respect to the surface normal). 
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Table 4 Atomic composition of different functional group (-COOH) ratios, expressed as percentage. 
 Binding energy (eV) 
COOH:OCH3 (%) Au4f O1s S2p C1s C-C/C-H C1s C-O C1s O=C-O 
0 52.06 5.58 2.12 29.8 8.84 1.6 
1 56.6 4.23 2.7 26.78 8.66 1.03 
5 31.57 8.54 1.81 28.93 26.6 2.55 
10 31.96 12.2 2.37 30.02 21.97 1.48 
50 26.29 15.04 1.82 27.98 26.54 2.32 
100 23.39 15.94 1.44 29.5 27.13 2.6 
 
In theory this technique allows to characterize the thickness and distribution of the 
monolayer, however it was not possible due to unexpected increase in gold percentage with 
increase in take-off angle. Nonetheless it was observed an unexpected increase in the 
percentage of gold composition with increasing take-off angles (Figure 59).  
 
 
  
Figure 59 Atomic content of 50% COOH:CH3 QCM surface based on beam 
incidence angle. 
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Antibody immobilization 
The choice of covalently immobilizing antibodies via carbodiimide crosslinking chemistry, as 
opposed to high-affinity ligand pairs such as G/A protein or even double antibody receptor 
(refer to Section 2.3.2), is accredited to the fact that these complexes have fast off-rates 
(>30 min). The duration of the assay here presented, including the surface preparation time 
,extends over two hours, making these immobilization strategies impractical [267]. 
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Figure 60 shows change in fundamental resonance frequency during immobilization of anti-
CD36 antibodies on the gold surface. A frequency shift of approximately 270 Hz, 
corresponding to approximately 2x105 IgG/µm2 (MW = 150 kDa) based on 𝛥𝑓 = −𝐶𝑓 ∙ 𝛥𝑚, 
where 𝐶𝑓 is Sauerbrey’s sensitivity factor (56.5 Hz.µg
-1.cm2). Considering a docking area of 
113nm2 [351] for IgG one should expect only 22,222 molecules/µm2, which may indicate the 
presence of a multilayered-film formation on the surface of the resonator.   
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Figure 380 Cumulative anti-CD36 immobilisation on QCR surface monitored by change in 
resonance frequency. 
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6.3.2. Determination of relative cell size by flow cytometry 
The average relative cell size was obtained by measuring the amount of forward scattered 
light (FSC). Figure 61a shows a heatmap of forward versus scattered light (SSC) with a 
polygonal outline in each graph defines the group of events (particles) that were analyzed for 
surface marker expression (gating). This selection is carried out in order to remove debris 
and dead cells from the analysis. The geometric mean of each distribution is shown in 
Figure 61b, showing cell size decreasing linearly after day 6. Moreover, a larger number of 
events recording high SSC values on day 17, could be explained by the presence of 
enucleated cells. 
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Figure 391 Flow cytometric analysis of human CD34+ cells differentiated into erythroid cells. (a) Density plot cytogram with gated CD34+ based on side scatter (SSC) and 
forward scatter (FSC) readings for each cell (dot) analysed. (b) FSC and SSC averages of biological replicates (n=10) across the culture period.
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6.3.3.  Relative quantification of surface marker expression 
One of the objectives of this study was to investigate potential relationships between surface 
marker expression and the QCR acoustic response. To this effect, the expression levels for 
CD36 on the cultured erythroblasts were analysed at days 2, 6, 9, 13 and 17. Potential 
confounding effects of changes in cell size and viscosity were accounted for by measuring 
the expression of CD44 in a QCR sensor running in parallel. The choice of CD44 as control 
marker was based on the findings of Hu et al. (2013), that concluded that the expression of 
CD44 decreased only threefold between proerythroblasts and orthochromatic stages of 
differentiation. Moreover, both CD36 and CD44 belong to the same group of adhesion 
molecules.  
In Figure 40, histograms show the distributions of relative fluorescence intensity of CD36 
and CD44 for the different culture samples. The histogram at day 13 is omitted from this 
comparison because it was measured by mistake at different light source voltages. This 
caused the fluorescence intensity distribution to fall outside the range presented for the other 
days. Here, fluorescence intensity corresponds to the average number of immune 
complexes formed per cell analysed (event). Fluorescence intensity provides therefore a 
relative quantification of the membrane-surface density of antigens (CD36 or CD44) present 
on each cell. These values are presented in a logarithmic scale so to facilitate visual 
interpretation of the large distributions obtained for different culture samples.  
The geometric means of the distributions for two technical replicates are shown in Figure 3, 
for CD36 and CD44. Furthermore, the proportion of CD36+ and CD44+ cells per sample is 
calculated based on the number of events that are higher and non-overlapping with the 
distribution of the isotype control (non-specific antibody with the same fluorophore) (insets in 
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Figure 402). The cut off is drawn so that less than 5% of the events run with the isotype 
control. 
Both the relative CD36 expression (membrane surface density) and the proportion of CD36+ 
cells vary in a similar way throughout the fifteen-day culture period. An initial increase in 
CD36 expression, transitioning to a progressive decrease around day 9. The progressive 
non-monotonic behavior was also reported by [346] Identified bimodal distribution at D6 and 
broad distribution of expression levels on day 17. Based on this approximately symmetrical 
distribution, the expression of CD36 can be categorized into to three distinct levels of 
expression: CD36hi (day 9), CD36med (days 6 and 13) and CD36low (days 2 and 17). Our 
results show a significant decrease in CD44 expression between day 2 and 17 of over 
fourfold. These findings therefore challenge the validity of CD44 as cell size/morphology 
control. Interestingly however, the percentages of CD44+ cells for each day (Figure 3d) 
follows very closely the respective distribution in cell sizes. 
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Figure 402 Flow cytometric analysis of human CD34 cells differentiated into erythroid cells. 
Histograms show CD34 cells at day 2 (red), 6 (blue), 9 (orange) and 17 (green) of erythroid 
differentiation stained with CD36 (a), CD44 (b) and corresponding IgG (inserts on a and b 
respectively). 
  
    
Page 185 of 289 
 
 
Figure 63 Geometric means of fluorescence intensity and percentage of marker-positive cells. 
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6.3.4. Acoustic monitoring of cell-surface interactions  
Each time point represented corresponds to average of three technical replicates, acquired 
by driving a uniform AT-cut QCR with a pure sinusoidal potential around its fundamental 
resonance frequency (𝑓0 ≈14.3 MHz) or third overtone (𝑓3 ≈42.9 MHz). The signal was 
allowed to stabilise under continuous buffer flow (20  L.min-1) and established as reference. 
Freshly sampled CD34+ erythroblasts were washed in PBS-Tween-20 (0.05%) three times 
and finally re-suspended in PBS. A concentrated cell sample was spiked in the buffer 
reservoir to a final sample concentration of 5 × 105 cells.mL-1 and continuously injected for 
45 min. The plots in Figure 64 show the average response of a QCR functionalised with 
anti-CD36 antibodies upon injection of CD34+ erythroblasts. Each data set corresponds to 
raw QCR data obtained for the different culture time points – days 2, 6, 9, 13 and 17. The 
exponential signal change as function of time, measured by resonance frequency (Δf) and 
bandwidth (ΔΓ), suggests that the acoustic response evolves monotonically with number of 
cells adsorbed on the QCR surface as observed under the microscope (data not shown).  
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Figure 414 Detection of CD36+ erythroblasts adsorbed on QCR operating at fundamental (𝑓0 ≈14.3 MHz) or third 
overtone resonance frequency (𝑓3 ≈42.9MHz). Time-dependent signal progression under continuous sample flow 
(20 µl/min) after injection of cell sample at 5x105 cells.mL-1. Driven at fundamental (a-c) and third overtone (d-f) 
frequencies. Data points represent averages calculated from replicate experiments (n=3).  
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Negative Δf and positive ΔΓ were observed across all samples at both fundamental and third 
overtone drive, albeit at different reaction rates. Because mass sensitivity is predicted to be 
proportional to drive frequency, both parameters were divided by the respective overtone 
order (Δfn/n and ΔΓn/n) for ease of comparison. The ratio ΔΓ/(-Δf), or Df ratio, compares the 
rate of energy dissipation normalized with mass coupling. A linear function (ΔΓ=-Δf) 
delineates the limit at which ΔΓ and Δf are linearly proportional. The Df ratios presented 
were also interpolated with a linear function and the slope and correlation coefficient detailed 
in Table 5. Figure 425 shows average and standard deviation of the last three time points 
(t=35-45 min) in the sensograms of both resonance frequency (Figure 42a and b), 
establishing a clear comparison between the derived acoustic parameters at different culture 
stages. 
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Figure 425 Average QCR response comparison anti-CD36. Column bars represent average and standard 
deviation (n=3) of the QCR signal taken at the end of assay (t = 35-45 min).  
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Table 5 Slope and correlation coefficient (R2) derived from fitting ΔΓ/Δf as shown in Figure 41, for fundamental 
(c) and third overtone drive (f). 
 
f
0
 f
3
 
Day m R2 m R2 
2 0.447 0.974 0.426 0.741 
6 1.581 0.995 1.148 0.999 
9 2.425 0.976 1.106 0.999 
13 1.584 0.948 1.380 0.981 
17 2.398 0.857 2.168 0.971 
 
The average QCR response based on CD44 detection for fundamental and overtone 
frequency drive. Due to time constraints QCR experiments based on expression of CD44 
were only measured for two culture stages, day 6 and 17. Since the aim of monitoring 
expression of CD44 was to account for differences in cell size, these two are very to 
potential confounding the size of erythroblasts differed significantly. Adsorption mediated by 
the two markers behaves similarly in regarding energy dissipation and resonance frequency 
shift.  
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Figure 436 Comparison of adsorption kinetics between CD36 and CD44 expression on days 6 and 17. 
Adsorption of erythroprogenitor cells monitored via shift in resonance frequency (Δf) and bandwidth (ΔΓ). Bar 
plots e and f show average and standard deviation (n=3) of the last three time points targeting CD34 expression. 
  
  
    
Page 192 of 289 
 
The magnitude of the third harmonic response at high-drive level scans was also analysed at 
both fundamental and third overtone drive. It is important to note that in the latter case, the 
measure of the third Fourier harmonic current actually corresponds to the ninth harmonic 
(9ω) since the resonator is driven at close to its third overtone.  
Contrary to Δf and ΔΓ, the behavior of Δ𝐼′3𝑓𝑚𝑎𝑥/𝐼
′
3𝑓𝑚𝑎𝑥 was erratic and non-monotonic even 
at high potentials Moreover, the reaction kinetics can hardly be described by an exponential 
function which resulted in poor fitting of sensograms. Such instability is particularly 
accentuated at third overtone drive (Figure 7d-f) possibly due to the expected lower 
magnitude of ninth harmonic excitation. 
 
Figure 67 Sensograms of  third overtone drive at fundamental drive (a,b,c) and third overtone drive (d,e,f). 
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6.3.5. QCR surface imaging 
Clear differences in QCR surface densities of erythroblasts across the different culture 
stages are observed on the micrographs taken at the end of the assay. Cell densities and 
diameters were obtained through automatic count using an image algorithm in ImageJ. 
Figure 6Figure 458b (left) shows differences in cell densities on the QCR surface between 
days, with the lowest and highest values corresponding to day 2 and day 9, respectively. 
Moreover, this symmetric distribution approximates that seen in Figure 63a and bFigure 45, 
demonstrating CD36 expression as measured by flow cytometry. Random spatial distribution 
of closely packed spheres yields a packing density of approximately 0.772 [352]. Assuming a 
uniform distribution of receptors on the surface, one can equate this to 6825 cells/mm2 (Ø 
=12  m) which in the present dataset is equivalent to 2% (day 2) and 8% (day 9) coverage. 
Moreover, microscopy observations of the QCR surface revealed that the cells were 
predominantly adsorbed individually (no aggregation) and uniformly across the QCR 
electrode.  
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Figure 68 Microscopic examination of cells on QCR surface. (a) Micrographs taken at the end of the assay (t = 45min) showing cell number and morphology. QCR surfaces 
were functionalised with monoclonal antibodies against CD36. (b) Cell density and diameter obtained from automated image analysis showing surface density. 
  
    
Page 195 of 289 
 
6.3.6.  Effect of cryopreservation on CD36 expression 
Figure 69 shows surface micrographs of two individual quartz crystal resonators, 
functionalized with either anti-CD71 or anti-CD36. Erythroblasts were detected on the QCR 
surface under continuous flow at a concentration of 5.5x104.mL-1 in PBS for 45 min. These 
cells had been previously sampled and cryopreserve at day 9 in CryoStor® CS10 (Sigma-
Aldrich). As it can be inferred from Figure 69a, the cell surface density is highest in the 
sensor functionalized with CD71, whereas only a low number of cells can be seen on the 
anti-CD36 sensor. Despite the fact that CD36 expression is highest around day 9 in culture 
conditions, its expression is somehow altered after cryopreservation as determined by flow 
cytometry results (69b inset). CD71 however retained relatively high expression, which 
facilitated antibody-antigen interactions to form between the cells and the QCR surface. For 
these experiments, the cells were thawed and “revived” in fresh media approximately three 
hours prior to QCR measurements. 
CD71 CD36 
Figure 69 Effect of cryopreservation on surface marker expression. 
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6.4. Discussion 
In this work, human cord-derived erythroblasts were differentiated in vitro within a fifteen-day 
period. Samples were taken at five different culture stages over a fifteen-day period and 
anlysed by flow cytometry for CD36 expression and cell relative size and complexity. The 
results were used to support the understanding of cell-surface interactions which where 
hypothesized to modulate the acoustic response of the quartz crystal resonator.  
The initial hypothesis was that surface antigen (CD36) density would be simply based on 
affinity-based adsorption, as predicted by two-dimensional kinetic models. That is, the higher 
CD36 density on the cell membrane, the higher the likelihood of adsorption mediated by 
surface-immobilized anti-CD36 [148], [261]. However, thermodynamic parameters could not 
be derived from the association curves, given by ΔΓ(t) or Δf/(t), due to significant deviations 
from an exponential function. Nonetheless, cell density distribution estimated from 
micrographs of the QCR surface (Figure 458b (left)) does approximate to a significant 
extent that of CD36 expression for different culture stages up to day 13 (Figure 3a,b). An 
unexpectedly high cell density on day 17 can however be hardly explained by two-
dimensional kinetics, given the relatively low CD36 expression measured for that specific 
sample. Heavier cells flowing over the sensor carry more momentum and thus the shear 
stress applied on the surface contact is also higher, thereby establishing a selective force 
towards higher affinity interactions [261]. Cell size on day 17 was in fact the lowest recorded, 
according to forward scatter light measurements (1b), which could explain the high surface 
density.  
A very interesting observation arising from this study is how closely ΔΓ/Δf approximates that 
of surface cell density (Figure 455c). Similarly to viscous fluids, cellular adsorption on the 
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QCR induces a relatively high increase in energy dissipation, while the resonance frequency 
decreases in proportion to surface coverage [290]. Therefore, a cell monolayer on the 
resonator’s surface can be represented as semi-infinite viscoelastic material, since the 
penetration depth (Equation 5) of the evanescent acoustic wave in PBS ( =1 cP [353]), for 
fundamental (~150 nm) and third overtone drive (~88 nm), is significantly lower than the 
height of the cell monolayer (see Section 2.2) [169], [290], [354]. However, unlike fluid films, 
cell monolayers are considered heterogeneous adsorbates, characterized by impartial 
surface coverage and a relatively small contact area [336]. Thus, it is impractical to estimate 
the mass of the cell monolayer from Δf based on Sauerbrey relation, as it is the case for 
uniform rigid films. Nevertheless, Δf is proportional to the number of QCR-adsorbed cells 
provided only that the variation in viscoelastic properties is reflected in energy dissipation 
(given by ΔΓ). Thus, this theory can explain the strong agreement between ΔΓ/Δf and 
surface density.  
From small load approximation, one should be able to estimate the relative contact strength, 
given by complex load impedance (Zl ) from ΔΓ/Δf, provided that the contact area (𝐴𝑐) 
between the cell and QCR surface remains constant [290]: 
∆𝑓 + i∆Γ
𝑓
=
i
πZq
√ρ(G′ + iG′′)𝐴𝑐 
(17) 
Here Zl  is given by the square root product of the material density and complex shear 
modulus, (𝑖𝜔𝜂𝑐 𝑐)
1
2. The contact area (𝐴𝑐) between a cell and the QCR surface should be 
proportional to the cell radius provided that its viscoelastic properties remain constant 
throughout the maturation process. Cell viscoelasticity dictates the level of membrane 
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deformation arising from hydrodymanic pressure and, as result, the contact area when 
adsorbed on the resonator’s surface (Figure 460). As the level of deformation increases, 
cells become more strongly coupled to the surface, thereby increasing energy dissipation 
(ΔΓ). Deformation could indeed help explain the discrepancies in cell area measured by flow 
cytometry and by surface imaging analysis. In order to understand the impact of 
deformability in the acoustic response, one has to first acknowledge the great diversity of 
morphologic changes characteristic of erythroid differentiation. Initially, CD34+ 
erythroprogenitors proliferate without significant changes in morphology as confirmed by 
FSC values. However, possibly around day 11, cell size heterogeneity increases within the 
population, leading up to the first enucleation stages around day 13/14. The high number of 
enucleation events (nucleus loss) gives rise to a population predominantly constituted by 
highly deformable reticulocytes [96]. Such capacity to deform stems from a critical red-blood 
cell function to deliver oxygen to microvessels without haemolysis. Enucleation can in fact be 
detected by measuring side-scattered light which is predominantly modulated by the 
nucleus[355]. Now, since the cell area distribution given by forward-scattered light 
measurements does not match the cell area estimated by QCR micrographs, one has to 
account for deformation in the estimation of contact area. Moreover, such explanation could 
underlie the significantly large cell area estimated from surface imaging, when expected 
values before enucleation range around 50-75 m2 [96]. One could in fact estimate such 
deformation through elastic contact model of a soft (deformable) sphere on a rigid substrate 
(Figure 460) [356], [357]. However, it is not possible to calculate the true contact area 
because of the arbitrary nature of the FSC scale. Moreover, it is important to note that light 
scatter is dependent on the cytoplasmic refractive index which may change with enucleation.  
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Even though forward scatter values can be converted to metric units by establishing a 
calibration with microparticles of known diameter prior to the cell measurements, such 
exercise was not carried out in this case. However, since light scattering measurements in 
flow cytometry are performed on cells under approximately uniform hydrostatic pressure, 
one can consider FSC to be a measure of cell area at rest. The diagram below depicts 
deformation of an elastic sphere, which could be approximated to the behavior of a 
suspension cell in contact with the QCR surface.  
 
Figure 460 Schematics of cell deformation under hydrostatic pressure when in contact with the QCR surface. 
Adapted from Salez et al. 2013 
𝑟𝑠𝑢𝑟𝑓𝑎𝑐𝑒 =
4𝑟𝐹𝑆𝐶
3
3ℎ2
+
ℎ
3
 
(18) 
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𝐴𝑐 𝑟𝑎𝑑𝑖𝑢𝑠 = √2𝑟𝑠𝑢𝑟𝑓𝑎𝑐𝑒ℎ − ℎ2 
(19) 
Due to incompressibility, the contact area radius can be estimated from knowledge of both 
radii values [356]. An approximation to the extent of cell deformation when in contact with 
the surface can be simply derived from the ratio between the cell area and FSC values 
(
𝐴𝑟𝑒𝑎𝑐𝑒𝑙𝑙
𝐹𝑆𝐶
), as estimated by surface imaging. By normalizing ΔΓ by this ratio, one obtains a 
distribution that closely follows that of CD36 expression (Figure 471).  
 
Figure 47 Linear correlation between CD36 expression and ΔΓ normalized by contact area (Ac*) and cell area 
estimated from microscopic examination of the QCR surface at the end of the assay. Ac* represents a proxy of 
the true contact area, resulting from the simple ratio of FSC and cell area estimated from QCR imaging. 
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It is important to note at this point that changes in the cell refractive index arising from 
enucleation could also contribute to the measure forward-scattered light. However, this was 
the only technique available capable of measuring cell size in suspension [82].  
In this perspective, the relationship between CD36 expression and ΔΓn/Ac* could be 
explained by the fact that the contact area between a soft spherical particle and a rigid 
substrate, increases with the strength of adhesion [356]. As the contact radius increases, the 
sphere becomes more strongly coupled to the substrate, resulting in an increase in 
dissipated oscillatory energy (ΔΓ). However, Ac alone does not approximate the distribution 
of CD36 expression, which would be estimated from imaging analysis of the QCR surface 
and FSC values. It is plausible to consider that the ΔΓn/Ac* is also dependent on interfacial 
processes, namely contact elastic stiffness or dissipative viscosity of cell-surface contact. 
Moreover, deconvolution of the effects of viscosity and density would require direct 
measurements, which were not carried out in this study. Nevertheless, erythroprogenitor 
cells have relatively high densities (  𝑐 =1.0770 g.cm
-3), conferred by their high 
nuclear/cytoplasmic ratios. If bulk cell density where to change dramatically, it would happen 
so due to enucleation towards the final stages of maturation. Therefore in theory, the 
distribution of ΔΓ/Ac* as a function of  𝑐 would approximate a decreasing monotonic function 
for the fifteen-day period. In such case, ΔΓ/Ac* would not follow the symmetrical (non-
monotonic) distribution in CD36 expression. 
A supporting piece of evidence for contact modulation of ΔΓ can be found in the force-
displacement relation. Figure 2 presents and interesting relationship showing a decrease in 
ΔΓ (but not Δf) with increasing contact stress modulated by surface amplitude for a day 2 
sample. This is particularly interesting since that, above a certain magnitude of tangential 
  
    
Page 202 of 289 
 
stress, partial slip at the cell-surface contact mechanics increases viscous dissipation. 
Moreover, both parameters are expected to depend linearly on based on Cattaneo–Mindlin 
model, providing a linear relationship between frictional forces and normal stress, from which 
the friction coefficient can be derived [358]. This nonlinear behavior stems from the fact that 
partial slip is absent at lower amplitudes. This effect is very prominent for ΔΓ in Figure 2, 
where a transition occurs at amplitudes above 10nm. The continuous increase in the sliding 
portion of the contact zone with stress, ultimately leads to desorption (rupture) [340], [359], 
[360]. However, such rupture event was not observed at long scan durations (30s), as 
described in the supplementary information (Appendix A7). From this perspective, it is 
possible to explain the decrease in both ΔΓ and Δf, given that a decrease in surface contact 
results in a decrease in the portion of acoustic energy dissipated into the highly viscous cell 
lipid bilayer. 
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Figure 72 Shift of frequency (Δf) and bandwidth (ΔΓ) and ratio of the two as a function of amplitude. Cells on day 
2 adsorbed on anti-CD36 surface.  
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Finally, the suitability of QCR technology as underpinning technology of online bioprocessing 
monitoring tools heavily depends on the capability to derive 𝐴𝑐  purely from acoustic 
parameters. A rather obvious strategy is the simultaneous analysis of a control marker, of 
which expression throughout the process remains high and constant. Such strategy was 
attempted in this study based on results published elsewhere [346]. The inadequacy of 
CD44 as a control marker in the culture system here presented, suggests that such choice 
has to be made based on prior knowledge of cell source and process dynamics. 
Nonetheless, variations in 𝐴𝑐 arising from mechanophenotypic changes could be isolated by 
the control sensor from the test acoustic response. Most importantly, ΔΓ/Δf is independent of 
the cell concentration in the sample which is also expected to vary at different process 
stages.   
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6.5. Conclusion 
The focus of this section was to investigate cell-surface contact mechanics mediated by 
specific antibody-antigen interactions. The initial research hypothesis was that, similarly to 
what was described thus far for coupled resonance models, the relative expression of any 
given cell membrane ligand (CD36) would modulate the stiffness of the cell-surface contact, 
which could in turn be probed by the acoustic response of a quartz crystal resonator. 
The linear acoustic response (ΔΓ and Δf), modified by adsorption of cord-derived CD34+ 
erythroprogenitor cells, was compared to QCR surface imaging and flow cytometry data, 
yielding a strong linear correlation between acoustic energy dissipation (ΔΓ) and the relative 
expression of CD36 on the cell membrane. Changes in viscoelastic properties arising from 
enucleation where accounted for by simply taking the ratio of cell areas measured by 
forward-scattered light and by imaging the QCR surface. Unfortunately, due to the low 
quality of the nonlinear acoustic signal presented in this study, it was not possible to make 
assumptions as to whether this parameter related to either viscosity or surface marker 
expression. 
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7. Chapter VII 
Conclusions and future work. 
 
7.1. PAT implementation in bioprocess quality monitoring 
A clear value proposition for online product quality monitoring in manufacturing of cell-based 
therapies was provided, while familiarising the reader with some general aspects of design 
and implementation of process analytical technology. While the diversity of clinical 
indications and modes of action challenges the conception of universal PAT solutions, it is 
important to recognize technological overlaps, where agile multi-purpose sensor technology 
(e.g. portable infrared spectroscopy), can be adapted to different products, raw material and 
manufacturing strategies. Affordable product quality monitoring and control would unlock a 
level of manufacturing safety and flexibility that is fundamentally linked to the chances of 
successful CBT commercialisation. The justification for PAT implementation is fundamentally 
linked to the inherent level of control attainable within a given process. This reason is the 
primary drive behind the low adoption of PAT in the pharmaceutical industry, where (ideally) 
process automation and control over raw materials lowers the chance of batch rejection and 
creates economies of scale that lower the impact of such events. The CBT industry is a 
newly evolving industry with a requirement for a technological paradigm shift that the existing 
pharmaceutical industry is yet to encounter. 
Analytical methods relying reporter-based signal transduction like FACS and ELISA, often 
require expensive and laborious sample preparation procedures, which are unsuitable to 
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meet the throughput and speed requirements of a manufacturing context. Advancements in 
design and fabrication of in nano- and micro-electromechanical systems, have enabled 
automation and miniaturization of complete bench workflows. Furthermore, surrogate 
mechanical parameters that are directly linked to product quality attributes or constitute 
proxies of metabolic markers, could replace reporter-based methods. This idea is best 
exemplified by measuring RBC deformability as CQA for artificial blood products. Future 
work should focus on reviewing mechanical cell parameters and linking them with CQA of 
existing CBT products where applicable. A second part would then discuss the technologic 
advancements made towards achieving rapid and high throughput analysis of bespoke 
parameters. 
Finally, it is important to recognise that the requirements for online quality characterization of 
cellular therapies overlap to a significant extent, those of infectious diseases diagnosis. The 
requirement for portable point-of-care devices to operate in low-resource environments 
requires similar technological advancements than the ones here discussed. 
 
  
  
    
Page 209 of 289 
 
7.2. Study of particle-surface interactions via nonlinear acoustic 
transduction 
To the best of the author’s knowledge, this work represents the first experimental attempt to 
interpret colloid-substrate contact mechanics of a coupled resonance system via nonlinear 
acoustic transduction. In the case here described, the resonator oscillates close its 
fundamental resonance mode and the third Fourier harmonic current (at three times the 
drive frequency 3f) is recorded. The elastic loading due to binding of microparticles to the 
quartz crystal resonator causes a nonlinear distortion of the pure sinusoidal oscillation, 
modifying the nonlinearity coefficient (β) of the resonator. Therefore, the value of β reflects 
the level of multivalent interactions that govern the stiffness of the bond between adhering 
particles and the resonator’s surface. The effect of increasing tangential contact stress on 
the particle-sensor systems was also investigated by modulating the amplitude of horizontal 
surface displacement, revealing a nonlinear behaviour of I3f characteristic of the specific 
affinity of the biomolecular complex underlying the particle-QCR contact. This observation 
was also made for amplitude increase as result of energy trapping. This observation could 
be further exploited to improve the estimation of thermodynamic parameter estimation of 
ligand-receptor interactions. This effect should be fully confirmed and characterized by 
studying the nonlinear response under pull force exerted by an AFM cantilever, contacting 
the QCR via a linker. Alternatively the force exerted on the resonator by any given point 
mass system could be tuned under different gravitational forces as demonstrated by 
Webster and colleagues (2014). Only I3f peak amplitude was analysed in this work due to 
late development of the analytical model describing amplitude of I3f close to resonance. 
Given that its frequency and dissipation values can also be extracted through interpolation of 
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the admittance spectrum at 3ω, it would be interesting to see how these parameters are 
affected at a variety of contact mechanic properties.   
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7.3. Acoustically-driven molecular dissociation 
Non-specific binding and fouling of sensor interfaces can negatively influence their analytical 
performance, thus limiting the conditions under which the sensor can operate at. Such 
challenges can be solved in practice through extensive assay development and chemically 
assisted molecular dissociation, although requiring skilled operators and additional reagents. 
This thesis also investigated how the generated mechanic and thermal energy of a vibrating 
TSM quartz crystal resonator could be applied for controlled dissociation of sensor-particle 
molecular interactions. Here bond rupture is accompanied by displacement of microparticles 
to the electrode periphery driven by acoustic flow streaming. In turn, as particles are radially 
displaced to less sensitive areas, the acoustic is modified as a result of that. Contrasting to 
previous studies on this topic, the effect of bond dissociation is measured at low potential 
scans. Aptamer-IgE multivalent interactions underlying particle-surface contact were in this 
way subjected to a range of disruptive forces, modulated through incremental increases in 
the oscillation amplitude after an adsorption phase. In general, this work concludes that the 
energy required to displace microparticles correlates with the level of multivalent interactions 
modulating the stiffness of the particle-surface contact, which is intuitively dependent on both 
the ligand and receptor density. This method could be applied in both sandwich assays or 
direct cell detection assays to regenerate the sensor interface while providing measurements 
of acoustic dissociation kinetics. Finally, the advantages of both microparticle association 
and dissociation here presented should be explored within the context of sandwich assays. 
The paramagnetic nature of the particles could be capitalized to capture free analytes in a 
sample (e.g. metabolites), followed by a QCR adsorption stage of the analyte-particle 
complex. The modulation of the nonlinear coefficient or the mechanically-assisted 
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dissociation constant would in this case depend on the concentration of the specific analyte 
in the sample.  
7.4. Estimation of surface-antigen expression 
Factors modulating cell-surface attachment and spreading have been extensively 
characterized with quartz crystal microbalances, through monitoring of acoustic energy 
dissipated via focal adhesions. However, characterization of cell-surface immunoadsorption 
with focus on quantification of surface marker density has rarely been investigated. In fact, 
the available studies rely on flow-assisted two-dimensional kinetic models to distinguish 
between membrane ligand densities, thus requiring a priori knowledge cell concentration in 
the sample. This work represents the first attempt to monitor simultaneous variations in cell 
size and marker expression via acoustic transduction independently of the reaction rate. 
The results concluded that ΔΓ/Δf (D-f ratio) is in good agreement with cell surface coverage 
after immunoadsoprtion, despite a poor correlation between the latter and the expression of 
CD36 on the cell membrane. Changes in cellular viscoelasticity driven by enucleation 
resulted in different levels of cell deformability, which altered the contact area between the 
cells and the resonator. A deformability factor was estimated by simply dividing the values of 
forward-scattered (FSC) light by the cell area, measured by imaging the QCR surface. When 
normalized by the deformability factor, ΔΓ was shown to be strongly correlated with CD36 
expression. In an on-/in-line quality monitoring context, all these parameters could be 
derived acoustically without light imaging, by using a control maker that could separate the 
effect of mechanophenotypic change from that of surface marker expression. Finally, this 
work has also exemplified how changes in surface marker expression after cryostorage 
could alter the surface coverage. Future efforts should focus on integrating the system in a 
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reactor sampling loop to assess the sensor’s performance under cell culture conditions. 
Additionally, the feasibility of acoustic cell dissociation should be assessed through the use 
of energy-trapped crystals oscillating at prolonged durations that may be able to overcome 
the viscous effects of the cell membrane. This is particularly valuable in the case where 
fouling of culture medium constituents and cell debris causes baseline drift.  
With respect to the detection sensitivity in these experiments, the author would recommend 
resorting to energy trapping to improve I3f signal-to-noise ratio, however, it is important to 
bear in mind that this will also lead to an increase in oscillation amplitude. All acoustic 
experiments described in this thesis were carried out under no thermal or electromagnetic 
isolation conditions. Noise reduction can be achieved by encasing the DUT in a Faraday 
cage as demonstrated in the case of cyclic voltammetry measurements of SH-D17.4ext 
monolayer. Further increase in sensitivity can be reached by engineering receptors that can 
achieve optimum surface densities and orientations, thereby maximizing the number of 
available binding sites.  
In order to increase the throughput and multiplexing capabilities of the presented method lie 
one can use multiple DUT’s in parallel or develop multichannel monolithic QCR array. The 
latter would be the best option since every quartz crystal is slightly different. This could also 
include the use of controls and reference state QCR that can measure the effects of noise, 
non-specific interactions due to sample matrix effects, as well as changes in either cell 
mechanics or surface marker expression.  
Developing fit-for-purpose synthetic receptors (e.g. aptamers and imprinted polymers) could 
also help reduce signal drifting and false positives arising from non-specific interactions. 
Such strategies are of even greater importance in online monitoring applications, as the 
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matrix effects of unprocessed samples would be amplified by the source when compared to 
the controlled conditions under which the experiments were carried out. Finally, the work 
presented on acoustic dissociation could be further developed to promote the formation of 
specific interactions during an assay. A constant mode scan for the time length of the assay 
at relatively low potential (2.5V) would not only be enough to excite I3f but could facilitate 
signal baselining as a form of “acoustic cleaning”.  
 
7.5. Conclusion 
The primary objective of this thesis was to investigate the feasibility of using acoustic 
transduction to study particle-surface interactions and thereby enabling characterization of 
non-invasive quality attributes, such as viscoelasticity or surface marker expression. The 
purpose was to demonstrate the feasibility of using a fully electronic system based on quartz 
crystal resonator technology that could be used as on-line sensor for in-process quality 
characterization of cellular material. The choice of sensing technology was made on the 
premise that label-free, relatively inexpensive and real-time analytic methods would better 
suit the operational requirements of the cell-based therapy manufacturing.  
QCR has been widely used in biosensing and, more importantly, in the study of cell-surface 
interactions where cytoskeletal rearrangements underpinning pathological phenotypes were 
monitored through measurements of energy dissipation and fundamental resonance 
frequency. Advancements in QCR technology such as wireless control and integration with 
MEMS presents a strong value proposition for implementation as PAT tool in CBT 
manufacturing.  
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In the end, cell-surface contact mechanics could not be evaluated via monitoring of the 
nonlinear QCR response but it has contributed to the study of coupled resonance systems, 
with direct applications in clinical diagnostics. Furthermore, even though changes in cell 
viscoelasticity could not be decoupled from changes in surface-marker density via 
monitoring of energy dissipation and frequency changes, the author suggests that use of 
housekeeping surface markers as mechanic controls could offer a solution to this problem. 
In the future, arrays of QCR sensors operating based on the principles here discussed, could 
provide real-time and inexpensive quantification of a panel of surface markers.  
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Appendix 
A1. Experimental setup 
  
a 
 
a 
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b 
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RF cable 
 
RF cable 
RF cable 
 
RF cable 
Syringe pump 
 
Syringe pump 
Microscope live feed 
 
Microscope live feed 
Sample tube 
 
Sample tube 
Figure A1. Experimental setup with 
zoomed-in view of device under test 
(DUT)(c). 
 
Figure A2. Experimental setup with 
zoomed-in view of device under test 
(DUT)(c). 
Inlet port 
 
Inlet port 
Outlet port 
 
Outlet port 
Chamber with 
QCR view 
 
Chamber with 
QCR view 
PCB 
 
PCB 
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A2. 𝑰𝟑𝒇 transition as function of particle number 
 
 
Figure A3. Nonlinear response of progressive SCMP binding showing a transition between negative and positive 
𝐼3𝑓 shifts.  
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A3. Surface density  
 
 
  
a 
 
a 
b 
 
b 
Figure A4. Quantification of mSCMP surface density (a) estimated from microhraphs of the QCR 
surface (b). 
 
Figure A4. Quantification of mSCMP surface density (a) estimated from microhraphs of the QCR 
surface (b). 
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A4. Mfold-predicted secondary structure of D17.4 aptamer 
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Figure A5. Secondary structure of D17.4ext generated with Mfold algprithm. 
This structure that presented by [362]  under the same folding temperature 
and ionic strength conditions.  
 
Figure A5. Secondary structure of D17.4ext generated with Mfold algprithm. 
This structure that presented by [362]  under the same folding temperature 
and ionic strength conditions.  
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A5. X-ray photoelectron spectroscopy 
Table 6. High resolution XPS spectra of carbon, carboxylic groups and sulphur. Scale is normalized according to 
element (column). 
COOH:
OCH3 
C1s (O=C-O) O1s S2p 
0% 
   
1% 
   
5% 
   
10% 
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-1000
4000
9000
14000
19000
24000
29000
537 534 532 -500
0
500
1000
1500
2000
2500
168 166 163 161
50% 
   
100%  
  
 
  
-100
400
900
1400
1900
293 291 288 286 283
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A6. Solution to colloid sedimentation 
During these experiments it was noticed a rapid cell sedimentation on the bottom of the 
sample reservoir resulting in a heterogeneous cell concentration in the sample. In the 
context of the experimental method described in this work, sampling of cells (and other 
micron-sized colloids) could benefit from a different fluidic system. A simple solution is 
presented in the figure below where the lower aperture of the pipette tip compared to an 
Eppendorf tube guarantees that cells do not sediment in areas inaccessible to the inlet tube. 
 
Figure A6. Photographs of experimental setup with vertical standing sample reservoir located above the DUT.  
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A7. Acoustic dissociation of CD34+ erythroprogenitor cells  
The acoustic dissociation process described in Section 5 was applied on cells adsorbed to the surface a uniform QCR via antibody-antigen 
interactions. Surface micrographs (Figure A7) were taken after exciting the resonator at increasing electrical potentials for 30s. No significant 
microparticle displacement was observed regardless of the oscillation amplitude. 
 
 
Figure A7. QCR surface micrographs showing erythroprogenitor cells immunoadsorbed on the QCR surface.  
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A8. Cell size and density analysis with ImageJ 
This method was adapted from [361]. Automatic particle analyses with “Analyze Particles” 
requires a binary image (Image>Type>8-bit) before colour threshold is applied. Adjusting the 
thresholds was found to be easier after flattening (Image>Overlay>Flatten) and subtracting 
background (Process>Subtract Background) due to reflective nature of the gold electrode. 
Automatic colour threshold is then applied to the image (Image>Adjust>Color Threshold) 
followed by delineation of close objects with watershed (Process>Binary>Watershed). 
Before cell count (Analyze>Analyze Particles), an area in the field of view deprived of 
scratches is selected. The settings for particle size and circularity are set to 30-infinity and 
0.1-1 respectively.  
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